AIA Group Ltd lowered its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 1.7% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 375,724 shares of the company’s stock after selling 6,570 shares during the period. Merck & Co., Inc. makes up about 0.7% of AIA Group Ltd’s investment portfolio, making the stock its 22nd largest holding. AIA Group Ltd’s holdings in Merck & Co., Inc. were worth $45,196,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Legacy Wealth Advisors LLC acquired a new position in shares of Merck & Co., Inc. during the 1st quarter worth $294,000. Spartan Wealth Advisory Services LLC bought a new position in shares of Merck & Co., Inc. during the 1st quarter valued at $308,000. Ascent Wealth Partners LLC lifted its stake in shares of Merck & Co., Inc. by 2.4% in the 1st quarter. Ascent Wealth Partners LLC now owns 16,833 shares of the company’s stock valued at $2,025,000 after purchasing an additional 394 shares during the last quarter. Paces Ferry Wealth Advisors LLC lifted its stake in shares of Merck & Co., Inc. by 3.0% in the 1st quarter. Paces Ferry Wealth Advisors LLC now owns 3,979 shares of the company’s stock valued at $479,000 after purchasing an additional 115 shares during the last quarter. Finally, Jennison Associates LLC boosted its holdings in Merck & Co., Inc. by 12.4% in the first quarter. Jennison Associates LLC now owns 6,249,337 shares of the company’s stock worth $751,733,000 after purchasing an additional 689,849 shares in the last quarter. Institutional investors and hedge funds own 76.07% of the company’s stock.
Merck & Co., Inc. News Summary Here are the key news stories impacting Merck & Co., Inc. this week:
Positive Sentiment: The FDA approval of LIPFENDRA gives Merck its first oral PCSK9 inhibitor, opening a new revenue stream in cardiovascular care and strengthening its non-oncology portfolio. Reuters article on FDA approval Positive Sentiment: Analysts highlighted continued oncology pipeline progress, including FDA acceptance of multiple regulatory filings and Merck’s broader effort to offset the eventual 2028 Keytruda patent cliff. Seeking Alpha article on pipeline expansion Neutral Sentiment: Coverage also noted that Lipfendra’s launch is expected soon and that the drug could become a major product over time, though sales will depend on uptake, pricing, and competition from existing cholesterol therapies. Zacks article on Lipfendra launch Neutral Sentiment: There was also a rumor that Merck may be in a takeover battle for genomics company Personalis, but this appears speculative and is not confirmed. Yahoo Finance article on Personalis rumor Merck & Co., Inc. Stock Down 0.1% NYSE MRK opened at $127.47 on Friday. Merck & Co., Inc. has a 1-year low of $76.66 and a 1-year high of $131.74. The company has a market capitalization of $314.83 billion, a price-to-earnings ratio of 35.91, a PEG ratio of 4.39 and a beta of 0.19. The stock’s 50 day moving average is $120.11 and its two-hundred day moving average is $116.94. The company has a current ratio of 1.30, a quick ratio of 1.06 and a debt-to-equity ratio of 1.02.
Merck & Co., Inc. (NYSE:MRK – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported ($1.28) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.19. The business had revenue of $16.29 billion during the quarter, compared to analysts’ expectations of $15.85 billion. Merck & Co., Inc. had a net margin of 13.59% and a return on equity of 27.55%. The firm’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter last year, the company posted $2.22 EPS. Merck & Co., Inc. has set its FY 2026 guidance at 5.040-5.160 EPS. Equities analysts forecast that Merck & Co., Inc. will post 2.76 earnings per share for the current fiscal year.
Merck & Co., Inc. Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 8th. Shareholders of record on Monday, June 15th were given a $0.85 dividend. This represents a $3.40 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Monday, June 15th. Merck & Co., Inc.’s dividend payout ratio (DPR) is presently 95.77%.
Analyst Upgrades and Downgrades Several brokerages have commented on MRK. Morgan Stanley increased their price target on Merck & Co., Inc. from $112.00 to $113.00 and gave the company an “equal weight” rating in a report on Thursday, July 9th. BMO Capital Markets boosted their price objective on shares of Merck & Co., Inc. from $135.00 to $142.00 and gave the stock an “outperform” rating in a research note on Monday, July 13th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $120.00 price objective on shares of Merck & Co., Inc. in a report on Monday, July 6th. Scotiabank raised their target price on shares of Merck & Co., Inc. from $136.00 to $155.00 and gave the company a “sector outperform” rating in a research note on Tuesday, June 30th. Finally, CICC Research began coverage on shares of Merck & Co., Inc. in a report on Wednesday, June 24th. They issued an “outperform” rating and a $138.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $133.94.
View Our Latest Stock Report on Merck & Co., Inc.
Merck & Co., Inc. Profile (Free Report)
Merck & Co, Inc is a global biopharmaceutical company engaged in the discovery, development, manufacture and marketing of prescription medicines, vaccines, biologic therapies and animal health products. Its portfolio spans multiple therapeutic areas with a particular emphasis on oncology, vaccines and infectious disease, as well as therapies for metabolic and chronic conditions. Among its well-known products are the cancer immunotherapy Keytruda (pembrolizumab) and the human papillomavirus vaccine Gardasil; the company also markets a range of medicines and vaccines for veterinary use through Merck Animal Health.
Founded in the late 19th century as the U.S.
See Also Five stocks we like better than Merck & Co., Inc. Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Merck & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEFranklin Dynamic Municipal Bond ETF $FLMI Shares Bought by Geneos Wealth Management Inc.
NEXT HEADLINE »Procter & Gamble Company (The) $PG Shares Bought by AIA Group Ltd
Allspring Global Investments Holdings LLC increased its holdings in shares of Chevron Corporation (NYSE:CVX – Free Report) by 35.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 302,380 shares of the oil and gas company’s stock after purchasing an additional 78,989 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Chevron were worth $59,693,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in the business. Midwest Capital Advisors LLC bought a new stake in Chevron in the 1st quarter valued at $25,000. Phillip James Consulting Co. bought a new position in Chevron during the fourth quarter worth $26,000. Core Wealth Advisors LLC acquired a new position in shares of Chevron in the fourth quarter valued at $26,000. Karpus Management Inc. acquired a new position in shares of Chevron in the fourth quarter valued at $27,000. Finally, Basso Capital Management L.P. bought a new position in shares of Chevron in the fourth quarter valued at about $27,000. Institutional investors own 72.42% of the company’s stock.
Chevron News Summary Here are the key news stories impacting Chevron this week:
Positive Sentiment: Chevron is expected to sign accords with Iraq to advance investments in major oil fields, including West Qurna 2 and Nassiriya, which could expand long-term production opportunities. Reuters article on Iraq oilfield MOUs Positive Sentiment: Reports that Chevron is exploring a pipeline alternative to the Strait of Hormuz suggest a potential way to boost Iraqi export capacity and lower shipping disruption risk, which investors may view as strategically important. The Motley Fool article on Hormuz bypass pipeline Positive Sentiment: Chevron is being highlighted as a relatively attractive long-term energy stock versus TotalEnergies because of its premium assets, strong balance sheet, and steadier earnings outlook. Yahoo Finance article comparing CVX and TTE Neutral Sentiment: Some commentary says Chevron stock looks closer to fairly valued after a strong five-year run, which may limit upside for investors expecting a clear bargain. Yahoo Finance article on valuation Neutral Sentiment: Chevron also benefited from broader energy-sector gains, with the sector rising even as the wider market was mixed. Yahoo Finance sector update Analyst Ratings Changes CVX has been the topic of several research analyst reports. Jefferies Financial Group reissued a “buy” rating and issued a $216.00 price target on shares of Chevron in a report on Friday, July 10th. Morgan Stanley decreased their target price on Chevron from $214.00 to $210.00 and set an “overweight” rating on the stock in a research report on Monday, June 29th. Mizuho lifted their price target on Chevron from $225.00 to $230.00 and gave the stock an “outperform” rating in a report on Wednesday, May 27th. Royal Bank Of Canada restated an “outperform” rating and issued a $220.00 price target on shares of Chevron in a research note on Tuesday, May 5th. Finally, Citigroup upped their price objective on Chevron from $210.00 to $235.00 and gave the company a “buy” rating in a report on Thursday, April 2nd. Nineteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $206.83.
Check Out Our Latest Stock Analysis on Chevron
Chevron Price Performance Chevron stock opened at $187.39 on Friday. The firm has a market cap of $373.21 billion, a PE ratio of 32.48, a price-to-earnings-growth ratio of 0.66 and a beta of 0.50. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 0.84. The stock’s fifty day moving average price is $181.54 and its two-hundred day moving average price is $182.44. Chevron Corporation has a one year low of $146.49 and a one year high of $214.71.
Chevron (NYSE:CVX – Get Free Report) last issued its quarterly earnings results on Friday, May 1st. The oil and gas company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.41. The company had revenue of $47.56 billion for the quarter, compared to analysts’ expectations of $51.86 billion. Chevron had a return on equity of 6.90% and a net margin of 5.79%.Chevron’s revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the business earned $2.18 earnings per share. As a group, research analysts expect that Chevron Corporation will post 14.78 EPS for the current fiscal year.
Chevron Announces Dividend The company also recently announced a quarterly dividend, which was paid on Wednesday, June 10th. Stockholders of record on Tuesday, May 19th were given a $1.78 dividend. The ex-dividend date was Tuesday, May 19th. This represents a $7.12 annualized dividend and a dividend yield of 3.8%. Chevron’s payout ratio is presently 123.40%.
Insider Buying and Selling at Chevron In related news, Director John B. Hess sold 380,000 shares of the stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $193.20, for a total transaction of $73,416,000.00. Following the sale, the director owned 278,045 shares in the company, valued at approximately $53,718,294. This trade represents a 57.75% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.56% of the company’s stock.
About Chevron (Free Report)
Chevron Corporation (NYSE: CVX) is an American multinational energy company engaged in virtually all aspects of the oil and gas industry. As an integrated energy firm, Chevron’s core activities include upstream oil and natural gas exploration and production, midstream transportation and storage, downstream refining and marketing of fuels and lubricants, and petrochemical manufacturing through joint ventures and subsidiaries. The company markets fuels under brands such as Chevron, Texaco and Caltex and supplies a range of products and services to retail customers, industrial users and commercial fleets worldwide.
Chevron traces its corporate lineage to the early petroleum companies that eventually became Standard Oil of California and has evolved through significant mergers and restructurings, including the acquisitions of Gulf Oil and Texaco.
Read More Five stocks we like better than Chevron Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding CVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chevron Corporation (NYSE:CVX – Free Report).
Receive News & Ratings for Chevron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chevron and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEGeneos Wealth Management Inc. Has $1.49 Million Holdings in Dimensional International Value ETF $DFIV
NEXT HEADLINE »Bessemer Group Inc. Has $26.39 Million Stock Holdings in MSA Safety Incorporporated $MSA
AIA Group Ltd lowered its position in Newmont Corporation (NYSE:NEM – Free Report) by 30.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 113,497 shares of the basic materials company’s stock after selling 50,446 shares during the quarter. AIA Group Ltd’s holdings in Newmont were worth $12,286,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Apella Capital LLC boosted its position in shares of Newmont by 4.1% during the 4th quarter. Apella Capital LLC now owns 2,198 shares of the basic materials company’s stock valued at $219,000 after acquiring an additional 86 shares in the last quarter. New Wave Wealth Advisors LLC lifted its stake in Newmont by 1.3% during the fourth quarter. New Wave Wealth Advisors LLC now owns 6,849 shares of the basic materials company’s stock worth $684,000 after purchasing an additional 88 shares during the period. Novem Group lifted its stake in Newmont by 3.7% during the fourth quarter. Novem Group now owns 2,487 shares of the basic materials company’s stock worth $248,000 after purchasing an additional 88 shares during the period. Norden Group LLC boosted its holdings in Newmont by 0.7% during the fourth quarter. Norden Group LLC now owns 12,367 shares of the basic materials company’s stock valued at $1,235,000 after purchasing an additional 90 shares in the last quarter. Finally, Parkside Financial Bank & Trust grew its stake in shares of Newmont by 1.4% in the 4th quarter. Parkside Financial Bank & Trust now owns 7,153 shares of the basic materials company’s stock valued at $714,000 after purchasing an additional 96 shares during the period. Institutional investors and hedge funds own 68.85% of the company’s stock.
Insider Buying and Selling In related news, EVP Peter Wexler sold 13,378 shares of the company’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $110.11, for a total value of $1,473,051.58. Following the completion of the sale, the executive vice president owned 67,865 shares in the company, valued at $7,472,615.15. This represents a 16.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider David John Thornton sold 2,296 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $110.11, for a total value of $252,812.56. Following the completion of the transaction, the insider owned 23,163 shares of the company’s stock, valued at $2,550,477.93. This represents a 9.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 28,556 shares of company stock valued at $3,058,146 over the last 90 days. 0.06% of the stock is owned by corporate insiders.
Key Newmont News Here are the key news stories impacting Newmont this week:
Positive Sentiment: Scotiabank raised its FY2026 EPS estimate for Newmont to $8.80 from $8.73 and kept a Sector Outperform rating with a $147 price target, signaling continued confidence in earnings power and valuation upside. Positive Sentiment: Analysts at other firms continue to view Newmont favorably, with coverage highlighting improving operational efficiency, stronger free cash flow, and ongoing share buybacks as potential supports for the stock. Positive Sentiment: Newmont resumed operations at its Cadia mine after a seismic event, with no injuries or material damage reported, helping ease concerns about operational disruption while the company advances growth projects such as Ahafo North and Tanami Expansion 2. Positive Sentiment: Some research notes argue Newmont remains undervalued relative to net asset value and could benefit from permit-driven growth catalysts, including the Red Chris Block Cave project. Neutral Sentiment: Newmont is expected to report quarterly earnings next week, and recent commentary suggests the company may have revenue growth ahead, though it may not have the strongest setup for a clear earnings beat. Negative Sentiment: Newmont was downgraded by Zacks Research from strong-buy to hold, adding a cautious note ahead of earnings. Negative Sentiment: The stock also fell more sharply than the broader market in the latest session, reflecting investor concern about softer gold prices, higher costs, and near-term earnings uncertainty. Analysts Set New Price Targets NEM has been the subject of a number of recent research reports. Bank of America dropped their target price on Newmont from $157.00 to $132.00 and set a “buy” rating for the company in a report on Thursday, July 9th. TD raised Newmont from a “hold” rating to a “buy” rating and decreased their price target for the company from $129.00 to $127.00 in a research note on Tuesday, July 14th. TD Cowen reiterated a “buy” rating on shares of Newmont in a research report on Monday, April 27th. Wall Street Zen lowered Newmont from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, National Bank Financial cut their price objective on Newmont from $140.00 to $125.00 and set a “sector perform” rating for the company in a report on Tuesday, July 14th. Two investment analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $136.26.
View Our Latest Report on NEM
Newmont Trading Down 1.1% NEM stock opened at $89.80 on Friday. The company has a quick ratio of 2.17, a current ratio of 2.44 and a debt-to-equity ratio of 0.15. Newmont Corporation has a twelve month low of $57.86 and a twelve month high of $134.88. The company has a market cap of $95.86 billion, a P/E ratio of 11.65, a PEG ratio of 1.02 and a beta of 0.46. The business has a fifty day moving average of $102.32 and a 200-day moving average of $110.20.
Newmont (NYSE:NEM – Get Free Report) last posted its quarterly earnings results on Thursday, April 23rd. The basic materials company reported $2.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.07 by $0.83. The business had revenue of $7.31 billion for the quarter, compared to analysts’ expectations of $6.83 billion. Newmont had a return on equity of 27.84% and a net margin of 33.87%.The firm’s quarterly revenue was up 45.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.25 earnings per share. As a group, equities research analysts expect that Newmont Corporation will post 9.25 EPS for the current year.
Newmont Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Monday, June 22nd. Shareholders of record on Wednesday, May 27th were issued a dividend of $0.26 per share. The ex-dividend date was Wednesday, May 27th. This represents a $1.04 dividend on an annualized basis and a yield of 1.2%. Newmont’s dividend payout ratio (DPR) is 13.49%.
Newmont Profile (Free Report)
Newmont Corporation (NYSE: NEM) is a leading global gold mining company engaged in the exploration, development, processing and reclamation of gold properties. The company’s core business centers on the production of gold, with additional byproduct metals produced from its operations. Newmont operates a portfolio of long‑lived mines and development projects, and its activities span the full mine life cycle from early-stage exploration through to mining, milling and closure.
Founded in 1921 and headquartered in Greenwood Village, Colorado, Newmont has grown through organic development and strategic acquisitions.
Featured Stories Five stocks we like better than Newmont Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Newmont Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newmont and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECadence Design Systems, Inc. $CDNS Stock Holdings Lifted by AIA Group Ltd
NEXT HEADLINE »AIA Group Ltd Has $8.97 Million Stake in Marriott International, Inc. $MAR
AIA Group Ltd purchased a new stake in shares of Parker-Hannifin Corporation (NYSE:PH – Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 10,564 shares of the industrial products company’s stock, valued at approximately $9,457,000.
Several other institutional investors and hedge funds have also bought and sold shares of the business. JFS Wealth Advisors LLC increased its position in Parker-Hannifin by 6.8% during the 4th quarter. JFS Wealth Advisors LLC now owns 173 shares of the industrial products company’s stock valued at $152,000 after purchasing an additional 11 shares during the period. Avion Wealth lifted its position in shares of Parker-Hannifin by 35.5% in the 4th quarter. Avion Wealth now owns 42 shares of the industrial products company’s stock worth $36,000 after purchasing an additional 11 shares during the period. Optas LLC lifted its position in shares of Parker-Hannifin by 3.1% in the 1st quarter. Optas LLC now owns 370 shares of the industrial products company’s stock worth $331,000 after purchasing an additional 11 shares during the period. Moneta Group Investment Advisors LLC boosted its stake in shares of Parker-Hannifin by 1.8% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 614 shares of the industrial products company’s stock valued at $540,000 after purchasing an additional 11 shares in the last quarter. Finally, Inspire Advisors LLC boosted its stake in shares of Parker-Hannifin by 1.2% during the 4th quarter. Inspire Advisors LLC now owns 917 shares of the industrial products company’s stock valued at $807,000 after purchasing an additional 11 shares in the last quarter. Hedge funds and other institutional investors own 82.44% of the company’s stock.
Parker-Hannifin Trading Down 0.5% Parker-Hannifin stock opened at $953.13 on Friday. Parker-Hannifin Corporation has a one year low of $692.02 and a one year high of $1,034.96. The business’s fifty day moving average is $912.84 and its 200 day moving average is $933.05. The stock has a market capitalization of $120.18 billion, a PE ratio of 35.16, a price-to-earnings-growth ratio of 2.54 and a beta of 1.11. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.13 and a quick ratio of 0.66.
Parker-Hannifin (NYSE:PH – Get Free Report) last issued its earnings results on Thursday, April 30th. The industrial products company reported $8.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.84 by $0.33. Parker-Hannifin had a net margin of 16.58% and a return on equity of 27.97%. The company had revenue of $5.49 billion for the quarter, compared to analysts’ expectations of $5.40 billion. During the same quarter last year, the company posted $6.94 earnings per share. The firm’s quarterly revenue was up 10.6% on a year-over-year basis. Parker-Hannifin has set its FY 2026 guidance at 31.200-31.200 EPS. On average, sell-side analysts predict that Parker-Hannifin Corporation will post 31.26 EPS for the current year.
Parker-Hannifin Increases Dividend The business also recently disclosed a quarterly dividend, which was paid on Friday, June 5th. Stockholders of record on Friday, May 8th were paid a $2.00 dividend. This represents a $8.00 annualized dividend and a dividend yield of 0.8%. This is an increase from Parker-Hannifin’s previous quarterly dividend of $1.80. The ex-dividend date of this dividend was Friday, May 8th. Parker-Hannifin’s dividend payout ratio is 29.51%.
Analyst Ratings Changes PH has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “buy (b)” rating on shares of Parker-Hannifin in a report on Tuesday, April 21st. Evercore set a $1,064.00 price target on Parker-Hannifin in a research report on Monday, May 11th. BMO Capital Markets assumed coverage on Parker-Hannifin in a research note on Friday, March 27th. They issued an “outperform” rating and a $1,090.00 price target on the stock. Mizuho set a $1,050.00 price objective on Parker-Hannifin in a report on Friday, May 1st. Finally, Sanford C. Bernstein reissued an “outperform” rating and set a $1,037.00 price objective on shares of Parker-Hannifin in a research report on Thursday. Eighteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $1,027.38.
View Our Latest Stock Report on PH
Parker-Hannifin Profile (Free Report)
Parker-Hannifin Corporation (NYSE: PH) is a global manufacturer and provider of motion and control technologies and systems. The company designs, manufactures and services a broad range of engineered components and systems used to control the movement and flow of liquids, gases and hydraulic power. Its product portfolio is applied across demanding environments and includes solutions for industrial manufacturing, aerospace, mobile equipment and other engineered applications.
Parker-Hannifin’s product and service offerings span hydraulic and pneumatic components, fittings and fluid connectors, valves, pumps and motors, electromechanical actuators and motion-control systems, filtration and separation products, and seals and sealing systems.
Recommended Stories Five stocks we like better than Parker-Hannifin Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding PH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Parker-Hannifin Corporation (NYSE:PH – Free Report).
Receive News & Ratings for Parker-Hannifin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parker-Hannifin and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAIA Group Ltd Purchases Shares of 36,720 Applied Materials, Inc. $AMAT
NEXT HEADLINE »Bessemer Group Inc. Sells 191,166 Shares of JBT Marel Corporation $JBTM
Chicago Partners Investment Group LLC acquired a new position in shares of Nordson Corporation (NASDAQ:NDSN – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 2,086 shares of the industrial products company’s stock, valued at approximately $583,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Private Trust Co. NA increased its holdings in Nordson by 70.8% during the 4th quarter. Private Trust Co. NA now owns 123 shares of the industrial products company’s stock worth $30,000 after purchasing an additional 51 shares during the period. CYBER HORNET ETFs LLC purchased a new position in shares of Nordson in the 2nd quarter valued at about $31,000. MUFG Securities EMEA plc purchased a new stake in shares of Nordson during the second quarter worth approximately $34,000. Hantz Financial Services Inc. raised its holdings in Nordson by 43.4% in the fourth quarter. Hantz Financial Services Inc. now owns 152 shares of the industrial products company’s stock valued at $37,000 after acquiring an additional 46 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC acquired a new position in Nordson during the 4th quarter worth approximately $40,000. 72.11% of the stock is currently owned by hedge funds and other institutional investors.
Nordson Trading Down 1.5% Shares of Nordson stock opened at $288.98 on Friday. The company has a 50-day moving average of $288.17 and a two-hundred day moving average of $279.45. The stock has a market cap of $16.10 billion, a PE ratio of 30.81, a price-to-earnings-growth ratio of 1.92 and a beta of 0.96. The company has a current ratio of 2.60, a quick ratio of 1.65 and a debt-to-equity ratio of 0.58. Nordson Corporation has a 12-month low of $207.08 and a 12-month high of $307.74.
Nordson (NASDAQ:NDSN – Get Free Report) last released its quarterly earnings results on Wednesday, May 20th. The industrial products company reported $2.86 earnings per share for the quarter, topping analysts’ consensus estimates of $2.82 by $0.04. The business had revenue of $740.85 million for the quarter, compared to analysts’ expectations of $728.78 million. Nordson had a return on equity of 20.08% and a net margin of 18.19%.The company’s revenue was up 8.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.42 EPS. Nordson has set its Q3 2026 guidance at 2.950-3.150 EPS and its FY 2026 guidance at 11.300-11.800 EPS. On average, research analysts anticipate that Nordson Corporation will post 11.59 EPS for the current fiscal year.
Nordson Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Monday, July 6th. Shareholders of record on Thursday, June 18th were issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 1.1%. The ex-dividend date was Thursday, June 18th. Nordson’s dividend payout ratio (DPR) is 34.97%.
Wall Street Analysts Forecast Growth NDSN has been the subject of several recent analyst reports. Oppenheimer lifted their price objective on shares of Nordson from $325.00 to $335.00 and gave the stock an “outperform” rating in a research report on Friday, May 29th. Wall Street Zen downgraded shares of Nordson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. BNP Paribas Exane boosted their price target on shares of Nordson from $285.00 to $290.00 and gave the company a “neutral” rating in a research report on Friday, May 22nd. Weiss Ratings raised Nordson from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, June 29th. Finally, DA Davidson lifted their price target on Nordson from $335.00 to $345.00 and gave the stock a “buy” rating in a research report on Wednesday, May 27th. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $311.29.
Get Our Latest Stock Analysis on Nordson
Nordson Profile (Free Report)
Nordson Corporation designs, manufactures and markets precision dispensing equipment and systems that apply adhesives, coatings, sealants and polymers in a broad range of industrial and medical applications. The company’s portfolio spans fluid systems, curing and surface preparation technologies, vacuum and thermal management products, and advanced test and inspection solutions. Nordson’s offerings serve critical manufacturing processes by delivering exacting dispensing accuracy and process control to ensure consistent product performance and high production throughput.
Nordson operates through multiple segments that cater to diverse markets including electronics, packaging, medical, energy, automotive and general industrial sectors.
See Also Five stocks we like better than Nordson Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Nordson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nordson and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEChicago Partners Investment Group LLC Invests $505,000 in AptarGroup, Inc. $ATR
NEXT HEADLINE »Fifth Third Bancorp Increases Stock Position in Powell Industries, Inc. $POWL
I haven't bought too many AI stocks in my portfolio yet, except for a few data center REITs and one major chipmaker. But recently, I pulled the trigger and added shares of Oracle (ORCL +1.77%) to my portfolio after shares declined by more than 60% from their 52-week high.
The short version is that the market has legitimate concerns about Oracle's massive backlog and the debt it is taking on to fulfill its contracted orders. But if the company's strategy works out, the stock could be an incredible bargain at the current share price. Here's a rundown of why Oracle's stock has been beaten down, why I bought, and why I may add even more to my position.
Image source: Getty Images.
Oracle: The good and the bad The biggest bull case for Oracle is also the same reason many investors are skeptical. The company has a $638 billion remaining performance obligation (RPO), which represents the contracted future revenue its customers have committed to. This is 363% higher than it was a year ago, and as you can probably guess, the surge in AI infrastructure spending is the main reason.
For its 2027 fiscal year, which started June 1, Oracle is guiding for $90 billion in revenue. For reference, in its 2026 fiscal year, the company generated about $67 billion. And keep in mind that the $638 billion figure represents only contracts that have already been signed -- as customer needs grow, this figure could increase.
However, many investors are justifiably skeptical about the massive backlog. And it's fair to say that if we knew Oracle would actually get all $638 billion of that contracted revenue, the stock wouldn't be as beaten down as it is.
For one thing, about half of the backlog comes from a single customer -- AI platform giant OpenAI. That company recently delayed its IPO, which added to major concerns about its ability to meet its obligations. In addition, Oracle is not only spending all of its income to set itself up to fulfill its backlog but is also taking on debt. The company added $43 billion in debt to its balance sheet in the 2026 fiscal year, and expects to raise an additional $40 billion between debt and equity in the current fiscal year.
In short, Oracle's spending plan is frightening investors, and it's not hard to see why. The company is spending billions of real dollars (much of which it doesn't have) in pursuit of promised revenue.
A substantial discount for a wonderful business After the recent decline, Oracle trades for less than 16 times forward earnings. The stock has a 1.6% dividend yield and has produced a net margin of nearly 27% over the past four quarters. This is a highly profitable business that is sacrificing short-term cash flow to take full advantage of the tailwinds from the AI infrastructure build-out.
Of course, there are some legitimate risks. It's entirely possible that OpenAI won't be able to raise the capital needed to cover all of the spending it has committed to (Oracle isn't the only one with a large, multi-year agreement with the AI giant). We could see a general downturn in AI capex instead of the multi-year spending surge investors are expecting.
I don't view those as particularly likely scenarios. OpenAI hasn't had much of an issue raising money at lofty valuations whenever it has tried to. And all recent signs point toward more infrastructure capex than originally expected in 2027 and beyond, not less.
The key question is whether a significant portion of the backlog will convert into actual revenue before Oracle's spending plan becomes unmanageable. If the answer is yes, Oracle at 16 times forward earnings could be a steal.
The bottom line is that Oracle has been a wonderful business for decades, and for most of its 35-year publicly traded history, it has been a mistake to bet against it. With the stock trading at its lowest price since 2023, before the AI investment boom even kicked into high gear, I decided to open a position in my portfolio. And if it stays this cheap, I plan on adding more shares very soon.
AIA Group Ltd raised its stake in shares of American Tower Corporation (NYSE:AMT – Free Report) by 8.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 68,285 shares of the real estate investment trust’s stock after buying an additional 5,074 shares during the quarter. AIA Group Ltd’s holdings in American Tower were worth $11,785,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of AMT. Riverwater Partners LLC increased its holdings in shares of American Tower by 3.8% in the fourth quarter. Riverwater Partners LLC now owns 1,536 shares of the real estate investment trust’s stock worth $270,000 after purchasing an additional 56 shares during the period. Triumph Capital Management grew its position in American Tower by 37.3% during the fourth quarter. Triumph Capital Management now owns 206 shares of the real estate investment trust’s stock worth $36,000 after buying an additional 56 shares in the last quarter. Personal CFO Solutions LLC increased its stake in American Tower by 3.5% in the 4th quarter. Personal CFO Solutions LLC now owns 1,667 shares of the real estate investment trust’s stock worth $293,000 after acquiring an additional 57 shares during the last quarter. Twin City Private Wealth LLC increased its stake in American Tower by 0.7% in the 4th quarter. Twin City Private Wealth LLC now owns 7,799 shares of the real estate investment trust’s stock worth $1,382,000 after acquiring an additional 58 shares during the last quarter. Finally, Asset Advisory Group Inc. raised its holdings in shares of American Tower by 3.0% in the 1st quarter. Asset Advisory Group Inc. now owns 2,072 shares of the real estate investment trust’s stock valued at $358,000 after acquiring an additional 60 shares in the last quarter. 92.69% of the stock is owned by institutional investors.
Analysts Set New Price Targets A number of brokerages recently weighed in on AMT. Scotiabank raised their target price on shares of American Tower from $214.00 to $218.00 and gave the company an “outperform” rating in a research note on Wednesday, April 29th. Sanford C. Bernstein raised shares of American Tower from a “market perform” rating to an “outperform” rating and set a $207.00 price target on the stock in a report on Tuesday, May 19th. Wolfe Research upgraded shares of American Tower from a “peer perform” rating to an “outperform” rating and set a $188.00 price objective on the stock in a research report on Wednesday, July 8th. Truist Financial lifted their price objective on shares of American Tower from $205.00 to $208.00 and gave the stock a “buy” rating in a report on Thursday, April 30th. Finally, Raymond James Financial reiterated a “strong-buy” rating and issued a $240.00 target price on shares of American Tower in a research report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, American Tower presently has an average rating of “Moderate Buy” and a consensus target price of $215.57.
View Our Latest Stock Analysis on AMT
Insider Buying and Selling In other news, EVP Ruth T. Dowling sold 416 shares of the firm’s stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $177.54, for a total transaction of $73,856.64. Following the sale, the executive vice president owned 29,461 shares of the company’s stock, valued at $5,230,505.94. This trade represents a 1.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.08% of the company’s stock.
American Tower Trading Up 0.7% NYSE AMT opened at $170.13 on Friday. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 3.07. American Tower Corporation has a twelve month low of $160.06 and a twelve month high of $234.33. The firm has a market capitalization of $79.26 billion, a PE ratio of 27.48, a P/E/G ratio of 0.71 and a beta of 0.91. The stock’s 50 day moving average is $177.64 and its 200 day moving average is $178.70.
American Tower (NYSE:AMT – Get Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $2.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $1.24. American Tower had a net margin of 26.81% and a return on equity of 27.79%. The business had revenue of $2.74 billion for the quarter, compared to analysts’ expectations of $2.66 billion. During the same quarter in the prior year, the company earned $2.75 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. American Tower has set its FY 2026 guidance at 10.900-11.07 EPS. Research analysts forecast that American Tower Corporation will post 10.66 earnings per share for the current fiscal year.
American Tower Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 13th. Investors of record on Friday, June 12th were given a dividend of $1.79 per share. The ex-dividend date of this dividend was Friday, June 12th. This represents a $7.16 annualized dividend and a dividend yield of 4.2%. American Tower’s dividend payout ratio (DPR) is 115.67%.
American Tower Profile (Free Report)
American Tower (NYSE: AMT) is a real estate investment trust (REIT) that owns, operates and develops wireless and broadcast communications infrastructure. The company’s core business is leasing space on communications sites — including towers, rooftops and other structures — to wireless carriers, broadcasters, government agencies and enterprise customers. Its business model centers on long-term site leases and contracts that provide recurring revenue tied to the footprint and density of wireless networks.
Beyond traditional tower assets, American Tower offers a range of infrastructure and network services to support mobile, broadband and broadcast connectivity.
Featured Stories Five stocks we like better than American Tower Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding AMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Tower Corporation (NYSE:AMT – Free Report).
Receive News & Ratings for American Tower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Tower and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECopart, Inc. $CPRT Shares Purchased by Allspring Global Investments Holdings LLC
NEXT HEADLINE »Franklin Dynamic Municipal Bond ETF $FLMI Shares Bought by Geneos Wealth Management Inc.
Bank of New York Mellon Corp decreased its holdings in Block, Inc. (NYSE:XYZ – Free Report) by 8.3% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,787,890 shares of the technology company’s stock after selling 252,761 shares during the period. Bank of New York Mellon Corp owned about 0.47% of Block worth $167,775,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently bought and sold shares of the stock. Capital World Investors raised its position in shares of Block by 41.8% in the 4th quarter. Capital World Investors now owns 16,023,441 shares of the technology company’s stock worth $1,042,966,000 after acquiring an additional 4,727,217 shares in the last quarter. Geode Capital Management LLC boosted its position in Block by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 14,406,899 shares of the technology company’s stock valued at $934,121,000 after purchasing an additional 67,560 shares in the last quarter. Ameriprise Financial Inc. purchased a new position in Block in the second quarter valued at about $535,305,000. Norges Bank purchased a new position in Block in the fourth quarter valued at about $484,387,000. Finally, Tiger Global Management LLC grew its stake in Block by 43.9% in the fourth quarter. Tiger Global Management LLC now owns 6,364,840 shares of the technology company’s stock valued at $414,287,000 after purchasing an additional 1,941,528 shares during the last quarter. Hedge funds and other institutional investors own 70.44% of the company’s stock.
Block Price Performance Shares of NYSE XYZ opened at $80.00 on Friday. Block, Inc. has a fifty-two week low of $48.21 and a fifty-two week high of $84.08. The company has a market cap of $47.62 billion, a PE ratio of 62.50, a P/E/G ratio of 1.01 and a beta of 2.54. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.99 and a current ratio of 1.99. The business has a 50-day simple moving average of $73.76 and a two-hundred day simple moving average of $66.62.
Block (NYSE:XYZ – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The technology company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.55. The firm had revenue of $6.06 billion for the quarter. Block had a net margin of 3.30% and a return on equity of 7.02%. The business’s revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.56 EPS. Block has set its Q2 2026 guidance at 0.860-0.860 EPS and its FY 2026 guidance at 3.850-3.850 EPS. As a group, equities analysts expect that Block, Inc. will post 2.48 EPS for the current fiscal year.
Analyst Ratings Changes XYZ has been the subject of several analyst reports. Citigroup increased their price target on shares of Block from $100.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday. Oppenheimer downgraded shares of Block from an “outperform” rating to a “market perform” rating in a research report on Tuesday, June 30th. Canaccord Genuity Group boosted their price objective on shares of Block from $80.00 to $85.00 and gave the stock a “buy” rating in a research note on Monday, May 18th. Truist Financial increased their target price on shares of Block from $81.00 to $82.00 and gave the company a “buy” rating in a research report on Wednesday, May 27th. Finally, Royal Bank Of Canada raised their target price on shares of Block from $90.00 to $93.00 and gave the company an “outperform” rating in a research note on Friday, May 8th. Six research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $88.64.
View Our Latest Stock Report on Block
Insider Buying and Selling at Block In other Block news, insider Brian Grassadonia sold 43,348 shares of the firm’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $80.00, for a total value of $3,467,840.00. Following the completion of the transaction, the insider owned 557,654 shares of the company’s stock, valued at approximately $44,612,320. This trade represents a 7.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Anthony Mathew Eisen sold 135,750 shares of Block stock in a transaction on Monday, June 1st. The stock was sold at an average price of $76.81, for a total transaction of $10,426,957.50. Following the sale, the director owned 2,032,990 shares of the company’s stock, valued at $156,153,961.90. The trade was a 6.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 357,219 shares of company stock worth $27,286,681. 11.37% of the stock is owned by corporate insiders.
About Block (Free Report)
Block (NYSE:XYZ) is a financial technology company that builds products and services to facilitate electronic payments, commerce, and consumer finance. Its principal business lines include a seller-focused ecosystem that provides point-of-sale hardware and software, payment processing, invoicing, payroll and lending services, and a consumer-facing platform that offers peer-to-peer payments, banking-like features, and investing. Block’s portfolio also encompasses music streaming and buy-now-pay-later capabilities through businesses acquired to broaden its reach beyond core payments.
The company was founded as Square in 2009 by Jack Dorsey and Jim McKelvey and later rebranded to Block to reflect a diversified set of businesses across payments, consumer finance, and emerging technologies.
Featured Articles Five stocks we like better than Block Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding XYZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Block, Inc. (NYSE:XYZ – Free Report).
Receive News & Ratings for Block Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Block and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECornerstone Advisory LLC Has $3.49 Million Stake in ExxonMobil Corporation $XOM
NEXT HEADLINE »D.A. Davidson & CO. Purchases 22,665 Shares of Amplify Cybersecurity ETF $HACK
Copeland Capital Management LLC cut its stake in Costco Wholesale Corporation (NASDAQ:COST – Free Report) by 6.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,871 shares of the retailer’s stock after selling 710 shares during the quarter. Copeland Capital Management LLC’s holdings in Costco Wholesale were worth $10,832,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of the stock. Gunpowder Capital Management LLC dba Oliver Wealth Management purchased a new stake in Costco Wholesale during the fourth quarter worth $27,000. Lifetime Wealth Management P.C. purchased a new position in Costco Wholesale in the fourth quarter valued at $28,000. Mcguire Capital Advisors Inc. purchased a new position in Costco Wholesale in the fourth quarter valued at $28,000. Entrust Financial LLC acquired a new position in shares of Costco Wholesale in the fourth quarter worth about $31,000. Finally, Joseph Group Capital Management purchased a new stake in shares of Costco Wholesale during the 4th quarter worth about $33,000. 68.48% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In Several equities analysts recently weighed in on COST shares. Oppenheimer lifted their price target on Costco Wholesale from $1,100.00 to $1,160.00 and gave the company an “outperform” rating in a research note on Tuesday, May 19th. DA Davidson reiterated a “neutral” rating and set a $1,000.00 price target on shares of Costco Wholesale in a research report on Thursday, June 4th. Truist Financial raised their price objective on Costco Wholesale from $977.00 to $1,011.00 and gave the company a “hold” rating in a report on Friday, May 29th. Mizuho set a $1,100.00 price objective on Costco Wholesale in a research report on Monday, June 1st. Finally, JPMorgan Chase & Co. reduced their target price on Costco Wholesale from $1,110.00 to $1,100.00 and set an “overweight” rating for the company in a research note on Thursday, July 9th. Twenty-two investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Costco Wholesale presently has an average rating of “Moderate Buy” and an average price target of $1,059.07.
Read Our Latest Analysis on Costco Wholesale
Costco Wholesale Stock Down 0.5% Shares of NASDAQ COST opened at $940.87 on Friday. Costco Wholesale Corporation has a 12-month low of $844.06 and a 12-month high of $1,096.50. The stock has a market cap of $417.26 billion, a PE ratio of 47.33, a P/E/G ratio of 4.56 and a beta of 0.88. The company has a current ratio of 1.07, a quick ratio of 0.61 and a debt-to-equity ratio of 0.17. The company has a 50-day moving average of $975.73 and a 200 day moving average of $977.54.
Costco Wholesale (NASDAQ:COST – Get Free Report) last released its earnings results on Thursday, May 28th. The retailer reported $4.93 earnings per share for the quarter, missing analysts’ consensus estimates of $4.94 by ($0.01). The business had revenue of $70.53 billion during the quarter, compared to analysts’ expectations of $70.12 billion. Costco Wholesale had a return on equity of 28.04% and a net margin of 3.01%.During the same period last year, the business earned $4.28 earnings per share. As a group, sell-side analysts predict that Costco Wholesale Corporation will post 20.39 EPS for the current fiscal year.
Costco Wholesale Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 24th will be issued a $1.47 dividend. This represents a $5.88 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, July 24th. Costco Wholesale’s dividend payout ratio is presently 29.58%.
Insider Activity In other Costco Wholesale news, Director Kenneth D. Denman sold 885 shares of the business’s stock in a transaction dated Tuesday, June 23rd. The shares were sold at an average price of $957.45, for a total value of $847,343.25. Following the transaction, the director directly owned 4,779 shares in the company, valued at $4,575,653.55. The trade was a 15.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.10% of the company’s stock.
More Costco Wholesale News Here are the key news stories impacting Costco Wholesale this week:
Positive Sentiment: Erste Group Bank raised its FY2026 EPS estimate for Costco to $20.52 from $20.49, slightly above the Street consensus of $20.38, suggesting analysts still see modest earnings upside. Earnings forecast boost article Positive Sentiment: Costco remains a favorite dividend name, with its next ex-dividend date set for July 24, which may attract income-focused investors ahead of the payout. Dividend article Neutral Sentiment: A profile of a longtime Costco cashier who became a millionaire highlights the company’s employee retention and compensation culture, but it is unlikely to materially affect near-term fundamentals. Employee profile article Neutral Sentiment: Several local news items about new warehouses, gas stations, and remodels point to ongoing store expansion and reinvestment, but they are not major stock-moving catalysts by themselves. Negative Sentiment: MarketBeat said Costco’s June sales showed cooling comparable sales and weak international results, keeping the stock in “neutral” territory despite its premium valuation. Cooling comp sales article Negative Sentiment: Additional commentary from Zacks and Yahoo Finance argued Costco shares still look expensive after a strong multi-year run, reinforcing valuation concerns that can weigh on the stock. Valuation debate article Costco Wholesale Company Profile (Free Report)
Costco Wholesale Corporation operates a global chain of membership-only warehouse clubs that sell a wide array of merchandise in bulk at discounted prices. The company’s product mix includes groceries, fresh and frozen food, household goods, electronics, apparel, and seasonal items, augmented by its prominent private-label brand, Kirkland Signature. Costco’s business model centers on annual membership fees and high-volume, low-margin sales, designed to drive repeat purchasing and strong customer loyalty among both consumers and small-business buyers.
Beyond merchandise, Costco provides a range of ancillary services that complement its warehouses, including gasoline stations, pharmacy and optical services, hearing aid centers, photo services, and travel and insurance products.
See Also Five stocks we like better than Costco Wholesale Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Costco Wholesale Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Costco Wholesale and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEComfort Systems USA, Inc. $FIX Shares Sold by Copeland Capital Management LLC
NEXT HEADLINE »Copeland Capital Management LLC Sells 46,821 Shares of Salesforce Inc. $CRM
Green energy just hit an inflection point that few investors are pricing correctly. The U.S. Energy Information Administration’s Annual Energy Outlook 2026 projects total electricity generation grows between 25% and 50% through 2050, with natural gas, solar and wind together climbing from about 60% of the mix in 2025 to roughly 80% in most scenarios by 2050. After 15 years of nearly flat U.S. electricity consumption, demand has risen 2.1% per year on average over the last five years, and data centers are the accelerant.
Below are three US-listed renewable names worth examining this month, each backed by real earnings data and each carrying a specific risk to weigh.
First Solar (NASDAQ: FSLR) First Solar (NASDAQ:FSLR | FSLR Price Prediction) is the largest U.S. thin-film solar manufacturer and the cleanest pure-play on domestic solar capacity. The stock traded around $213.54 as of July 17, down 16.20% over the past month and 22.16% year-to-date, yet still up more than 23% over the past year. That pullback resets the entry point for a name still compounding earnings.
Q1 2026 was a margin story. First Solar delivered EPS of $3.22, beating consensus of $2.98 by 8.02%, on revenue of $1.044 billion, up 23.6% year over year. Adjusted EBITDA hit $519.81 million at a 50% margin, and net income climbed 65% to $346.62 million. Contracted backlog stood at 47.9 GW as of March 31, and management reaffirmed 2026 net sales guidance of $4.9 billion to $5.20 billion with adjusted EBITDA of $2.60 billion to $2.8 billion.
CEO Mark Widmar framed the quarter succinctly: “We delivered a strong start to 2026, with record first-quarter revenue, record sales in India, meaningful margin expansion, and Adjusted EBITDA above the top end of our first quarter preview range.” The bull case rests on three legs: a domestic manufacturing moat, independence from Chinese crystalline silicon supply chains and Section 45X tax credit monetization worth $2.10 billion to $2.19 billion in 2026.
Risk to watch: Underutilization costs of $115 million to $155 million in 2026 and the Section 45X phase-out between 2030 and 2033. Q2 earnings drop after the close on July 29, 2026.
GE Vernova (NYSE: GEV) GE Vernova (NYSE:GEV) is the purest listed proxy on AI-driven power demand. Shares traded around $1,061.58 on July 17, up 56.22% year-to-date and 86.19% over the past year.
Q1 2026 was extraordinary. Revenue rose 15.8% year over year to $9.30 billion, adjusted EBITDA nearly doubled to $900 million with margin expanding 390 basis points to 9.6% and orders reached $18.30 billion, up 71% organically. The Electrification segment booked $2.4 billion in data center equipment orders in Q1 alone, more than all of 2025, driving a book-to-bill ratio near 2.5x.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Brookfield Renewable Partners didn't make the cut. Grab the names FREE today.
CEO Scott Strazik said it plainly: “Demand is accelerating for our Power and Electrification solutions from a diverse set of customers, with our backlog growing by more than $13 billion quarter-over-quarter.” Management raised 2026 revenue guidance to $44.5 billion to $45.5 billion, adjusted EBITDA margin to 12% to 14%, and free cash flow to $6.5 billion to $7.5 billion. GEV also doubled its quarterly dividend to $0.50 per share and repurchased roughly 1.8 million shares for $1.3 billion at an average price of $720 in Q1.
Risk to watch: The Wind segment continues bleeding, with approximately $400 million in EBITDA losses expected in 2026 and revenue down 23% in Q1. Q2 results arrive before the open on July 22.
Brookfield Renewable Partners (NYSE: BEP) Brookfield Renewable Partners (NYSE:BEP) is the income-and-growth entry. Units traded around $31.76 on July 17, up 13.69% year to date and 18.27% over the past year. Note the structure: BEP is a Canadian-domiciled Bermuda limited partnership listed on the NYSE, and American investors should factor in potential Canadian withholding-tax treatment on distributions.
The Q1 2026 headline was ugly. Revenue of $1.514 billion missed consensus by 10.79%, and GAAP net income swung to a $295 million loss, weighed down by a $193 million mark-to-market hit on long-term energy derivatives. Look past that. Funds from operations rose 19% year over year to $375 million, or 55 cents per unit. The quarterly distribution stepped up to $0.392 per unit, an annualized $1.568, with management targeting 5% to 9% annual distribution growth.
The pipeline supports it. Brookfield operates a 200+ GW global development pipeline, is 92% contracted for the remainder of 2026, and inked a Google Hydro Framework Agreement for up to 3,000 MW alongside an announced Boralex acquisition adding roughly 4,000 MW operating plus 8,000 MW pipeline.
Risk to watch: Corporate borrowings climbed to $4.8 billion from $3.7 billion and the consolidated debt-to-capitalization ratio sits at 45%. Hydrology and FX add variability quarter to quarter.
The Bigger Picture FSLR offers the highest-margin domestic solar exposure at a discounted entry. GEV is the momentum name riding the AI power supercycle with raised guidance. BEP pairs a growing distribution with a hyperscaler-linked growth pipeline. Different risk profiles, one thesis: electricity demand growth is structural, and the capital cycle behind it has only started.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Brookfield Renewable Partners didn't make the cut. Grab the names FREE today.
Allspring Global Investments Holdings LLC decreased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 357,901 shares of the biopharmaceutical company’s stock after selling 5,662 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Gilead Sciences were worth $50,214,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of GILD. Norges Bank purchased a new position in Gilead Sciences during the 4th quarter worth $2,617,152,000. Boston Partners purchased a new stake in Gilead Sciences during the 4th quarter valued at approximately $517,808,000. Massachusetts Financial Services Co. MA raised its stake in shares of Gilead Sciences by 3,763.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,223,304 shares of the biopharmaceutical company’s stock worth $518,368,000 after purchasing an additional 4,113,999 shares during the last quarter. Bank of America Corp DE lifted its holdings in shares of Gilead Sciences by 15.2% during the fourth quarter. Bank of America Corp DE now owns 23,121,620 shares of the biopharmaceutical company’s stock worth $2,837,948,000 after purchasing an additional 3,046,688 shares during the period. Finally, Vanguard Group Inc. grew its position in Gilead Sciences by 1.8% in the 4th quarter. Vanguard Group Inc. now owns 121,097,336 shares of the biopharmaceutical company’s stock valued at $14,863,487,000 after buying an additional 2,113,692 shares during the last quarter. Institutional investors and hedge funds own 83.67% of the company’s stock.
Insider Buying and Selling at Gilead Sciences In other news, CFO Andrew D. Dickinson sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $125.40, for a total transaction of $376,200.00. Following the completion of the transaction, the chief financial officer directly owned 171,646 shares of the company’s stock, valued at $21,524,408.40. This trade represents a 1.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Patrick O’day sold 15,000 shares of Gilead Sciences stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $126.29, for a total value of $1,894,350.00. Following the transaction, the chief executive officer owned 607,133 shares of the company’s stock, valued at $76,674,826.57. This represents a 2.41% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 77,000 shares of company stock valued at $9,978,740 over the last quarter. Corporate insiders own 0.30% of the company’s stock.
Analyst Upgrades and Downgrades A number of brokerages have recently issued reports on GILD. Cantor Fitzgerald reiterated an “overweight” rating and set a $155.00 price target on shares of Gilead Sciences in a research note on Monday, July 6th. Truist Financial lowered their price objective on Gilead Sciences from $157.00 to $156.00 and set a “buy” rating on the stock in a report on Tuesday, July 7th. Leerink Partners dropped their target price on Gilead Sciences from $148.00 to $146.00 in a research report on Friday, May 8th. Maxim Group raised Gilead Sciences from a “hold” rating to a “buy” rating and set a $165.00 target price for the company in a research note on Wednesday, May 20th. Finally, Royal Bank Of Canada reduced their price target on Gilead Sciences from $122.00 to $120.00 and set a “sector perform” rating for the company in a report on Tuesday, July 7th. Twenty-six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $159.04.
View Our Latest Research Report on GILD
Gilead Sciences Price Performance GILD stock opened at $134.28 on Friday. The firm has a 50 day moving average of $129.73 and a 200-day moving average of $135.22. The company has a market cap of $166.72 billion, a price-to-earnings ratio of 18.29 and a beta of 0.32. The company has a current ratio of 1.97, a quick ratio of 1.77 and a debt-to-equity ratio of 0.89. Gilead Sciences, Inc. has a 12-month low of $107.75 and a 12-month high of $157.29.
Gilead Sciences (NASDAQ:GILD – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The biopharmaceutical company reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.91 by $0.12. The business had revenue of $6.96 billion for the quarter, compared to analysts’ expectations of $6.91 billion. Gilead Sciences had a return on equity of 48.19% and a net margin of 30.99%.The company’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.81 EPS. Gilead Sciences has set its FY 2026 guidance at -1.050–0.650 EPS. As a group, equities analysts expect that Gilead Sciences, Inc. will post -0.77 EPS for the current fiscal year.
Gilead Sciences Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Monday, June 29th. Shareholders of record on Monday, June 15th were given a dividend of $0.82 per share. The ex-dividend date was Monday, June 15th. This represents a $3.28 dividend on an annualized basis and a yield of 2.4%. Gilead Sciences’s payout ratio is presently 44.69%.
Gilead Sciences Company Profile (Free Report)
Gilead Sciences, Inc, founded in 1987 and headquartered in Foster City, California, is a biopharmaceutical company focused on the discovery, development and commercialization of medicines in areas of high unmet medical need. The company initially built its reputation in antiviral therapies and has since expanded into oncology, cell therapy and inflammatory diseases. Gilead operates a global research and commercial organization, conducting clinical development and selling medicines in markets around the world.
Gilead’s product portfolio is anchored by antiviral therapies for HIV and viral hepatitis.
Featured Articles Five stocks we like better than Gilead Sciences Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding GILD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Gilead Sciences, Inc. (NASDAQ:GILD – Free Report).
Receive News & Ratings for Gilead Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gilead Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp decreased its holdings in shares of CF Industries Holdings, Inc. (NYSE:CF – Free Report) by 15.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,731,908 shares of the basic materials company’s stock after selling 323,729 shares during the period. Bank of New York Mellon Corp owned 1.13% of CF Industries worth $224,871,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in CF. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of CF Industries by 3.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,500 shares of the basic materials company’s stock valued at $1,368,000 after acquiring an additional 518 shares in the last quarter. Jones Financial Companies Lllp increased its position in CF Industries by 161.1% in the 1st quarter. Jones Financial Companies Lllp now owns 11,870 shares of the basic materials company’s stock valued at $928,000 after buying an additional 7,324 shares in the last quarter. Woodline Partners LP increased its position in CF Industries by 40.7% in the 1st quarter. Woodline Partners LP now owns 14,703 shares of the basic materials company’s stock valued at $1,149,000 after buying an additional 4,252 shares in the last quarter. Focus Partners Wealth raised its stake in CF Industries by 21.8% during the 1st quarter. Focus Partners Wealth now owns 3,558 shares of the basic materials company’s stock worth $278,000 after buying an additional 638 shares during the period. Finally, Geneos Wealth Management Inc. boosted its holdings in CF Industries by 141.6% in the first quarter. Geneos Wealth Management Inc. now owns 790 shares of the basic materials company’s stock worth $62,000 after acquiring an additional 463 shares in the last quarter. Institutional investors and hedge funds own 93.06% of the company’s stock.
CF Industries Price Performance CF opened at $121.17 on Friday. CF Industries Holdings, Inc. has a 1 year low of $75.42 and a 1 year high of $141.96. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.54 and a quick ratio of 3.15. The company has a market capitalization of $18.62 billion, a price-to-earnings ratio of 10.89 and a beta of 0.40. The firm’s fifty day moving average price is $114.30 and its two-hundred day moving average price is $109.29.
CF Industries Increases Dividend The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 2.0%. This is a boost from CF Industries’s previous quarterly dividend of $0.50. The ex-dividend date is Friday, August 14th. CF Industries’s dividend payout ratio is presently 21.56%.
Analyst Upgrades and Downgrades CF has been the subject of a number of research reports. JPMorgan Chase & Co. raised their price objective on CF Industries from $94.00 to $115.00 and gave the company a “neutral” rating in a research note on Wednesday, June 3rd. BMO Capital Markets lowered their target price on CF Industries from $140.00 to $135.00 and set an “outperform” rating on the stock in a research report on Tuesday, June 30th. Freedom Capital upgraded CF Industries from a “hold” rating to a “strong-buy” rating in a report on Monday, May 18th. Canadian Imperial Bank of Commerce lifted their price target on shares of CF Industries from $118.00 to $128.00 and gave the company a “neutral” rating in a research report on Thursday, April 30th. Finally, Morgan Stanley decreased their price target on shares of CF Industries from $135.00 to $115.00 and set an “equal weight” rating for the company in a research note on Tuesday, July 7th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, CF Industries currently has an average rating of “Hold” and an average price target of $116.62.
Check Out Our Latest Stock Analysis on CF Industries
CF Industries Profile (Free Report)
CF Industries Holdings, Inc is a leading global manufacturer of hydrogen and nitrogen products for agricultural and industrial customers. The company specializes in the production of ammonia, granular urea, urea ammonium nitrate (UAN), nitric acid and ammonium nitrate, which serve as key inputs for fertilizer blends, industrial chemicals and other downstream applications.
Headquartered in Deerfield, Illinois, CF Industries operates production facilities and distribution terminals across North America and the United Kingdom.
Recommended Stories Five stocks we like better than CF Industries Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding CF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CF Industries Holdings, Inc. (NYSE:CF – Free Report).
Receive News & Ratings for CF Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CF Industries and related companies with MarketBeat.com's FREE daily email newsletter.
AIA Group Ltd raised its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 23.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 74,580 shares of the company’s stock after buying an additional 14,163 shares during the period. AIA Group Ltd’s holdings in AbbVie were worth $16,220,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new position in AbbVie in the fourth quarter worth $5,865,055,000. Wellington Management Group LLP lifted its position in AbbVie by 457.4% during the 3rd quarter. Wellington Management Group LLP now owns 10,536,901 shares of the company’s stock worth $2,439,714,000 after buying an additional 8,646,424 shares in the last quarter. Capital World Investors grew its holdings in AbbVie by 106.3% during the 4th quarter. Capital World Investors now owns 13,071,444 shares of the company’s stock worth $2,986,777,000 after acquiring an additional 6,736,161 shares during the last quarter. Cardano Risk Management B.V. increased its position in AbbVie by 914.6% in the 4th quarter. Cardano Risk Management B.V. now owns 5,444,930 shares of the company’s stock valued at $1,244,112,000 after acquiring an additional 4,908,260 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in AbbVie by 10.4% in the 4th quarter. Geode Capital Management LLC now owns 44,629,980 shares of the company’s stock valued at $10,179,099,000 after acquiring an additional 4,190,487 shares in the last quarter. Institutional investors own 70.23% of the company’s stock.
Wall Street Analysts Forecast Growth A number of brokerages have recently issued reports on ABBV. DZ Bank upgraded shares of AbbVie from a “hold” rating to a “strong-buy” rating in a research report on Thursday, April 30th. Evercore set a $235.00 price objective on shares of AbbVie in a research report on Friday, May 15th. Canaccord Genuity Group upped their price objective on AbbVie from $265.00 to $273.00 and gave the stock a “buy” rating in a report on Tuesday, June 23rd. HSBC reiterated a “buy” rating and issued a $300.00 price objective on shares of AbbVie in a research report on Monday, July 6th. Finally, Citigroup lifted their target price on AbbVie from $230.00 to $260.00 and gave the company a “neutral” rating in a research note on Wednesday. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, AbbVie has a consensus rating of “Moderate Buy” and a consensus target price of $267.67.
Check Out Our Latest Report on AbbVie
AbbVie Trading Up 0.1% Shares of NYSE ABBV opened at $254.53 on Friday. The company has a fifty day moving average price of $229.80 and a 200 day moving average price of $221.94. The firm has a market cap of $449.70 billion, a PE ratio of 125.38, a PEG ratio of 0.84 and a beta of 0.30. AbbVie Inc. has a 1-year low of $184.63 and a 1-year high of $261.64.
AbbVie (NYSE:ABBV – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $2.65 EPS for the quarter, topping the consensus estimate of $2.59 by $0.06. AbbVie had a net margin of 5.79% and a negative return on equity of 576.45%. The business had revenue of $15 billion during the quarter, compared to analysts’ expectations of $14.72 billion. During the same quarter in the prior year, the company posted $2.46 earnings per share. The firm’s revenue was up 12.4% on a year-over-year basis. Equities research analysts forecast that AbbVie Inc. will post 14.18 EPS for the current year.
AbbVie Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Wednesday, July 15th will be issued a dividend of $1.73 per share. The ex-dividend date of this dividend is Wednesday, July 15th. This represents a $6.92 dividend on an annualized basis and a dividend yield of 2.7%. AbbVie’s payout ratio is presently 340.89%.
Trending Headlines about AbbVie Here are the key news stories impacting AbbVie this week:
Positive Sentiment: AbbVie’s Allergan Aesthetics unit won European Commission approval for Boey® (trenibotulinumtoxinE), a new facial injectable for glabellar lines. The approval gives AbbVie a differentiated aesthetics product in all 30 EEA countries and could add another growth driver to offset Humira-related declines. Article Title Positive Sentiment: Investors are also focusing on AbbVie’s neuroscience franchise and other newer product catalysts, with analysts expecting solid Q2 growth and continued momentum from brands such as Vyalev, RINVOQ, and SKYRIZI ahead of earnings. Article Title Positive Sentiment: Brokerage sentiment remains constructive, with recent coverage showing a “Moderate Buy” consensus and multiple price-target increases in July, reinforcing confidence in AbbVie’s long-term pipeline and earnings outlook. Article Title Neutral Sentiment: Erste Group slightly lowered its FY2026 EPS estimate for AbbVie to $14.08 from $14.23, though the new estimate remains close to the consensus of $14.18 and is not a major deviation. Article Title About AbbVie (Free Report)
AbbVie is a global, research-driven biopharmaceutical company that was created as a spin-off from Abbott Laboratories in 2013 and is headquartered in North Chicago, Illinois. The company focuses on discovering, developing and commercializing therapies for complex and often chronic medical conditions. Its operations span research and development, manufacturing, regulatory affairs and commercialization, with an emphasis on bringing specialty medicines to market across multiple therapeutic areas.
AbbVie’s product portfolio and pipeline cover several major therapeutic categories, including immunology, oncology, neuroscience, virology and women’s health.
Featured Articles Five stocks we like better than AbbVie Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding ABBV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AbbVie Inc. (NYSE:ABBV – Free Report).
Receive News & Ratings for AbbVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAIA Group Ltd Sells 3,503 Shares of MercadoLibre, Inc. $MELI
NEXT HEADLINE »Geneos Wealth Management Inc. Makes New Investment in iShares MSCI USA Quality GARP ETF $GARP
Nvidia (NVDA 1.97%) is a $5.1 trillion company, roughly six times the size of AMD (AMD 0.66%). But in the $45 billion iShares Semiconductor ETF (SOXX 1.64%), the chipmaker no longer sits on top.
As of July 15, AMD was the fund's largest holding at 8.51% of assets, with Nvidia second at 8.35% and Micron Technology (MU +0.04%) close behind at 7.73%, according to the fund's own holdings data. Broadcom sits fourth at 7.32%, packing the top four into a spread of just over one percentage point. The gaps are thin enough that a single trading day could reorder them.
A year ago, that ordering would have been hard to imagine. Micron traded below $120 per share last July. As of this writing, the stock is up more than 600% over the past 12 months, and AMD has gained more than 200%. Nvidia, over the same stretch, has risen about 22%.
Of course, the fund isn't making a judgment about which company is best. Its math is mechanical. But that math is worth understanding, because it measures where the semiconductor rally's gains have actually landed over the past year.
Image source: Nvidia.
A cap that levels the giants The exchange-traded fund (ETF) tracks the NYSE Semiconductor Index, which holds the 30 largest U.S.-listed semiconductor companies and weights them by float-adjusted market capitalization -- with a catch. The five largest stocks are capped at 8% of the index when weights are reset, and every other holding at 4%. The index rebalances quarterly, most recently after the third Friday of June.
That cap is arguably the most important thing to understand about the fund. Left to pure market-cap math, Nvidia's $5.1 trillion valuation would run several times the 8% limit and dominate the entire fund. Instead, Nvidia gets pinned at the ceiling alongside anything else that outgrows it. Between resets, weights simply drift with share prices.
Today's Change
(
-1.64
%) $
-8.69
Current Price
$
521.81
So the top of this fund doesn't rank company size. It ranks share-price momentum since the last reset. AMD's stock has outrun Nvidia's since the June rebalance, and that is the entire reason it now sits on top. Come the index's September reconstitution, anything riding above the cap gets pinned right back at 8%, and the drift starts over.
What the reshuffle actually measures The reshuffle's real message is in the stock charts -- and in the results behind them.
Micron reported revenue of $41.5 billion for its fiscal third quarter of 2026 (the period ended May 28, 2026), up from $23.9 billion the prior quarter and $9.3 billion in the year-ago period. It was a record quarter, and net income reached $28.2 billion. Micron's high-bandwidth memory (the stacked chips that feed artificial intelligence (AI) accelerators) is at the center of that demand, and its newest generation is already shipping in high volume.
Today's Change
(
0.04
%) $
0.37
Current Price
$
853.57
"Micron's record fiscal Q3 financial results and even stronger outlook for Q4 reflect the strategic value of memory in the AI era," said CEO Sanjay Mehrotra in the company's fiscal third-quarter earnings release.
AMD's run has a similar shape. First-quarter revenue rose 38% year over year to $10.3 billion, with data center revenue up 57% to $5.8 billion as its Instinct graphics processing units (GPUs) ramp. Management guided for about $11.2 billion of revenue in the second quarter, which would be an acceleration.
Today's Change
(
-0.66
%) $
-3.32
Current Price
$
497.63
And Nvidia? Its business hasn't slowed at all. Revenue for its fiscal first quarter of 2027 (the period ended April 26, 2026) rose 85% year over year to a record $81.6 billion, with data center revenue up 92% to $75.2 billion. The slip in the fund is not a slip in the business.
What changed is everything around Nvidia. A year ago, it was the AI trade. Now the trade has widened -- to the memory makers feeding the data centers and to a second source of AI accelerators -- and the widening shows up as faster stock appreciation everywhere else in the fund.
Today's Change
(
-1.97
%) $
-4.09
Current Price
$
203.31
For Nvidia shareholders, however, I don't think the demotion is a sell signal. The company just posted 85% growth on record revenue of $81.6 billion. But the leaderboard is a useful reminder that the AI buildout now has more than one way to win, and more than one way to cool.
Sure, Nvidia lost its spot at the top of the fund. But I don't believe the investment case for the stock changed with it.
BlackBerry Limited (TSE:BB – Get Free Report) (NASDAQ:BBRY) insider Philip Simon Kurtz sold 30,000 shares of the firm’s stock in a transaction on Tuesday, July 14th. The stock was sold at an average price of C$15.92, for a total value of C$477,600.00. Following the sale, the insider directly owned 95,158 shares in the company, valued at C$1,514,915.36. The trade was a 23.97% decrease in their position.
Philip Simon Kurtz also recently made the following trade(s):
On Thursday, July 2nd, Philip Simon Kurtz sold 4,195 shares of BlackBerry stock. The stock was sold at an average price of C$16.39, for a total value of C$68,756.05. BlackBerry Trading Down 1.9% TSE BB opened at C$12.60 on Friday. The firm has a market cap of C$7.38 billion, a P/E ratio of 126.00, a P/E/G ratio of 0.06 and a beta of 1.16. The company has a debt-to-equity ratio of 29.45, a current ratio of 2.20 and a quick ratio of 1.49. The stock’s 50-day moving average is C$12.93 and its 200-day moving average is C$7.98. BlackBerry Limited has a one year low of C$4.35 and a one year high of C$18.45.
BlackBerry (TSE:BB – Get Free Report) (NASDAQ:BBRY) last released its quarterly earnings data on Thursday, June 25th. The company reported C$0.06 earnings per share for the quarter. BlackBerry had a return on equity of 8.10% and a net margin of 10.32%.The business had revenue of C$210.94 million for the quarter. Sell-side analysts anticipate that BlackBerry Limited will post 0.0551903 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In Separately, Stifel Nicolaus set a C$12.00 price target on shares of BlackBerry and gave the company a “buy” rating in a report on Wednesday, June 24th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of C$12.00.
Read Our Latest Research Report on BB
BlackBerry Company Profile (Get Free Report)
BlackBerry (NYSE:BB)(TSX:BB) provides enterprises and governments the intelligent software and services that power the world around us. Based in Waterloo, Ontario, the company’s high-performance foundational software enables major automakers and industrial giants alike to unlock transformative applications, drive new revenue streams and launch innovative business models, all without sacrificing safety, security, and reliability. With a deep heritage in Secure Communications, BlackBerry delivers operational resiliency with a comprehensive, highly secure, and extensively certified portfolio for mobile fortification, mission-critical communications, and critical events management.
Recommended Stories Five stocks we like better than BlackBerry Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for BlackBerry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackBerry and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEFifth Third Bancorp Acquires New Shares in SPDR Nuveen ICE Municipal Bond ETF $TFI
NEXT HEADLINE »Jean-Paul Henri Lachance Sells 32,500 Shares of Peyto Exploration & Development (TSE:PEY) Stock
New York, New York--(Newsfile Corp. - July 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A or Class C common stock of Zillow Group, Inc. (NASDAQ: ZG) (NASDAQ: Z) between February 11, 2025 and May 7, 2026, both dates inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
SO WHAT: If you purchased Zillow common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Zillow's agreement with Redfin Corporation was not a "partnership," but rather an acquisition of Redfin's business; (2) as a result of the Redfin Agreement, Zillow faced a materially heightened risk of regulatory scrutiny and liability under federal antitrust laws; (3) upon the filing of an antitrust lawsuit, Zillow continued to downplay its legal exposure; and (4) as a result, defendants' statements about Zillow's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305704
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
AIA Group Ltd trimmed its position in shares of MercadoLibre, Inc. (NASDAQ:MELI – Free Report) by 35.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,371 shares of the company’s stock after selling 3,503 shares during the quarter. AIA Group Ltd’s holdings in MercadoLibre were worth $11,016,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Brown Advisory Inc. increased its position in shares of MercadoLibre by 2,494.9% during the fourth quarter. Brown Advisory Inc. now owns 15,362 shares of the company’s stock valued at $30,943,000 after acquiring an additional 14,770 shares during the last quarter. Thompson Siegel & Walmsley LLC boosted its position in MercadoLibre by 238.3% in the fourth quarter. Thompson Siegel & Walmsley LLC now owns 2,030 shares of the company’s stock worth $4,089,000 after purchasing an additional 1,430 shares during the last quarter. TIAA Trust National Association boosted its position in MercadoLibre by 10.9% in the fourth quarter. TIAA Trust National Association now owns 11,011 shares of the company’s stock worth $22,179,000 after purchasing an additional 1,083 shares during the last quarter. Deepwater Asset Management LLC grew its stake in MercadoLibre by 38.6% in the 4th quarter. Deepwater Asset Management LLC now owns 7,765 shares of the company’s stock valued at $15,641,000 after purchasing an additional 2,164 shares during the period. Finally, Employees Retirement System of Texas grew its stake in MercadoLibre by 18.2% in the 4th quarter. Employees Retirement System of Texas now owns 40,184 shares of the company’s stock valued at $80,941,000 after purchasing an additional 6,200 shares during the period. 87.62% of the stock is currently owned by institutional investors.
Insider Activity In other news, Director Alejandro Nicolas Aguzin acquired 600 shares of the business’s stock in a transaction dated Friday, May 22nd. The stock was bought at an average cost of $1,655.93 per share, for a total transaction of $993,558.00. Following the completion of the transaction, the director owned 5,355 shares of the company’s stock, valued at $8,867,505.15. The trade was a 12.62% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.26% of the company’s stock.
MercadoLibre Trading Down 2.3% Shares of MELI stock opened at $1,813.91 on Friday. The company’s fifty day simple moving average is $1,681.90 and its two-hundred day simple moving average is $1,822.69. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.16 and a quick ratio of 1.14. MercadoLibre, Inc. has a 1 year low of $1,495.00 and a 1 year high of $2,548.50. The stock has a market capitalization of $91.97 billion, a price-to-earnings ratio of 47.87, a PEG ratio of 1.12 and a beta of 1.35.
MercadoLibre (NASDAQ:MELI – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $8.23 EPS for the quarter, missing the consensus estimate of $8.75 by ($0.52). The company had revenue of $8.85 billion during the quarter, compared to the consensus estimate of $8.29 billion. MercadoLibre had a return on equity of 29.58% and a net margin of 6.04%.The firm’s revenue for the quarter was up 49.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $9.74 EPS. As a group, analysts anticipate that MercadoLibre, Inc. will post 41 earnings per share for the current year.
Analyst Ratings Changes A number of equities research analysts have recently commented on MELI shares. Daiwa Securities Group cut MercadoLibre from a “buy” rating to a “hold” rating and set a $1,800.00 target price on the stock. in a research note on Friday, May 8th. JPMorgan Chase & Co. reduced their price target on shares of MercadoLibre from $2,100.00 to $1,900.00 and set a “neutral” rating for the company in a research report on Wednesday, May 13th. Zacks Research upgraded shares of MercadoLibre from a “strong sell” rating to a “hold” rating in a report on Monday, July 13th. Benchmark lowered their price objective on shares of MercadoLibre from $2,780.00 to $2,380.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Finally, Cantor Fitzgerald dropped their target price on shares of MercadoLibre from $2,400.00 to $2,350.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 21st. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $2,258.67.
View Our Latest Research Report on MercadoLibre
MercadoLibre Profile (Free Report)
MercadoLibre, Inc operates an integrated e-commerce and fintech ecosystem serving consumers and businesses across Latin America. The company provides an online marketplace that connects buyers and sellers for a wide range of goods and services, supported by tools for merchants, advertising, and classifieds. Over time MercadoLibre has expanded beyond its marketplace roots into complementary areas that support digital commerce end to end.
Key offerings include its marketplace platform and a suite of logistics and payment services.
See Also Five stocks we like better than MercadoLibre Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for MercadoLibre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MercadoLibre and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINETotalEnergies SE Sponsored ADR $TTE Stake Raised by Allspring Global Investments Holdings LLC
NEXT HEADLINE »AIA Group Ltd Has $16.22 Million Stock Position in AbbVie Inc. $ABBV
Two of the most important stocks in the semiconductor value chain today are Taiwan Semiconductor Manufacturing (TSM 2.96%) and ASML (ASML 2.06%). TSMC has a virtual monopoly on the manufacturing of advanced logic chips, such as graphics processing units (GPUs) and high-performance central processing units (CPUs), while ASML has a full-blown monopoly on the machines that make these chips possible.
I think both stocks look like solid long-term buys given their dominant positions within the semiconductor ecosystem, but if I could buy only one, it would be TSMC.
Let's dive into both semiconductor stocks to see why I prefer TSMC.
Image source: The Motley Fool.
TSMC: The AI chip manufacturing leader Nvidia has been the company leading the AI revolution with its GPUs, and its CEO, Jensen Huang, understands the importance that TSMC plays in the whole process. Last year, he called TSMC "one of the greatest companies in the history of humanity" while adding that "anybody who wants to buy TSMC stock is a very smart person."
Today's Change
(
-2.96
%) $
-12.12
Current Price
$
397.62
Manufacturing advanced logic chips is a difficult task, and TSMC is the only company that has proven it can do it at high yields (producing chips with few defects) at scale. Rivals Samsung and Intel have both experienced struggles with yields, and it is why Huang warned Elon Musk that pulling off his TerraFab project is going to be very difficult.
TSMC's technological lead has given it a virtual monopoly in the space, making it a close partner with chip designers with whom it works closely to increase capacity to meet future chip demand. Future demand is so high that TSMC has been ramping up its own capital expenditure (capex) to increase capacity, which will drive strong future growth. The company's position has also afforded it strong pricing power, which has nicely lifted its gross margins and helped drive profitability.
The beauty of an investment in TSMC is that it generally benefits no matter which chip technology takes share, as it is the primary manufacturer of most types of advanced logic chips. This includes Nvidia and AMD GPUs, AI ASICs (application-specific integrated circuits), and central processing units (CPUs).
Trading at a forward price-to-earnings (P/E) ratio of 19 times 2027 analyst estimates, the stock is undervalued given its growth prospects and position in the semiconductor ecosystem.
ASML: A vital monopoly ASML is arguably the most important company on the planet. It is the only company to have developed extreme ultraviolet lithography (EUV), and without its technology, it would not be possible to make advanced chips. That means not only would there be no AI boom but also no smartphones.
Today's Change
(
-2.06
%) $
-36.70
Current Price
$
1,748.17
The company's EUV machines are used to make both advanced logic chips and high-bandwidth memory (HBM), a specialized form of DRAM (dynamic random access memory) that is packaged with GPUs and other AI chips to help optimize their performance. Right now, demand for AI accelerators, high-performance CPUs, and HBM is through the roof as is demand for its EUV machines.
The company will increase its own capacity by 30% this year and 30% in 2027. It is also looking to potentially bump it up by another 30% in 2028 as well.
While ASML plays an important role in the semiconductor ecosystem, it has not enjoyed the same revenue or gross margin boost as others in the space. In the second quarter, its revenue grew a solid 21% while its gross margins ticked up 30 basis points to 54%. However, compare that to TSMC whose Q2 revenue jumped by 34% while its gross margins ballooned by 910 basis points to 67.6%.
Trading at a forward P/E of 30.5 times 2027 analyst estimates, AMSL's valuation is reflective of its growth and strong positioning in the market. As such, I prefer TSMC, which currently looks undervalued while producing stronger growth.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Allspring Global Investments Holdings LLC raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 11.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 468,676 shares of the healthcare product maker’s stock after acquiring an additional 50,017 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Abbott Laboratories were worth $47,983,000 as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. One Day In July LLC boosted its holdings in Abbott Laboratories by 3.6% in the first quarter. One Day In July LLC now owns 3,669 shares of the healthcare product maker’s stock worth $377,000 after purchasing an additional 127 shares during the last quarter. Independent Financial Group LLC purchased a new position in shares of Abbott Laboratories in the 1st quarter worth $1,545,000. Frazier Financial Advisors LLC boosted its stake in shares of Abbott Laboratories by 7.8% in the 1st quarter. Frazier Financial Advisors LLC now owns 28,864 shares of the healthcare product maker’s stock worth $2,964,000 after buying an additional 2,089 shares during the last quarter. D.A. Davidson & CO. grew its holdings in shares of Abbott Laboratories by 2.5% in the first quarter. D.A. Davidson & CO. now owns 186,786 shares of the healthcare product maker’s stock worth $19,177,000 after acquiring an additional 4,553 shares during the period. Finally, Beaumont Financial Advisors LLC increased its position in Abbott Laboratories by 193.8% during the first quarter. Beaumont Financial Advisors LLC now owns 69,183 shares of the healthcare product maker’s stock valued at $7,103,000 after acquiring an additional 45,634 shares during the last quarter. Hedge funds and other institutional investors own 75.18% of the company’s stock.
Abbott Laboratories Price Performance NYSE:ABT opened at $100.71 on Friday. The business’s 50-day simple moving average is $89.89 and its two-hundred day simple moving average is $102.17. Abbott Laboratories has a 52 week low of $81.97 and a 52 week high of $137.49. The stock has a market cap of $175.41 billion, a PE ratio of 32.59, a P/E/G ratio of 1.73 and a beta of 0.61. The company has a quick ratio of 1.01, a current ratio of 1.39 and a debt-to-equity ratio of 0.56.
Abbott Laboratories (NYSE:ABT – Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The healthcare product maker reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.03. Abbott Laboratories had a return on equity of 17.65% and a net margin of 11.65%.The business had revenue of $12.51 billion during the quarter, compared to the consensus estimate of $12.52 billion. During the same period in the prior year, the company posted $1.26 EPS. The firm’s revenue for the quarter was up 13.0% compared to the same quarter last year. Abbott Laboratories has set its Q3 2026 guidance at 1.380-1.46 EPS and its FY 2026 guidance at 5.450-5.60 EPS. As a group, analysts forecast that Abbott Laboratories will post 5.48 EPS for the current fiscal year.
Abbott Laboratories Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Wednesday, July 15th will be paid a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Wednesday, July 15th. Abbott Laboratories’s dividend payout ratio (DPR) is presently 70.59%.
Trending Headlines about Abbott Laboratories Here are the key news stories impacting Abbott Laboratories this week:
Positive Sentiment: Abbott beat Q2 earnings expectations and raised 2026 adjusted EPS guidance to $5.45-$5.60, signaling better profit momentum for the rest of the year. Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance Positive Sentiment: Management pointed to stronger second-half demand across multiple businesses, including nutrition, medical devices, diagnostics, and diabetes care, which supports a faster growth profile. ABT Q2 Earnings Call Flags Stronger Second-Half Setup Positive Sentiment: Analysts turned more constructive after the results, with JPMorgan, Citi, Piper Sandler, Wells Fargo, TD Cowen, BTIG, and RBC all lifting targets or reaffirming bullish views. These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results Insider Activity In related news, Director Daniel J. Starks acquired 10,000 shares of Abbott Laboratories stock in a transaction on Monday, April 27th. The shares were bought at an average cost of $92.65 per share, with a total value of $926,500.00. Following the completion of the purchase, the director directly owned 6,751,103 shares of the company’s stock, valued at $625,489,692.95. The trade was a 0.15% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Philip P. Boudreau bought 2,200 shares of the business’s stock in a transaction dated Thursday, April 23rd. The shares were bought at an average cost of $91.50 per share, for a total transaction of $201,300.00. Following the transaction, the chief financial officer owned 2,200 shares in the company, valued at approximately $201,300. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 0.46% of the company’s stock.
Wall Street Analyst Weigh In Several equities research analysts have recently commented on ABT shares. Daiwa Securities Group lowered shares of Abbott Laboratories from an “outperform” rating to a “neutral” rating and set a $92.00 price target for the company. in a research report on Wednesday, April 22nd. Raymond James Financial dropped their price objective on shares of Abbott Laboratories from $130.00 to $115.00 and set an “outperform” rating on the stock in a report on Friday, April 17th. Stifel Nicolaus reduced their target price on shares of Abbott Laboratories from $145.00 to $120.00 and set a “buy” rating for the company in a report on Friday, April 17th. Oppenheimer decreased their price target on shares of Abbott Laboratories from $132.00 to $115.00 and set an “outperform” rating on the stock in a research report on Friday, April 17th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Abbott Laboratories from $110.00 to $120.00 and gave the company an “overweight” rating in a research report on Friday. Three research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Abbott Laboratories has an average rating of “Moderate Buy” and a consensus target price of $118.61.
View Our Latest Report on Abbott Laboratories
Abbott Laboratories Profile (Free Report)
Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.
In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability.
Recommended Stories Five stocks we like better than Abbott Laboratories Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAMG National Trust Bank Grows Position in JPMorgan Chase & Co. $JPM
NEXT HEADLINE »Concordia Financial Group (OTCMKTS:CCRDF) Director Purchases $1,003,436.10 in Stock
AIA Group Ltd grew its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 49.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 442,653 shares of the healthcare product maker’s stock after purchasing an additional 147,225 shares during the period. Abbott Laboratories makes up 0.7% of AIA Group Ltd’s portfolio, making the stock its 21st biggest holding. AIA Group Ltd’s holdings in Abbott Laboratories were worth $45,447,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Abbott Laboratories by 1.4% during the 4th quarter. Vanguard Group Inc. now owns 175,556,716 shares of the healthcare product maker’s stock valued at $21,995,501,000 after acquiring an additional 2,402,408 shares during the last quarter. State Street Corp lifted its position in Abbott Laboratories by 2.1% during the fourth quarter. State Street Corp now owns 79,853,782 shares of the healthcare product maker’s stock valued at $10,004,880,000 after purchasing an additional 1,627,791 shares during the last quarter. Capital International Investors grew its stake in Abbott Laboratories by 2.6% in the 4th quarter. Capital International Investors now owns 63,229,445 shares of the healthcare product maker’s stock worth $7,922,519,000 after buying an additional 1,614,706 shares in the last quarter. J. Stern & Co. LLP increased its holdings in shares of Abbott Laboratories by 12,439.6% in the 4th quarter. J. Stern & Co. LLP now owns 39,319,009 shares of the healthcare product maker’s stock worth $4,926,279,000 after buying an additional 39,005,451 shares during the last quarter. Finally, Capital Research Global Investors increased its holdings in shares of Abbott Laboratories by 1.0% in the 4th quarter. Capital Research Global Investors now owns 39,169,239 shares of the healthcare product maker’s stock worth $4,907,523,000 after buying an additional 400,400 shares during the last quarter. Institutional investors own 75.18% of the company’s stock.
Abbott Laboratories Stock Performance Shares of ABT stock opened at $100.71 on Friday. The company has a market capitalization of $175.41 billion, a P/E ratio of 32.59, a PEG ratio of 1.73 and a beta of 0.61. Abbott Laboratories has a fifty-two week low of $81.97 and a fifty-two week high of $137.49. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.01 and a current ratio of 1.39. The stock has a 50 day moving average price of $89.89 and a two-hundred day moving average price of $102.17.
Abbott Laboratories (NYSE:ABT – Get Free Report) last issued its earnings results on Thursday, July 16th. The healthcare product maker reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.03. Abbott Laboratories had a net margin of 11.65% and a return on equity of 17.65%. The firm had revenue of $12.51 billion for the quarter, compared to analysts’ expectations of $12.52 billion. During the same quarter last year, the business earned $1.26 earnings per share. The business’s revenue was up 13.0% on a year-over-year basis. Abbott Laboratories has set its Q3 2026 guidance at 1.380-1.46 EPS and its FY 2026 guidance at 5.450-5.60 EPS. Analysts expect that Abbott Laboratories will post 5.48 earnings per share for the current year.
Abbott Laboratories Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Stockholders of record on Wednesday, July 15th will be paid a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Wednesday, July 15th. Abbott Laboratories’s dividend payout ratio is 70.59%.
Key Headlines Impacting Abbott Laboratories Here are the key news stories impacting Abbott Laboratories this week:
Positive Sentiment: Abbott beat Q2 earnings expectations and raised 2026 adjusted EPS guidance to $5.45-$5.60, signaling better profit momentum for the rest of the year. Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance Positive Sentiment: Management pointed to stronger second-half demand across multiple businesses, including nutrition, medical devices, diagnostics, and diabetes care, which supports a faster growth profile. ABT Q2 Earnings Call Flags Stronger Second-Half Setup Positive Sentiment: Analysts turned more constructive after the results, with JPMorgan, Citi, Piper Sandler, Wells Fargo, TD Cowen, BTIG, and RBC all lifting targets or reaffirming bullish views. These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results Analyst Ratings Changes A number of research firms recently commented on ABT. BTIG Research increased their target price on Abbott Laboratories from $131.00 to $134.00 and gave the company a “buy” rating in a research note on Friday. Mizuho decreased their price objective on Abbott Laboratories from $125.00 to $115.00 and set a “neutral” rating on the stock in a report on Friday, April 17th. Argus cut their target price on Abbott Laboratories from $140.00 to $125.00 and set a “buy” rating for the company in a research note on Tuesday, April 21st. Jefferies Financial Group decreased their price target on shares of Abbott Laboratories from $145.00 to $135.00 and set a “buy” rating on the stock in a research note on Friday, April 17th. Finally, Robert W. Baird started coverage on shares of Abbott Laboratories in a report on Wednesday, July 1st. They issued an “outperform” rating and a $121.00 price objective for the company. Three research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $118.61.
Read Our Latest Research Report on Abbott Laboratories
Insider Transactions at Abbott Laboratories In other Abbott Laboratories news, CFO Philip P. Boudreau bought 2,200 shares of the business’s stock in a transaction that occurred on Thursday, April 23rd. The shares were bought at an average cost of $91.50 per share, with a total value of $201,300.00. Following the completion of the purchase, the chief financial officer directly owned 2,200 shares of the company’s stock, valued at $201,300. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Daniel J. Starks purchased 10,000 shares of the stock in a transaction on Monday, April 27th. The shares were acquired at an average cost of $92.65 per share, with a total value of $926,500.00. Following the transaction, the director directly owned 6,751,103 shares in the company, valued at $625,489,692.95. The trade was a 0.15% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 0.46% of the company’s stock.
About Abbott Laboratories (Free Report)
Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.
In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability.
Featured Stories Five stocks we like better than Abbott Laboratories Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding ABT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abbott Laboratories (NYSE:ABT – Free Report).
Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
Assetmark Inc. grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 8.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,552 shares of the healthcare product maker’s stock after purchasing an additional 16,506 shares during the period. Assetmark Inc.’s holdings in Abbott Laboratories were worth $20,796,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. MidAtlantic Capital Management Inc. bought a new stake in Abbott Laboratories during the 4th quarter valued at approximately $25,000. Cornerstone Financial Management LLC bought a new position in shares of Abbott Laboratories in the 4th quarter worth approximately $25,000. Purpose Unlimited Inc. purchased a new position in shares of Abbott Laboratories in the 4th quarter valued at approximately $25,000. Portfolio Resources Advisor Group Inc. bought a new stake in shares of Abbott Laboratories during the fourth quarter valued at approximately $26,000. Finally, Abound Financial LLC purchased a new stake in Abbott Laboratories in the fourth quarter worth $26,000. Hedge funds and other institutional investors own 75.18% of the company’s stock.
Wall Street Analyst Weigh In ABT has been the subject of a number of research reports. JPMorgan Chase & Co. increased their price objective on Abbott Laboratories from $110.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday. Barclays decreased their price target on shares of Abbott Laboratories from $144.00 to $143.00 and set an “overweight” rating for the company in a research note on Monday, April 20th. Leerink Partners lowered their price target on shares of Abbott Laboratories from $119.00 to $106.00 and set a “market perform” rating for the company in a research report on Tuesday, April 21st. Raymond James Financial dropped their price objective on shares of Abbott Laboratories from $130.00 to $115.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $130.00 price objective on shares of Abbott Laboratories in a report on Friday. Three equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $118.61.
View Our Latest Stock Report on ABT
Abbott Laboratories Trading Up 1.9% Abbott Laboratories stock opened at $100.71 on Friday. Abbott Laboratories has a one year low of $81.97 and a one year high of $137.49. The business’s fifty day moving average is $89.89 and its 200 day moving average is $102.17. The stock has a market capitalization of $175.41 billion, a PE ratio of 32.59, a price-to-earnings-growth ratio of 1.73 and a beta of 0.61. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.39 and a quick ratio of 1.01.
Abbott Laboratories (NYSE:ABT – Get Free Report) last posted its earnings results on Thursday, July 16th. The healthcare product maker reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.03. The business had revenue of $12.51 billion for the quarter, compared to analysts’ expectations of $12.52 billion. Abbott Laboratories had a net margin of 11.65% and a return on equity of 17.65%. The business’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.26 EPS. Abbott Laboratories has set its Q3 2026 guidance at 1.380-1.46 EPS and its FY 2026 guidance at 5.450-5.60 EPS. On average, sell-side analysts predict that Abbott Laboratories will post 5.48 EPS for the current year.
Abbott Laboratories Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Investors of record on Wednesday, July 15th will be given a dividend of $0.63 per share. The ex-dividend date is Wednesday, July 15th. This represents a $2.52 dividend on an annualized basis and a yield of 2.5%. Abbott Laboratories’s dividend payout ratio is 70.59%.
Key Abbott Laboratories News Here are the key news stories impacting Abbott Laboratories this week:
Positive Sentiment: Abbott beat Q2 earnings expectations and raised 2026 adjusted EPS guidance to $5.45-$5.60, signaling better profit momentum for the rest of the year. Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance Positive Sentiment: Management pointed to stronger second-half demand across multiple businesses, including nutrition, medical devices, diagnostics, and diabetes care, which supports a faster growth profile. ABT Q2 Earnings Call Flags Stronger Second-Half Setup Positive Sentiment: Analysts turned more constructive after the results, with JPMorgan, Citi, Piper Sandler, Wells Fargo, TD Cowen, BTIG, and RBC all lifting targets or reaffirming bullish views. These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results Insider Activity at Abbott Laboratories In other news, CFO Philip P. Boudreau purchased 2,200 shares of the stock in a transaction dated Thursday, April 23rd. The shares were purchased at an average cost of $91.50 per share, with a total value of $201,300.00. Following the acquisition, the chief financial officer directly owned 2,200 shares of the company’s stock, valued at $201,300. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Daniel J. Starks purchased 10,000 shares of the company’s stock in a transaction dated Monday, April 27th. The stock was purchased at an average price of $92.65 per share, for a total transaction of $926,500.00. Following the completion of the purchase, the director owned 6,751,103 shares in the company, valued at approximately $625,489,692.95. The trade was a 0.15% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.46% of the company’s stock.
Abbott Laboratories Profile (Free Report)
Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.
In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability.
Read More Five stocks we like better than Abbott Laboratories Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEGilead Sciences, Inc. $GILD Shares Sold by Allspring Global Investments Holdings LLC
Ascent Wealth Partners LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 29.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,255 shares of the healthcare product maker’s stock after selling 27,145 shares during the quarter. Ascent Wealth Partners LLC’s holdings in Abbott Laboratories were worth $6,700,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in the stock. Freemont Management S.A. grew its position in Abbott Laboratories by 197.2% in the fourth quarter. Freemont Management S.A. now owns 10,700 shares of the healthcare product maker’s stock valued at $1,341,000 after acquiring an additional 7,100 shares in the last quarter. PFA Pension Forsikringsaktieselskab purchased a new position in shares of Abbott Laboratories in the fourth quarter valued at $116,580,000. Thrivent Financial for Lutherans boosted its stake in shares of Abbott Laboratories by 24.3% in the fourth quarter. Thrivent Financial for Lutherans now owns 246,586 shares of the healthcare product maker’s stock valued at $30,931,000 after purchasing an additional 48,286 shares during the period. Net Worth Advisory Group acquired a new stake in Abbott Laboratories during the 4th quarter valued at $1,366,000. Finally, Mn Services Vermogensbeheer B.V. increased its stake in Abbott Laboratories by 2.1% during the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 671,743 shares of the healthcare product maker’s stock worth $84,163,000 after buying an additional 13,543 shares during the period. Institutional investors and hedge funds own 75.18% of the company’s stock.
Abbott Laboratories Stock Performance Abbott Laboratories stock opened at $100.71 on Friday. The company has a market cap of $175.41 billion, a PE ratio of 32.59, a P/E/G ratio of 1.73 and a beta of 0.61. The company has a fifty day moving average price of $89.89 and a two-hundred day moving average price of $102.17. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.39 and a quick ratio of 1.01. Abbott Laboratories has a 12 month low of $81.97 and a 12 month high of $137.49.
Abbott Laboratories (NYSE:ABT – Get Free Report) last issued its earnings results on Thursday, July 16th. The healthcare product maker reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.03. Abbott Laboratories had a net margin of 11.65% and a return on equity of 17.65%. The company had revenue of $12.51 billion for the quarter, compared to analysts’ expectations of $12.52 billion. During the same period in the prior year, the company earned $1.26 earnings per share. The firm’s revenue was up 13.0% compared to the same quarter last year. Abbott Laboratories has set its Q3 2026 guidance at 1.380-1.46 EPS and its FY 2026 guidance at 5.450-5.60 EPS. Research analysts expect that Abbott Laboratories will post 5.48 earnings per share for the current year.
Abbott Laboratories Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Wednesday, July 15th will be paid a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Wednesday, July 15th. Abbott Laboratories’s payout ratio is presently 70.59%.
Insider Activity at Abbott Laboratories In related news, CFO Philip P. Boudreau acquired 2,200 shares of the stock in a transaction that occurred on Thursday, April 23rd. The stock was purchased at an average cost of $91.50 per share, for a total transaction of $201,300.00. Following the purchase, the chief financial officer directly owned 2,200 shares in the company, valued at $201,300. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Daniel J. Starks bought 10,000 shares of the company’s stock in a transaction on Monday, April 27th. The stock was bought at an average cost of $92.65 per share, for a total transaction of $926,500.00. Following the completion of the transaction, the director directly owned 6,751,103 shares of the company’s stock, valued at $625,489,692.95. This trade represents a 0.15% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.46% of the stock is currently owned by corporate insiders.
Abbott Laboratories News Summary Here are the key news stories impacting Abbott Laboratories this week:
Positive Sentiment: Abbott beat Q2 earnings expectations and raised 2026 adjusted EPS guidance to $5.45-$5.60, signaling better profit momentum for the rest of the year. Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance Positive Sentiment: Management pointed to stronger second-half demand across multiple businesses, including nutrition, medical devices, diagnostics, and diabetes care, which supports a faster growth profile. ABT Q2 Earnings Call Flags Stronger Second-Half Setup Positive Sentiment: Analysts turned more constructive after the results, with JPMorgan, Citi, Piper Sandler, Wells Fargo, TD Cowen, BTIG, and RBC all lifting targets or reaffirming bullish views. These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results Analysts Set New Price Targets A number of equities analysts have weighed in on the stock. UBS Group decreased their price objective on shares of Abbott Laboratories from $158.00 to $135.00 and set a “buy” rating for the company in a research report on Monday, April 20th. JPMorgan Chase & Co. boosted their price target on Abbott Laboratories from $110.00 to $120.00 and gave the stock an “overweight” rating in a research note on Friday. Leerink Partners reduced their price target on Abbott Laboratories from $119.00 to $106.00 and set a “market perform” rating for the company in a report on Tuesday, April 21st. Oppenheimer lowered their price objective on Abbott Laboratories from $132.00 to $115.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. Finally, Weiss Ratings raised Abbott Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, July 7th. Three analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, Abbott Laboratories has a consensus rating of “Moderate Buy” and a consensus target price of $118.61.
Check Out Our Latest Stock Analysis on Abbott Laboratories
About Abbott Laboratories (Free Report)
Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.
In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability.
Read More Five stocks we like better than Abbott Laboratories Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAlphabet Inc. $GOOGL Position Reduced by First National Bank & Trust Co. of Newtown
AIA Group Ltd lowered its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 6.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 86,693 shares of the medical research company’s stock after selling 5,759 shares during the period. Thermo Fisher Scientific comprises about 0.6% of AIA Group Ltd’s portfolio, making the stock its 24th largest position. AIA Group Ltd’s holdings in Thermo Fisher Scientific were worth $42,612,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. J. Stern & Co. LLP lifted its position in shares of Thermo Fisher Scientific by 58,006.4% during the 4th quarter. J. Stern & Co. LLP now owns 31,509,332 shares of the medical research company’s stock worth $18,258,082,000 after buying an additional 31,455,105 shares in the last quarter. Norges Bank bought a new position in shares of Thermo Fisher Scientific in the fourth quarter valued at approximately $3,072,744,000. Auto Owners Insurance Co increased its position in shares of Thermo Fisher Scientific by 57,845.0% during the fourth quarter. Auto Owners Insurance Co now owns 2,427,896 shares of the medical research company’s stock valued at $1,406,844,000 after acquiring an additional 2,423,706 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in Thermo Fisher Scientific by 2,183.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,328,845 shares of the medical research company’s stock worth $770,000,000 after acquiring an additional 1,270,643 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its position in Thermo Fisher Scientific by 19.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,701,353 shares of the medical research company’s stock worth $4,462,550,000 after purchasing an additional 1,230,872 shares during the last quarter. 89.23% of the stock is currently owned by hedge funds and other institutional investors.
Thermo Fisher Scientific Stock Performance Shares of TMO opened at $532.17 on Friday. Thermo Fisher Scientific Inc. has a 12-month low of $403.36 and a 12-month high of $643.99. The company has a current ratio of 1.53, a quick ratio of 1.15 and a debt-to-equity ratio of 0.77. The company has a market cap of $197.77 billion, a PE ratio of 29.26, a price-to-earnings-growth ratio of 2.36 and a beta of 0.87. The stock has a 50-day moving average price of $484.57 and a 200-day moving average price of $514.88.
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) last released its earnings results on Thursday, April 23rd. The medical research company reported $5.44 EPS for the quarter, beating analysts’ consensus estimates of $5.25 by $0.19. The business had revenue of $11.01 billion for the quarter, compared to analysts’ expectations of $10.86 billion. Thermo Fisher Scientific had a return on equity of 16.86% and a net margin of 15.15%.The firm’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.15 earnings per share. Thermo Fisher Scientific has set its FY 2026 guidance at 24.640-25.120 EPS. As a group, equities analysts forecast that Thermo Fisher Scientific Inc. will post 24.84 earnings per share for the current fiscal year.
Thermo Fisher Scientific Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Tuesday, September 15th will be paid a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Tuesday, September 15th. Thermo Fisher Scientific’s dividend payout ratio is 10.34%.
Insider Activity at Thermo Fisher Scientific In other Thermo Fisher Scientific news, COO Gianluca Pettiti sold 400 shares of the stock in a transaction on Monday, April 27th. The shares were sold at an average price of $462.66, for a total transaction of $185,064.00. Following the completion of the sale, the chief operating officer owned 25,051 shares of the company’s stock, valued at $11,590,095.66. This represents a 1.57% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.33% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In TMO has been the topic of a number of research analyst reports. Jefferies Financial Group raised shares of Thermo Fisher Scientific to a “strong-buy” rating in a report on Friday, April 24th. DZ Bank assumed coverage on shares of Thermo Fisher Scientific in a research note on Friday, March 27th. They issued a “buy” rating and a $610.00 target price on the stock. Wells Fargo & Company reduced their target price on shares of Thermo Fisher Scientific from $675.00 to $615.00 and set an “overweight” rating for the company in a research report on Friday, May 8th. Piper Sandler initiated coverage on shares of Thermo Fisher Scientific in a report on Thursday, June 11th. They issued a “neutral” rating and a $510.00 price target on the stock. Finally, Weiss Ratings upgraded Thermo Fisher Scientific from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $602.14.
Read Our Latest Analysis on TMO
Thermo Fisher Scientific Profile (Free Report)
Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.
Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.
See Also Five stocks we like better than Thermo Fisher Scientific Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
Dorsey Wright & Associates purchased a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The firm purchased 508 shares of the company’s stock, valued at approximately $468,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC increased its position in shares of Eli Lilly and Company by 22.0% during the fourth quarter. Brighton Jones LLC now owns 9,597 shares of the company’s stock worth $7,409,000 after purchasing an additional 1,730 shares in the last quarter. Revolve Wealth Partners LLC increased its position in Eli Lilly and Company by 2.8% during the 4th quarter. Revolve Wealth Partners LLC now owns 1,471 shares of the company’s stock valued at $1,136,000 after buying an additional 40 shares in the last quarter. Schnieders Capital Management LLC. increased its position in Eli Lilly and Company by 16.7% during the 2nd quarter. Schnieders Capital Management LLC. now owns 7,993 shares of the company’s stock valued at $6,231,000 after buying an additional 1,141 shares in the last quarter. Flow Traders U.S. LLC purchased a new stake in Eli Lilly and Company in the second quarter valued at about $356,000. Finally, Nebula Research & Development LLC acquired a new stake in Eli Lilly and Company in the second quarter worth about $749,000. Hedge funds and other institutional investors own 82.53% of the company’s stock.
Analyst Upgrades and Downgrades A number of brokerages have recently weighed in on LLY. Berenberg Bank boosted their price target on Eli Lilly and Company from $1,050.00 to $1,135.00 and gave the stock a “hold” rating in a research note on Monday, June 22nd. Wolfe Research reiterated an “outperform” rating and issued a $1,350.00 target price on shares of Eli Lilly and Company in a research note on Thursday, May 21st. UBS Group boosted their target price on shares of Eli Lilly and Company from $1,250.00 to $1,425.00 and gave the stock a “buy” rating in a research report on Monday, July 13th. Citigroup upped their price target on shares of Eli Lilly and Company from $1,500.00 to $1,600.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, Royal Bank Of Canada raised their price target on shares of Eli Lilly and Company from $1,250.00 to $1,500.00 and gave the stock an “outperform” rating in a report on Wednesday, July 8th. Two analysts have rated the stock with a Strong Buy rating, twenty-four have given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Eli Lilly and Company currently has an average rating of “Moderate Buy” and an average target price of $1,283.64.
Check Out Our Latest Analysis on LLY
Key Eli Lilly and Company News Here are the key news stories impacting Eli Lilly and Company this week:
Positive Sentiment: Lilly’s acquisition of AtaiBeckley adds late-stage psychedelic assets, including BPL-003, and broadens its neuroscience pipeline. Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions Positive Sentiment: Analysts and market commentary say the deal reinforces Big Pharma’s interest in psychedelic therapies and could strengthen Lilly’s long-term growth story beyond obesity and diabetes. AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelics, says Jefferies Neutral Sentiment: Lilly also announced an update on an ongoing ALS study, indicating continued clinical development activity across its broader pipeline. Lilly Expands ALS Pipeline With Long-Term Safety Study for LY4256984 Neutral Sentiment: LLY stock is being described as holding near a buy zone and key support ahead of second-quarter results, suggesting investors are also watching upcoming earnings for confirmation of the growth outlook. Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal Negative Sentiment: Some market commentary suggests the acquisition may pressure sentiment in the near term because Lilly is paying a significant price for an asset that still carries clinical and regulatory risk. This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover Talks Eli Lilly and Company Stock Performance LLY opened at $1,178.01 on Friday. The firm has a fifty day moving average price of $1,118.87 and a 200 day moving average price of $1,036.80. Eli Lilly and Company has a 1 year low of $623.78 and a 1 year high of $1,249.45. The stock has a market cap of $1.11 trillion, a P/E ratio of 41.85, a P/E/G ratio of 1.48 and a beta of 0.51. The company has a debt-to-equity ratio of 1.26, a current ratio of 1.50 and a quick ratio of 1.10.
Eli Lilly and Company (NYSE:LLY – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $8.55 EPS for the quarter, beating the consensus estimate of $6.97 by $1.58. Eli Lilly and Company had a net margin of 34.98% and a return on equity of 105.77%. The company had revenue of $19.80 billion for the quarter, compared to analyst estimates of $17.82 billion. During the same quarter last year, the business earned $3.34 earnings per share. The firm’s revenue was up 55.5% on a year-over-year basis. Eli Lilly and Company has set its FY 2026 guidance at 35.500-37.000 EPS. Equities research analysts anticipate that Eli Lilly and Company will post 34.55 earnings per share for the current year.
Eli Lilly and Company Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 10th. Stockholders of record on Friday, August 14th will be given a dividend of $1.73 per share. The ex-dividend date is Friday, August 14th. This represents a $6.92 dividend on an annualized basis and a dividend yield of 0.6%. Eli Lilly and Company’s dividend payout ratio (DPR) is 24.58%.
Eli Lilly and Company Profile (Free Report)
Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide. Eli Lilly maintains operations and commercial presence across North America, Europe, Asia and other regions, serving both developed and emerging markets. The company has been led in recent years by President and Chief Executive Officer David A.
Featured Articles Five stocks we like better than Eli Lilly and Company Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly and Company and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEHartline Investment Corp Has $29.93 Million Stock Holdings in Amazon.com, Inc. $AMZN
NEXT HEADLINE »Amazon.com, Inc. $AMZN is Fishman Jay A Ltd. MI’s 3rd Largest Position
The three biggest US pharma names by market cap trade at very different setups right now: Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) at $247.02 screens as the most compelling on fundamentals, Eli Lilly (NYSE:LLY) at $1,156.63 looks fully valued, and AbbVie (NYSE:ABBV) at $244.11 appears stretched relative to its growth outlook.
AIA Group Ltd lessened its holdings in shares of Texas Instruments Incorporated (NASDAQ:TXN – Free Report) by 19.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 191,444 shares of the semiconductor company’s stock after selling 45,193 shares during the period. Texas Instruments accounts for approximately 0.5% of AIA Group Ltd’s investment portfolio, making the stock its 29th biggest holding. AIA Group Ltd’s holdings in Texas Instruments were worth $37,167,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Strategic Wealth Investment Group LLC purchased a new stake in shares of Texas Instruments in the second quarter valued at about $25,000. Portus Wealth Advisors LLC acquired a new position in Texas Instruments during the 1st quarter worth approximately $27,000. High Point Wealth Management LLC acquired a new position in shares of Texas Instruments in the fourth quarter worth about $25,000. Advocate Investing Services LLC acquired a new position in shares of Texas Instruments in the 4th quarter valued at approximately $25,000. Finally, Ares Financial Consulting LLC acquired a new stake in Texas Instruments in the fourth quarter valued at $26,000. 84.99% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets In other Texas Instruments news, CFO Rafael R. Lizardi sold 47,734 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $308.10, for a total transaction of $14,706,845.40. Following the transaction, the chief financial officer owned 85,485 shares in the company, valued at $26,337,928.50. This represents a 35.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Haviv Ilan sold 20,000 shares of the firm’s stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $280.32, for a total transaction of $5,606,400.00. Following the completion of the transaction, the chief executive officer directly owned 204,339 shares in the company, valued at approximately $57,280,308.48. This represents a 8.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 303,475 shares of company stock valued at $85,666,638 in the last three months. Insiders own 0.60% of the company’s stock.
Texas Instruments Price Performance Shares of TXN stock opened at $284.02 on Friday. The stock has a market cap of $258.48 billion, a PE ratio of 48.63, a PEG ratio of 1.42 and a beta of 1.32. Texas Instruments Incorporated has a 52-week low of $152.73 and a 52-week high of $334.03. The firm’s 50 day moving average price is $302.59 and its two-hundred day moving average price is $243.46. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.94 and a current ratio of 4.46.
Texas Instruments (NASDAQ:TXN – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.31. The company had revenue of $4.83 billion during the quarter, compared to analyst estimates of $4.85 billion. Texas Instruments had a net margin of 29.11% and a return on equity of 32.49%. The firm’s revenue was up 18.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.23 EPS. Texas Instruments has set its Q2 2026 guidance at 1.770-2.050 EPS. As a group, analysts forecast that Texas Instruments Incorporated will post 7.7 EPS for the current year.
Texas Instruments Announces Dividend The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 11th. Investors of record on Friday, July 31st will be issued a dividend of $1.42 per share. The ex-dividend date of this dividend is Friday, July 31st. This represents a $5.68 annualized dividend and a dividend yield of 2.0%. Texas Instruments’s payout ratio is presently 97.26%.
Analyst Ratings Changes TXN has been the topic of a number of research reports. Sanford C. Bernstein began coverage on Texas Instruments in a research report on Friday, May 22nd. They set a “market perform” rating on the stock. Robert W. Baird upped their price target on shares of Texas Instruments from $225.00 to $300.00 and gave the company an “outperform” rating in a research report on Thursday, April 23rd. Mizuho boosted their price target on Texas Instruments from $255.00 to $300.00 and gave the company a “neutral” rating in a research note on Tuesday, May 19th. Bank of America raised their target price on shares of Texas Instruments from $320.00 to $370.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. Finally, Weiss Ratings raised shares of Texas Instruments from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, May 6th. Thirteen research analysts have rated the stock with a Buy rating, ten have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $281.84.
Check Out Our Latest Research Report on Texas Instruments
More Texas Instruments News Here are the key news stories impacting Texas Instruments this week:
Positive Sentiment: Multiple reports suggest TXN could beat Q2 earnings estimates as demand improves across analog and embedded chips, especially in industrial, data center, and automotive markets. That strengthens the case for an earnings-driven rally. TXN Likely to Beat Q2 Earnings Estimates: How to Play the Stock? Positive Sentiment: Texas Instruments declared a quarterly dividend of $1.42 per share, reinforcing its appeal as an income stock and highlighting the company’s long record of returning cash to shareholders. Texas Instruments board declares third quarter 2026 quarterly dividend Positive Sentiment: TXN was also named to a Zacks Rank #1 (Strong Buy) income stocks list, which may be supporting investor sentiment around the stock’s dividend quality and relative defensiveness. Best Income Stocks to Buy for July 17th Neutral Sentiment: Analyst coverage remains constructive, with KeyCorp maintaining an Overweight rating and a $390 price target, implying Wall Street still sees upside if execution stays strong. Analysts Have Conflicting Sentiments on These Technology Companies: Texas Instruments (TXN) and ASMPT Ltd (OtherASMVF) Negative Sentiment: One analyst note called TXN a “dangerous setup” into Q2 earnings, arguing expectations are elevated and the stock already reflects a bullish inflection in margins, free cash flow, and growth. That raises the risk of disappointment if results are merely solid rather than exceptional. Texas Instruments: Dangerous Setup Into Q2 Earnings Texas Instruments Company Profile (Free Report)
Texas Instruments Inc (NASDAQ: TXN) is a global semiconductor company headquartered in Dallas, Texas, that designs and manufactures analog and embedded processing chips. The company’s products are used across a wide range of end markets, including industrial, automotive, personal electronics, communications and enterprise equipment. TI’s business emphasizes components that condition, convert, manage and move electrical signals—capabilities that are foundational to modern electronic systems.
TI’s product portfolio includes a broad array of analog integrated circuits—such as power management, amplifiers, data converters and interface devices—as well as embedded processors and microcontrollers used to control systems and run real-time applications.
See Also Five stocks we like better than Texas Instruments Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Texas Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Texas Instruments and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAIA Group Ltd Has $8.97 Million Stake in Marriott International, Inc. $MAR
NEXT HEADLINE »UnitedHealth Group Incorporated $UNH Shares Sold by AIA Group Ltd
Aubrey Capital Management Ltd trimmed its position in Broadcom Inc. (NASDAQ:AVGO – Free Report) by 10.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,680 shares of the semiconductor manufacturer’s stock after selling 1,620 shares during the quarter. Broadcom comprises approximately 2.3% of Aubrey Capital Management Ltd’s holdings, making the stock its 13th biggest position. Aubrey Capital Management Ltd’s holdings in Broadcom were worth $4,233,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. ROSS JOHNSON & Associates LLC boosted its stake in shares of Broadcom by 1,320.0% in the fourth quarter. ROSS JOHNSON & Associates LLC now owns 71 shares of the semiconductor manufacturer’s stock worth $25,000 after acquiring an additional 66 shares during the period. Networth Advisors LLC grew its holdings in Broadcom by 546.2% during the 1st quarter. Networth Advisors LLC now owns 84 shares of the semiconductor manufacturer’s stock valued at $26,000 after buying an additional 71 shares in the last quarter. SWAN Capital LLC grew its holdings in Broadcom by 261.9% during the 4th quarter. SWAN Capital LLC now owns 76 shares of the semiconductor manufacturer’s stock valued at $26,000 after buying an additional 55 shares in the last quarter. Miller Global Investments LLC bought a new stake in shares of Broadcom during the fourth quarter valued at approximately $31,000. Finally, Nvest Wealth Strategies Inc. bought a new stake in shares of Broadcom during the fourth quarter valued at approximately $33,000. Institutional investors own 76.43% of the company’s stock.
Broadcom Trading Down 1.0% Shares of AVGO opened at $370.83 on Friday. The stock has a market capitalization of $1.76 trillion, a PE ratio of 61.81, a P/E/G ratio of 0.65 and a beta of 1.45. The company’s fifty day moving average is $401.29 and its 200 day moving average is $365.31. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.01 and a current ratio of 2.24. Broadcom Inc. has a fifty-two week low of $273.00 and a fifty-two week high of $495.00.
Broadcom (NASDAQ:AVGO – Get Free Report) last issued its quarterly earnings data on Wednesday, June 3rd. The semiconductor manufacturer reported $2.44 EPS for the quarter, topping analysts’ consensus estimates of $2.40 by $0.04. The business had revenue of $22.19 billion during the quarter, compared to analysts’ expectations of $22.13 billion. Broadcom had a net margin of 38.85% and a return on equity of 41.61%. The business’s revenue was up 47.9% on a year-over-year basis. During the same period last year, the company posted $1.58 EPS. Sell-side analysts expect that Broadcom Inc. will post 10.24 earnings per share for the current fiscal year.
Broadcom Announces Dividend The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, June 22nd were given a $0.65 dividend. The ex-dividend date was Monday, June 22nd. This represents a $2.60 dividend on an annualized basis and a yield of 0.7%. Broadcom’s dividend payout ratio (DPR) is currently 43.33%.
Analysts Set New Price Targets A number of equities analysts recently weighed in on the stock. Mizuho upped their target price on shares of Broadcom from $480.00 to $530.00 and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Wells Fargo & Company reiterated an “overweight” rating and issued a $545.00 price target (up from $430.00) on shares of Broadcom in a report on Thursday, May 14th. Zacks Research cut shares of Broadcom from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 21st. UBS Group set a $485.00 price objective on shares of Broadcom and gave the company a “buy” rating in a report on Thursday, June 4th. Finally, Bank of America raised their price objective on Broadcom from $450.00 to $530.00 and gave the company a “buy” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $493.24.
View Our Latest Analysis on Broadcom
Insider Buying and Selling In other Broadcom news, Director Justine Page sold 1,602 shares of Broadcom stock in a transaction on Monday, June 29th. The shares were sold at an average price of $373.86, for a total transaction of $598,923.72. Following the completion of the transaction, the director directly owned 17,426 shares of the company’s stock, valued at $6,514,884.36. The trade was a 8.42% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mark David Brazeal sold 25,000 shares of the business’s stock in a transaction on Friday, July 10th. The shares were sold at an average price of $401.33, for a total transaction of $10,033,250.00. Following the transaction, the insider owned 194,989 shares in the company, valued at $78,254,935.37. This trade represents a 11.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 61,644 shares of company stock valued at $24,016,214 in the last three months. Corporate insiders own 1.90% of the company’s stock.
More Broadcom News Here are the key news stories impacting Broadcom this week:
Positive Sentiment: Standard Chartered chose Broadcom to support a long-term modernization of its global banking infrastructure, underscoring Broadcom’s role in secure private-cloud and enterprise networking solutions. Standard Chartered Selects Broadcom to Deliver Secure, Always-On Banking Services at Global Scale Positive Sentiment: Wall Street commentary continues to describe Broadcom as a core AI beneficiary, and some analysts have raised price targets even after the stock pullback. As Shares Fall, Analyst Are Boosting Their Broadcom Price Targets Neutral Sentiment: Broadcom remains a major talking point in AI-focused market coverage, with some investors viewing it as an indicator for the broader market and semiconductor cycle. Jim Cramer Says Broadcom Will Tell You When the Market Is About to Turn Negative Sentiment: Broadcom is facing renewed skepticism around valuation, with one report asking whether the AI story has made the stock too expensive. Has Broadcom Become Too Expensive for Its AI Story? Negative Sentiment: The stock is also being hit by a broader selloff in semiconductor names as investors rotate away from AI-capex winners and worry about a slowdown in chip spending. Marvell Drops 8% as AI Capex Slowdown Fears Weigh on Chips; Broadcom, AMD, and Intel Slide Negative Sentiment: Broadcom is also dealing with regulatory uncertainty after reports said it faces an EU antitrust review tied to VMware licensing changes. Broadcom (AVGO) Faces EU Antitrust Review Over VMware Licensing Changes About Broadcom (Free Report)
Broadcom Inc (NASDAQ: AVGO) is a global technology company that designs, develops and supplies semiconductor and infrastructure software solutions for a broad range of markets. The company’s semiconductor business provides components and systems for wired and wireless communications, enterprise and cloud storage, networking and broadband access, serving original equipment manufacturers, cloud service providers, telecommunications carriers and industrial customers worldwide. Broadcom is headquartered in Irvine, California, and operates globally with research, development and sales organizations across North America, Europe and Asia.
On the semiconductor side, Broadcom’s portfolio includes system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions, radio-frequency and connectivity components, Ethernet switching and PHY devices, storage adapters and controllers, optical transceivers and other networking silicon.
Featured Stories Five stocks we like better than Broadcom Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding AVGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Broadcom Inc. (NASDAQ:AVGO – Free Report).
Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEUnitedHealth Group Incorporated $UNH Shares Sold by AIA Group Ltd
NEXT HEADLINE »Assetmark Inc. Has $26.77 Million Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Harel Insurance Investments & Financial Services Ltd. lifted its stake in Broadcom Inc. (NASDAQ:AVGO – Free Report) by 61.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 736,534 shares of the semiconductor manufacturer’s stock after acquiring an additional 280,124 shares during the quarter. Broadcom makes up approximately 1.5% of Harel Insurance Investments & Financial Services Ltd.’s investment portfolio, making the stock its 20th largest position. Harel Insurance Investments & Financial Services Ltd.’s holdings in Broadcom were worth $227,960,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the stock. Avanda Investment Management Pte. Ltd. grew its stake in shares of Broadcom by 43.1% in the first quarter. Avanda Investment Management Pte. Ltd. now owns 9,160 shares of the semiconductor manufacturer’s stock valued at $2,835,000 after buying an additional 2,760 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in shares of Broadcom by 8.9% in the 1st quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 289,518 shares of the semiconductor manufacturer’s stock valued at $89,562,000 after purchasing an additional 23,700 shares during the period. Advisors Preferred LLC raised its holdings in shares of Broadcom by 62.5% in the 1st quarter. Advisors Preferred LLC now owns 19,962 shares of the semiconductor manufacturer’s stock valued at $6,178,000 after purchasing an additional 7,677 shares during the period. Opinicus Capital Inc. lifted its stake in Broadcom by 1.9% in the 1st quarter. Opinicus Capital Inc. now owns 4,115 shares of the semiconductor manufacturer’s stock valued at $1,274,000 after purchasing an additional 75 shares during the last quarter. Finally, Meridian Management Co. lifted its stake in Broadcom by 0.3% in the 1st quarter. Meridian Management Co. now owns 9,425 shares of the semiconductor manufacturer’s stock valued at $2,917,000 after purchasing an additional 28 shares during the last quarter. 76.43% of the stock is owned by institutional investors and hedge funds.
Broadcom Trading Down 1.0% AVGO opened at $370.83 on Friday. The company has a market cap of $1.76 trillion, a P/E ratio of 61.81, a PEG ratio of 0.65 and a beta of 1.45. The company has a current ratio of 2.24, a quick ratio of 2.01 and a debt-to-equity ratio of 0.71. The company’s 50 day moving average is $401.29 and its 200-day moving average is $365.31. Broadcom Inc. has a 1-year low of $273.00 and a 1-year high of $495.00.
Broadcom (NASDAQ:AVGO – Get Free Report) last posted its earnings results on Wednesday, June 3rd. The semiconductor manufacturer reported $2.44 EPS for the quarter, beating the consensus estimate of $2.40 by $0.04. Broadcom had a return on equity of 41.61% and a net margin of 38.85%.The firm had revenue of $22.19 billion during the quarter, compared to the consensus estimate of $22.13 billion. During the same period last year, the company earned $1.58 earnings per share. The business’s quarterly revenue was up 47.9% on a year-over-year basis. Equities research analysts predict that Broadcom Inc. will post 10.24 earnings per share for the current fiscal year.
Broadcom Announces Dividend The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, June 22nd were paid a dividend of $0.65 per share. This represents a $2.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Monday, June 22nd. Broadcom’s dividend payout ratio (DPR) is currently 43.33%.
Broadcom News Summary Here are the key news stories impacting Broadcom this week:
Positive Sentiment: Standard Chartered chose Broadcom to support a long-term modernization of its global banking infrastructure, underscoring Broadcom’s role in secure private-cloud and enterprise networking solutions. Standard Chartered Selects Broadcom to Deliver Secure, Always-On Banking Services at Global Scale Positive Sentiment: Wall Street commentary continues to describe Broadcom as a core AI beneficiary, and some analysts have raised price targets even after the stock pullback. As Shares Fall, Analyst Are Boosting Their Broadcom Price Targets Neutral Sentiment: Broadcom remains a major talking point in AI-focused market coverage, with some investors viewing it as an indicator for the broader market and semiconductor cycle. Jim Cramer Says Broadcom Will Tell You When the Market Is About to Turn Negative Sentiment: Broadcom is facing renewed skepticism around valuation, with one report asking whether the AI story has made the stock too expensive. Has Broadcom Become Too Expensive for Its AI Story? Negative Sentiment: The stock is also being hit by a broader selloff in semiconductor names as investors rotate away from AI-capex winners and worry about a slowdown in chip spending. Marvell Drops 8% as AI Capex Slowdown Fears Weigh on Chips; Broadcom, AMD, and Intel Slide Negative Sentiment: Broadcom is also dealing with regulatory uncertainty after reports said it faces an EU antitrust review tied to VMware licensing changes. Broadcom (AVGO) Faces EU Antitrust Review Over VMware Licensing Changes Analysts Set New Price Targets A number of research analysts recently weighed in on AVGO shares. Benchmark boosted their target price on Broadcom from $485.00 to $545.00 and gave the stock a “buy” rating in a report on Thursday, June 4th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $515.00 price target (up from $430.00) on shares of Broadcom in a report on Thursday, June 4th. DA Davidson upped their price objective on shares of Broadcom from $375.00 to $400.00 and gave the company a “neutral” rating in a report on Thursday, June 4th. Susquehanna reissued a “positive” rating and issued a $490.00 price objective (up from $450.00) on shares of Broadcom in a research report on Thursday, May 28th. Finally, TD Cowen restated a “buy” rating and set a $500.00 target price on shares of Broadcom in a research note on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $493.24.
View Our Latest Stock Analysis on AVGO
Insider Activity In related news, Director Harry L. You bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The shares were bought at an average price of $373.57 per share, for a total transaction of $373,570.00. Following the transaction, the director directly owned 38,466 shares of the company’s stock, valued at approximately $14,369,743.62. The trade was a 2.67% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Mark David Brazeal sold 25,000 shares of the stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $401.33, for a total transaction of $10,033,250.00. Following the transaction, the insider directly owned 194,989 shares in the company, valued at $78,254,935.37. This trade represents a 11.36% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 61,644 shares of company stock worth $24,016,214 over the last ninety days. Corporate insiders own 1.90% of the company’s stock.
Broadcom Profile (Free Report)
Broadcom Inc (NASDAQ: AVGO) is a global technology company that designs, develops and supplies semiconductor and infrastructure software solutions for a broad range of markets. The company’s semiconductor business provides components and systems for wired and wireless communications, enterprise and cloud storage, networking and broadband access, serving original equipment manufacturers, cloud service providers, telecommunications carriers and industrial customers worldwide. Broadcom is headquartered in Irvine, California, and operates globally with research, development and sales organizations across North America, Europe and Asia.
On the semiconductor side, Broadcom’s portfolio includes system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions, radio-frequency and connectivity components, Ethernet switching and PHY devices, storage adapters and controllers, optical transceivers and other networking silicon.
Read More Five stocks we like better than Broadcom Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.
Avanda Investment Management Pte. Ltd. raised its position in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) by 43.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,160 shares of the semiconductor manufacturer’s stock after purchasing an additional 2,760 shares during the quarter. Broadcom accounts for 4.5% of Avanda Investment Management Pte. Ltd.’s investment portfolio, making the stock its 6th biggest holding. Avanda Investment Management Pte. Ltd.’s holdings in Broadcom were worth $2,835,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. ROSS JOHNSON & Associates LLC lifted its stake in Broadcom by 1,320.0% in the 4th quarter. ROSS JOHNSON & Associates LLC now owns 71 shares of the semiconductor manufacturer’s stock worth $25,000 after acquiring an additional 66 shares in the last quarter. SWAN Capital LLC boosted its position in Broadcom by 261.9% during the 4th quarter. SWAN Capital LLC now owns 76 shares of the semiconductor manufacturer’s stock worth $26,000 after acquiring an additional 55 shares during the period. Networth Advisors LLC boosted its position in Broadcom by 546.2% during the 1st quarter. Networth Advisors LLC now owns 84 shares of the semiconductor manufacturer’s stock worth $26,000 after acquiring an additional 71 shares during the period. Miller Global Investments LLC purchased a new position in Broadcom during the 4th quarter valued at about $31,000. Finally, Nvest Wealth Strategies Inc. purchased a new position in Broadcom during the 4th quarter valued at about $33,000. Hedge funds and other institutional investors own 76.43% of the company’s stock.
Analyst Ratings Changes A number of research firms have recently issued reports on AVGO. The Goldman Sachs Group reissued a “buy” rating and issued a $525.00 price target on shares of Broadcom in a research report on Thursday, June 4th. Bank of America upped their price objective on shares of Broadcom from $450.00 to $530.00 and gave the company a “buy” rating in a research note on Thursday, June 4th. Truist Financial increased their target price on shares of Broadcom from $545.00 to $550.00 and gave the stock a “buy” rating in a research report on Thursday, June 4th. KeyCorp reiterated an “overweight” rating and issued a $575.00 target price (up from $500.00) on shares of Broadcom in a research report on Thursday, June 4th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $515.00 target price (up from $430.00) on shares of Broadcom in a research note on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $493.24.
View Our Latest Stock Report on AVGO
Broadcom News Summary Here are the key news stories impacting Broadcom this week:
Positive Sentiment: Standard Chartered chose Broadcom to support a long-term modernization of its global banking infrastructure, underscoring Broadcom’s role in secure private-cloud and enterprise networking solutions. Standard Chartered Selects Broadcom to Deliver Secure, Always-On Banking Services at Global Scale Positive Sentiment: Wall Street commentary continues to describe Broadcom as a core AI beneficiary, and some analysts have raised price targets even after the stock pullback. As Shares Fall, Analyst Are Boosting Their Broadcom Price Targets Neutral Sentiment: Broadcom remains a major talking point in AI-focused market coverage, with some investors viewing it as an indicator for the broader market and semiconductor cycle. Jim Cramer Says Broadcom Will Tell You When the Market Is About to Turn Negative Sentiment: Broadcom is facing renewed skepticism around valuation, with one report asking whether the AI story has made the stock too expensive. Has Broadcom Become Too Expensive for Its AI Story? Negative Sentiment: The stock is also being hit by a broader selloff in semiconductor names as investors rotate away from AI-capex winners and worry about a slowdown in chip spending. Marvell Drops 8% as AI Capex Slowdown Fears Weigh on Chips; Broadcom, AMD, and Intel Slide Negative Sentiment: Broadcom is also dealing with regulatory uncertainty after reports said it faces an EU antitrust review tied to VMware licensing changes. Broadcom (AVGO) Faces EU Antitrust Review Over VMware Licensing Changes Insider Buying and Selling at Broadcom In other news, Director Justine Page sold 1,602 shares of the stock in a transaction on Monday, June 29th. The shares were sold at an average price of $373.86, for a total transaction of $598,923.72. Following the transaction, the director owned 17,426 shares in the company, valued at $6,514,884.36. This represents a 8.42% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Harry L. You purchased 1,000 shares of the business’s stock in a transaction dated Thursday, June 11th. The shares were acquired at an average price of $373.57 per share, for a total transaction of $373,570.00. Following the acquisition, the director directly owned 38,466 shares in the company, valued at $14,369,743.62. This represents a 2.67% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have sold 61,644 shares of company stock worth $24,016,214. Company insiders own 1.90% of the company’s stock.
Broadcom Stock Down 1.0% Shares of Broadcom stock opened at $370.83 on Friday. The firm has a market cap of $1.76 trillion, a price-to-earnings ratio of 61.81, a P/E/G ratio of 0.65 and a beta of 1.45. The stock has a 50-day simple moving average of $401.29 and a 200-day simple moving average of $365.31. Broadcom Inc. has a 52-week low of $273.00 and a 52-week high of $495.00. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.24 and a quick ratio of 2.01.
Broadcom (NASDAQ:AVGO – Get Free Report) last released its quarterly earnings data on Wednesday, June 3rd. The semiconductor manufacturer reported $2.44 EPS for the quarter, topping analysts’ consensus estimates of $2.40 by $0.04. The firm had revenue of $22.19 billion for the quarter, compared to the consensus estimate of $22.13 billion. Broadcom had a return on equity of 41.61% and a net margin of 38.85%.The firm’s revenue was up 47.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.58 earnings per share. On average, equities research analysts expect that Broadcom Inc. will post 10.24 earnings per share for the current fiscal year.
Broadcom Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, June 22nd were given a $0.65 dividend. This represents a $2.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Monday, June 22nd. Broadcom’s payout ratio is currently 43.33%.
Broadcom Company Profile (Free Report)
Broadcom Inc (NASDAQ: AVGO) is a global technology company that designs, develops and supplies semiconductor and infrastructure software solutions for a broad range of markets. The company’s semiconductor business provides components and systems for wired and wireless communications, enterprise and cloud storage, networking and broadband access, serving original equipment manufacturers, cloud service providers, telecommunications carriers and industrial customers worldwide. Broadcom is headquartered in Irvine, California, and operates globally with research, development and sales organizations across North America, Europe and Asia.
On the semiconductor side, Broadcom’s portfolio includes system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions, radio-frequency and connectivity components, Ethernet switching and PHY devices, storage adapters and controllers, optical transceivers and other networking silicon.
See Also Five stocks we like better than Broadcom Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEHarel Insurance Investments & Financial Services Ltd. Has $227.96 Million Stake in Broadcom Inc. $AVGO
NEXT HEADLINE »Bank of New York Mellon Corp Reduces Stock Position in Broadcom Inc. $AVGO
Bank of New York Mellon Corp decreased its holdings in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) by 4.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,712,968 shares of the semiconductor manufacturer’s stock after selling 1,285,490 shares during the quarter. Broadcom makes up 1.6% of Bank of New York Mellon Corp’s holdings, making the stock its 6th biggest position. Bank of New York Mellon Corp owned about 0.61% of Broadcom worth $8,886,951,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Fullerton Advisors LLC lifted its stake in shares of Broadcom by 1.3% during the 1st quarter. Fullerton Advisors LLC now owns 1,989 shares of the semiconductor manufacturer’s stock worth $616,000 after buying an additional 25 shares during the last quarter. NORTHSTAR ASSET MANAGEMENT Co grew its stake in Broadcom by 0.5% in the 1st quarter. NORTHSTAR ASSET MANAGEMENT Co now owns 5,350 shares of the semiconductor manufacturer’s stock valued at $1,656,000 after buying an additional 25 shares during the last quarter. RFG Holdings Inc. raised its holdings in Broadcom by 0.3% in the 1st quarter. RFG Holdings Inc. now owns 8,499 shares of the semiconductor manufacturer’s stock valued at $2,631,000 after acquiring an additional 26 shares during the period. Yukon Wealth Management Inc. raised its holdings in Broadcom by 1.1% in the 1st quarter. Yukon Wealth Management Inc. now owns 2,501 shares of the semiconductor manufacturer’s stock valued at $774,000 after acquiring an additional 26 shares during the period. Finally, Capital Planning LLC lifted its position in Broadcom by 0.7% during the first quarter. Capital Planning LLC now owns 4,044 shares of the semiconductor manufacturer’s stock worth $1,252,000 after acquiring an additional 28 shares during the last quarter. 76.43% of the stock is owned by institutional investors.
Key Broadcom News Here are the key news stories impacting Broadcom this week:
Positive Sentiment: Standard Chartered chose Broadcom to support a long-term modernization of its global banking infrastructure, underscoring Broadcom’s role in secure private-cloud and enterprise networking solutions. Standard Chartered Selects Broadcom to Deliver Secure, Always-On Banking Services at Global Scale Positive Sentiment: Wall Street commentary continues to describe Broadcom as a core AI beneficiary, and some analysts have raised price targets even after the stock pullback. As Shares Fall, Analyst Are Boosting Their Broadcom Price Targets Neutral Sentiment: Broadcom remains a major talking point in AI-focused market coverage, with some investors viewing it as an indicator for the broader market and semiconductor cycle. Jim Cramer Says Broadcom Will Tell You When the Market Is About to Turn Negative Sentiment: Broadcom is facing renewed skepticism around valuation, with one report asking whether the AI story has made the stock too expensive. Has Broadcom Become Too Expensive for Its AI Story? Negative Sentiment: The stock is also being hit by a broader selloff in semiconductor names as investors rotate away from AI-capex winners and worry about a slowdown in chip spending. Marvell Drops 8% as AI Capex Slowdown Fears Weigh on Chips; Broadcom, AMD, and Intel Slide Negative Sentiment: Broadcom is also dealing with regulatory uncertainty after reports said it faces an EU antitrust review tied to VMware licensing changes. Broadcom (AVGO) Faces EU Antitrust Review Over VMware Licensing Changes Wall Street Analysts Forecast Growth Several equities analysts have recently commented on AVGO shares. Seaport Research Partners reaffirmed a “neutral” rating on shares of Broadcom in a research report on Wednesday, April 8th. Royal Bank Of Canada lifted their price target on Broadcom from $360.00 to $400.00 and gave the stock a “sector perform” rating in a report on Thursday, June 4th. The Goldman Sachs Group restated a “buy” rating and issued a $525.00 price target on shares of Broadcom in a research note on Thursday, June 4th. UBS Group set a $485.00 price objective on Broadcom and gave the company a “buy” rating in a report on Thursday, June 4th. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $545.00 target price (up from $430.00) on shares of Broadcom in a report on Thursday, May 14th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $493.24.
View Our Latest Stock Report on AVGO
Broadcom Trading Down 1.0% Shares of NASDAQ:AVGO opened at $370.83 on Friday. The company has a market capitalization of $1.76 trillion, a P/E ratio of 61.81, a P/E/G ratio of 0.65 and a beta of 1.45. Broadcom Inc. has a 1 year low of $273.00 and a 1 year high of $495.00. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.24 and a quick ratio of 2.01. The business’s 50 day simple moving average is $401.29 and its 200 day simple moving average is $365.31.
Broadcom (NASDAQ:AVGO – Get Free Report) last posted its quarterly earnings data on Wednesday, June 3rd. The semiconductor manufacturer reported $2.44 EPS for the quarter, topping analysts’ consensus estimates of $2.40 by $0.04. The firm had revenue of $22.19 billion for the quarter, compared to analyst estimates of $22.13 billion. Broadcom had a return on equity of 41.61% and a net margin of 38.85%.The company’s revenue was up 47.9% on a year-over-year basis. During the same quarter last year, the company earned $1.58 EPS. On average, research analysts anticipate that Broadcom Inc. will post 10.24 EPS for the current fiscal year.
Broadcom Dividend Announcement The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, June 22nd were given a $0.65 dividend. The ex-dividend date was Monday, June 22nd. This represents a $2.60 dividend on an annualized basis and a dividend yield of 0.7%. Broadcom’s dividend payout ratio (DPR) is presently 43.33%.
Insider Buying and Selling In related news, Director Justine Page sold 1,602 shares of the business’s stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $373.86, for a total value of $598,923.72. Following the completion of the transaction, the director owned 17,426 shares of the company’s stock, valued at $6,514,884.36. The trade was a 8.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Harry L. You acquired 1,000 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The shares were purchased at an average cost of $373.57 per share, with a total value of $373,570.00. Following the transaction, the director directly owned 38,466 shares of the company’s stock, valued at $14,369,743.62. This trade represents a 2.67% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders sold 61,644 shares of company stock worth $24,016,214 in the last ninety days. 1.90% of the stock is owned by company insiders.
Broadcom Profile (Free Report)
Broadcom Inc (NASDAQ: AVGO) is a global technology company that designs, develops and supplies semiconductor and infrastructure software solutions for a broad range of markets. The company’s semiconductor business provides components and systems for wired and wireless communications, enterprise and cloud storage, networking and broadband access, serving original equipment manufacturers, cloud service providers, telecommunications carriers and industrial customers worldwide. Broadcom is headquartered in Irvine, California, and operates globally with research, development and sales organizations across North America, Europe and Asia.
On the semiconductor side, Broadcom’s portfolio includes system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions, radio-frequency and connectivity components, Ethernet switching and PHY devices, storage adapters and controllers, optical transceivers and other networking silicon.
Read More Five stocks we like better than Broadcom Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding AVGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Broadcom Inc. (NASDAQ:AVGO – Free Report).
Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.
Blackhawk Capital Partners LLC increased its holdings in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) by 37.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 11,404 shares of the semiconductor manufacturer’s stock after acquiring an additional 3,130 shares during the period. Broadcom makes up about 1.3% of Blackhawk Capital Partners LLC’s portfolio, making the stock its 17th largest holding. Blackhawk Capital Partners LLC’s holdings in Broadcom were worth $3,530,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Fullerton Advisors LLC grew its holdings in Broadcom by 1.3% in the first quarter. Fullerton Advisors LLC now owns 1,989 shares of the semiconductor manufacturer’s stock valued at $616,000 after purchasing an additional 25 shares during the period. NORTHSTAR ASSET MANAGEMENT Co increased its position in shares of Broadcom by 0.5% in the first quarter. NORTHSTAR ASSET MANAGEMENT Co now owns 5,350 shares of the semiconductor manufacturer’s stock valued at $1,656,000 after buying an additional 25 shares in the last quarter. RFG Holdings Inc. raised its stake in shares of Broadcom by 0.3% during the 1st quarter. RFG Holdings Inc. now owns 8,499 shares of the semiconductor manufacturer’s stock worth $2,631,000 after buying an additional 26 shares during the period. Yukon Wealth Management Inc. raised its stake in shares of Broadcom by 1.1% during the 1st quarter. Yukon Wealth Management Inc. now owns 2,501 shares of the semiconductor manufacturer’s stock worth $774,000 after buying an additional 26 shares during the period. Finally, Capital Planning LLC lifted its position in shares of Broadcom by 0.7% during the 1st quarter. Capital Planning LLC now owns 4,044 shares of the semiconductor manufacturer’s stock valued at $1,252,000 after buying an additional 28 shares in the last quarter. Hedge funds and other institutional investors own 76.43% of the company’s stock.
Key Stories Impacting Broadcom Here are the key news stories impacting Broadcom this week:
Positive Sentiment: Standard Chartered chose Broadcom to support a long-term modernization of its global banking infrastructure, underscoring Broadcom’s role in secure private-cloud and enterprise networking solutions. Standard Chartered Selects Broadcom to Deliver Secure, Always-On Banking Services at Global Scale Positive Sentiment: Wall Street commentary continues to describe Broadcom as a core AI beneficiary, and some analysts have raised price targets even after the stock pullback. As Shares Fall, Analyst Are Boosting Their Broadcom Price Targets Neutral Sentiment: Broadcom remains a major talking point in AI-focused market coverage, with some investors viewing it as an indicator for the broader market and semiconductor cycle. Jim Cramer Says Broadcom Will Tell You When the Market Is About to Turn Negative Sentiment: Broadcom is facing renewed skepticism around valuation, with one report asking whether the AI story has made the stock too expensive. Has Broadcom Become Too Expensive for Its AI Story? Negative Sentiment: The stock is also being hit by a broader selloff in semiconductor names as investors rotate away from AI-capex winners and worry about a slowdown in chip spending. Marvell Drops 8% as AI Capex Slowdown Fears Weigh on Chips; Broadcom, AMD, and Intel Slide Negative Sentiment: Broadcom is also dealing with regulatory uncertainty after reports said it faces an EU antitrust review tied to VMware licensing changes. Broadcom (AVGO) Faces EU Antitrust Review Over VMware Licensing Changes Analysts Set New Price Targets A number of research firms recently issued reports on AVGO. Jefferies Financial Group set a $550.00 price target on shares of Broadcom and gave the company a “buy” rating in a research note on Thursday, June 4th. Dbs Bank upgraded shares of Broadcom to a “moderate buy” rating in a research report on Thursday, June 18th. Bank of America increased their price objective on shares of Broadcom from $450.00 to $530.00 and gave the company a “buy” rating in a report on Thursday, June 4th. Benchmark lifted their target price on shares of Broadcom from $485.00 to $545.00 and gave the company a “buy” rating in a research report on Thursday, June 4th. Finally, Morgan Stanley set a $502.00 target price on shares of Broadcom and gave the stock an “overweight” rating in a research note on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Broadcom presently has an average rating of “Moderate Buy” and an average price target of $493.24.
Read Our Latest Stock Report on AVGO
Broadcom Stock Performance Shares of NASDAQ:AVGO opened at $370.83 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.24 and a quick ratio of 2.01. Broadcom Inc. has a 1 year low of $273.00 and a 1 year high of $495.00. The firm has a market capitalization of $1.76 trillion, a PE ratio of 61.81, a P/E/G ratio of 0.65 and a beta of 1.45. The business’s 50 day moving average price is $401.29 and its 200-day moving average price is $365.31.
Broadcom (NASDAQ:AVGO – Get Free Report) last posted its quarterly earnings data on Wednesday, June 3rd. The semiconductor manufacturer reported $2.44 EPS for the quarter, beating the consensus estimate of $2.40 by $0.04. Broadcom had a return on equity of 41.61% and a net margin of 38.85%.The firm had revenue of $22.19 billion during the quarter, compared to the consensus estimate of $22.13 billion. During the same period in the prior year, the company earned $1.58 EPS. The firm’s revenue was up 47.9% compared to the same quarter last year. As a group, equities research analysts expect that Broadcom Inc. will post 10.24 earnings per share for the current fiscal year.
Broadcom Announces Dividend The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, June 22nd were given a dividend of $0.65 per share. The ex-dividend date was Monday, June 22nd. This represents a $2.60 dividend on an annualized basis and a yield of 0.7%. Broadcom’s payout ratio is presently 43.33%.
Insider Buying and Selling at Broadcom In other Broadcom news, Director Harry L. You bought 1,000 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were acquired at an average cost of $373.57 per share, with a total value of $373,570.00. Following the purchase, the director directly owned 38,466 shares of the company’s stock, valued at $14,369,743.62. This trade represents a 2.67% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Mark David Brazeal sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $401.33, for a total transaction of $10,033,250.00. Following the completion of the transaction, the insider directly owned 194,989 shares in the company, valued at $78,254,935.37. This trade represents a 11.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 61,644 shares of company stock valued at $24,016,214. Insiders own 1.90% of the company’s stock.
Broadcom Profile (Free Report)
Broadcom Inc (NASDAQ: AVGO) is a global technology company that designs, develops and supplies semiconductor and infrastructure software solutions for a broad range of markets. The company’s semiconductor business provides components and systems for wired and wireless communications, enterprise and cloud storage, networking and broadband access, serving original equipment manufacturers, cloud service providers, telecommunications carriers and industrial customers worldwide. Broadcom is headquartered in Irvine, California, and operates globally with research, development and sales organizations across North America, Europe and Asia.
On the semiconductor side, Broadcom’s portfolio includes system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions, radio-frequency and connectivity components, Ethernet switching and PHY devices, storage adapters and controllers, optical transceivers and other networking silicon.
Featured Articles Five stocks we like better than Broadcom Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.
Geneos Wealth Management Inc. reduced its position in Broadcom Inc. (NASDAQ:AVGO – Free Report) by 7.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 51,899 shares of the semiconductor manufacturer’s stock after selling 4,280 shares during the period. Geneos Wealth Management Inc.’s holdings in Broadcom were worth $16,063,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. ROSS JOHNSON & Associates LLC increased its holdings in Broadcom by 1,320.0% in the fourth quarter. ROSS JOHNSON & Associates LLC now owns 71 shares of the semiconductor manufacturer’s stock worth $25,000 after buying an additional 66 shares during the last quarter. SWAN Capital LLC raised its position in Broadcom by 261.9% during the fourth quarter. SWAN Capital LLC now owns 76 shares of the semiconductor manufacturer’s stock valued at $26,000 after acquiring an additional 55 shares in the last quarter. Networth Advisors LLC lifted its stake in Broadcom by 546.2% in the first quarter. Networth Advisors LLC now owns 84 shares of the semiconductor manufacturer’s stock valued at $26,000 after acquiring an additional 71 shares during the last quarter. Miller Global Investments LLC acquired a new stake in Broadcom in the fourth quarter valued at approximately $31,000. Finally, Nvest Wealth Strategies Inc. bought a new stake in Broadcom in the fourth quarter worth approximately $33,000. 76.43% of the stock is owned by hedge funds and other institutional investors.
Broadcom Trading Down 1.0% Shares of AVGO stock opened at $370.83 on Friday. Broadcom Inc. has a 12 month low of $273.00 and a 12 month high of $495.00. The company has a market cap of $1.76 trillion, a PE ratio of 61.81, a price-to-earnings-growth ratio of 0.65 and a beta of 1.45. The company has a quick ratio of 2.01, a current ratio of 2.24 and a debt-to-equity ratio of 0.71. The business’s 50 day moving average is $401.29 and its two-hundred day moving average is $365.31.
Broadcom (NASDAQ:AVGO – Get Free Report) last issued its quarterly earnings data on Wednesday, June 3rd. The semiconductor manufacturer reported $2.44 earnings per share for the quarter, topping analysts’ consensus estimates of $2.40 by $0.04. The business had revenue of $22.19 billion during the quarter, compared to analysts’ expectations of $22.13 billion. Broadcom had a net margin of 38.85% and a return on equity of 41.61%. Broadcom’s revenue for the quarter was up 47.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.58 earnings per share. Equities analysts predict that Broadcom Inc. will post 10.24 EPS for the current year.
Broadcom Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, June 22nd were issued a $0.65 dividend. This represents a $2.60 annualized dividend and a yield of 0.7%. The ex-dividend date was Monday, June 22nd. Broadcom’s dividend payout ratio (DPR) is 43.33%.
Trending Headlines about Broadcom Here are the key news stories impacting Broadcom this week:
Positive Sentiment: Standard Chartered chose Broadcom to support a long-term modernization of its global banking infrastructure, underscoring Broadcom’s role in secure private-cloud and enterprise networking solutions. Standard Chartered Selects Broadcom to Deliver Secure, Always-On Banking Services at Global Scale Positive Sentiment: Wall Street commentary continues to describe Broadcom as a core AI beneficiary, and some analysts have raised price targets even after the stock pullback. As Shares Fall, Analyst Are Boosting Their Broadcom Price Targets Neutral Sentiment: Broadcom remains a major talking point in AI-focused market coverage, with some investors viewing it as an indicator for the broader market and semiconductor cycle. Jim Cramer Says Broadcom Will Tell You When the Market Is About to Turn Negative Sentiment: Broadcom is facing renewed skepticism around valuation, with one report asking whether the AI story has made the stock too expensive. Has Broadcom Become Too Expensive for Its AI Story? Negative Sentiment: The stock is also being hit by a broader selloff in semiconductor names as investors rotate away from AI-capex winners and worry about a slowdown in chip spending. Marvell Drops 8% as AI Capex Slowdown Fears Weigh on Chips; Broadcom, AMD, and Intel Slide Negative Sentiment: Broadcom is also dealing with regulatory uncertainty after reports said it faces an EU antitrust review tied to VMware licensing changes. Broadcom (AVGO) Faces EU Antitrust Review Over VMware Licensing Changes Wall Street Analyst Weigh In Several research analysts have recently commented on the stock. Oppenheimer restated an “outperform” rating and set a $535.00 price target (up from $450.00) on shares of Broadcom in a research note on Thursday, June 4th. Benchmark lifted their price objective on shares of Broadcom from $485.00 to $545.00 and gave the company a “buy” rating in a research note on Thursday, June 4th. The Goldman Sachs Group reiterated a “buy” rating and issued a $525.00 price objective on shares of Broadcom in a report on Thursday, June 4th. Dbs Bank raised shares of Broadcom to a “moderate buy” rating in a research report on Thursday, June 18th. Finally, JPMorgan Chase & Co. raised their target price on Broadcom from $500.00 to $580.00 and gave the company an “overweight” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $493.24.
Check Out Our Latest Research Report on Broadcom
Insider Activity In other Broadcom news, Director Gayla J. Delly sold 1,890 shares of the company’s stock in a transaction dated Wednesday, July 8th. The shares were sold at an average price of $385.38, for a total transaction of $728,368.20. Following the completion of the sale, the director directly owned 31,326 shares in the company, valued at $12,072,413.88. This represents a 5.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Harry L. You purchased 1,000 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were purchased at an average price of $373.57 per share, with a total value of $373,570.00. Following the completion of the acquisition, the director directly owned 38,466 shares of the company’s stock, valued at approximately $14,369,743.62. This trade represents a 2.67% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders sold 61,644 shares of company stock worth $24,016,214 in the last 90 days. Insiders own 1.90% of the company’s stock.
Broadcom Profile (Free Report)
Broadcom Inc (NASDAQ: AVGO) is a global technology company that designs, develops and supplies semiconductor and infrastructure software solutions for a broad range of markets. The company’s semiconductor business provides components and systems for wired and wireless communications, enterprise and cloud storage, networking and broadband access, serving original equipment manufacturers, cloud service providers, telecommunications carriers and industrial customers worldwide. Broadcom is headquartered in Irvine, California, and operates globally with research, development and sales organizations across North America, Europe and Asia.
On the semiconductor side, Broadcom’s portfolio includes system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions, radio-frequency and connectivity components, Ethernet switching and PHY devices, storage adapters and controllers, optical transceivers and other networking silicon.
See Also Five stocks we like better than Broadcom Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding AVGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Broadcom Inc. (NASDAQ:AVGO – Free Report).
Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBlackhawk Capital Partners LLC Boosts Stake in Broadcom Inc. $AVGO
Taiwan Semiconductor Manufacturing (TSM 2.96%) just reported earnings, showcasing that the AI build-out is alive and well. This makes several stocks attractive buys, including TSMC itself. I'm also bullish on Nvidia (NVDA 1.97%) and Broadcom (AVGO 0.70%), as increased semiconductor demand means that these two will sell more chips.
That's a bullish combination, and if you've missed out on the massive gain of these three over the past few years, now is the perfect time to buy, as they're each on sale.
Image source: Getty Images.
1. Taiwan Semiconductor Manufacturing TSMC has had a rough few weeks and is down about 15% from its all-time high despite reporting incredible second quarter earnings. When a company reports strong earnings and gives a rosy outlook, yet the stock doesn't rally, that's my sign as an investor that the market isn't fully buying what TSMC is selling, which leaves a great investment opportunity for individual investors who can be contrarian.
Today's Change
(
-2.96
%) $
-12.12
Current Price
$
397.62
During Q2, TSMC's revenue increased 36% year over year (in New Taiwan Dollars), and earnings per share skyrocketed 77%, showcasing improving operating leverage. TSMC has a grip on the chip industry, as it's the only one with enough capacity and advanced enough technology to support a major AI computing build-out, so as long as demand persists, TSMC will be a great investment.
Speaking of investments, TSMC is planning to invest another $100 billion in its Arizona fabrication facilities, highlighting growing demand for chips.
If the AI build-out were nearing completion, TSMC would be more cautious to invest this large sum in new production. However, CEO C.C. Wei stated that strong chip demand will persist through 2029 or 2030. This bodes well for TSMC's future and the other two. It's a great buy now and will remain a top stock pick in the AI-fueled market.
2. Nvidia Nvidia's stock has rallied over the past few weeks, but it's still down more than 10% from its all-time high. With TSMC's strong future projections, it's clear that Nvidia will be in a great spot, and Wall Street analysts back this up.
For the remainder of the current fiscal year, Wall Street analysts estimate 82% revenue growth for Nvidia and 42% next year. That's strong growth for the world's largest company, yet none of that is priced into the stock.
When you analyze Nvidia's stock price using next year's earnings estimates, it looks incredibly cheap, and I wouldn't be surprised to see it rally by the end of the year to bring its valuation back up, much like it has each of the past two years.
NVDA PE Ratio (Forward) data by YCharts
This bodes well for Nvidia's future, and I think it's one of the top stocks to buy in the market.
3. Broadcom Broadcom is the furthest from its all-time high of the trio, recently down more than 20%. However, its future is arguably brighter than either Nvidia or TSMC.
For the remainder of this year and into next, Broadcom expects massive growth from its custom AI chip business. Next year, Broadcom expects $100 billion in AI semiconductor revenue, yet this division reported only $10.8 billion in revenue last quarter. This indicates huge, explosive growth over the next year and will transform Broadcom into a completely new business.
Today's Change
(
-0.70
%) $
-2.64
Current Price
$
371.81
After Broadcom's sell-off, the stock is more reasonably priced at 32 times forward earnings, but it's still quite expensive overall. However, with major growth expected next year, looking at FY 2027 earnings estimates to value the stock is also smart (as with Nvidia). Broadcom trades for 19 times next year's earnings, which isn't a bad price to pay at all for a rising star in the AI world.
All three stocks are fantastic buys right now, and investors should be loading up on them before the market gets bullish on AI again.
Archer Daniels Midland (NYSE:ADM – Get Free Report) and Edible Garden (NASDAQ:EDBL – Get Free Report) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.
Earnings & Valuation This table compares Archer Daniels Midland and Edible Garden”s top-line revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Archer Daniels Midland $80.58 billion 0.51 $1.08 billion $2.23 38.50 Edible Garden $12.81 million 0.03 -$17.33 million ($4,939.64) -0.00 Archer Daniels Midland has higher revenue and earnings than Edible Garden. Edible Garden is trading at a lower price-to-earnings ratio than Archer Daniels Midland, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings This is a breakdown of current ratings and target prices for Archer Daniels Midland and Edible Garden, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Archer Daniels Midland 2 5 1 0 1.88 Edible Garden 1 0 1 0 2.00 Archer Daniels Midland presently has a consensus price target of $75.33, suggesting a potential downside of 12.26%. Edible Garden has a consensus price target of $45.00, suggesting a potential upside of 1,293.19%. Given Edible Garden’s stronger consensus rating and higher possible upside, analysts clearly believe Edible Garden is more favorable than Archer Daniels Midland.
Insider & Institutional Ownership 78.3% of Archer Daniels Midland shares are held by institutional investors. Comparatively, 13.0% of Edible Garden shares are held by institutional investors. 0.6% of Archer Daniels Midland shares are held by insiders. Comparatively, 0.8% of Edible Garden shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability This table compares Archer Daniels Midland and Edible Garden’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Archer Daniels Midland 1.34% 7.37% 3.15% Edible Garden -131.59% N/A -88.36% Risk and Volatility Archer Daniels Midland has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Edible Garden has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500.
Summary Archer Daniels Midland beats Edible Garden on 9 of the 13 factors compared between the two stocks.
About Archer Daniels Midland (Get Free Report)
Archer-Daniels-Midland Company engages in the procurement, transportation, storage, processing, and merchandising of agricultural commodities, ingredients, flavors, and solutions in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. It operates in three segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The company originates, merchandises, stores, and transports agricultural raw materials, such as oilseeds and soft seeds. It also engages in the agricultural commodity and feed product import, export, and distribution; and various structured trade finance activities. In addition, the company offers soybean meal and oil; vegetable and salad oils and protein meals; ingredients for the food, feed, energy, and industrial customers; margarine, shortening, and other food products; and partially refined oils to produce biodiesel and glycols for use in chemicals, paints, and other industrial products. Further, it provides peanuts, peanut-derived ingredients, and cotton cellulose pulp; sweeteners, corn and wheat starches, syrup, glucose, wheat flour, and dextrose; alcohol, and other food and animal feed ingredients; ethyl alcohol and ethanol; corn gluten feed and meal; distillers' grains; corn germ; and citric acids. Additionally, the company provides proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, postbiotics, enzymes, and botanical extracts; and other specialty food and feed ingredients; edible beans; formula feeds, and animal health and nutrition products; and contract and private label pet treats and food products. It also offers futures commission merchant; commodity brokerage services; cash margins and securities pledged to commodity exchange clearinghouse; and cash pledged as security under certain insurance arrangements. The company was founded in 1902 and is headquartered in Chicago, Illinois.
About Edible Garden (Get Free Report)
Edible Garden AG Incorporated, together with its subsidiaries, operate as a controlled environment agriculture farming company. It offers various packaged products, including cilantro, rosemary, mint, thyme, oregano, bay leaves, chives, poultry mix, sage, dill, buttercrunch living lettuce, basil, living butterhead lettuce, basil, parsley, arugula spring mix, baby arugula blend, baby romaine, and crisp ranch and Caesar salad kits. The company sells its products to various regional and national supermarkets. Edible Garden AG Incorporated was founded in 2020 and is based in Belvidere, New Jersey.
Receive News & Ratings for Archer Daniels Midland Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Archer Daniels Midland and related companies with MarketBeat.com's FREE daily email newsletter.
Bessemer Group Inc. reduced its position in Ryman Hospitality Properties, Inc. (NYSE:RHP – Free Report) by 23.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 187,126 shares of the real estate investment trust’s stock after selling 57,820 shares during the quarter. Bessemer Group Inc. owned approximately 0.30% of Ryman Hospitality Properties worth $17,265,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Global Retirement Partners LLC raised its stake in shares of Ryman Hospitality Properties by 155.0% in the 4th quarter. Global Retirement Partners LLC now owns 283 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 172 shares in the last quarter. International Assets Investment Management LLC boosted its position in shares of Ryman Hospitality Properties by 437.0% during the 1st quarter. International Assets Investment Management LLC now owns 290 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 236 shares in the last quarter. Los Angeles Capital Management LLC bought a new stake in Ryman Hospitality Properties in the fourth quarter valued at about $28,000. Caitong International Asset Management Co. Ltd increased its stake in Ryman Hospitality Properties by 61.7% in the third quarter. Caitong International Asset Management Co. Ltd now owns 296 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 113 shares during the period. Finally, Geneos Wealth Management Inc. increased its stake in Ryman Hospitality Properties by 240.2% in the first quarter. Geneos Wealth Management Inc. now owns 296 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 209 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.
Ryman Hospitality Properties Stock Up 1.5% RHP opened at $126.83 on Friday. The firm has a market cap of $8.00 billion, a price-to-earnings ratio of 33.46, a PEG ratio of 2.29 and a beta of 1.20. The company has a debt-to-equity ratio of 5.15, a quick ratio of 1.35 and a current ratio of 1.35. The firm’s 50-day simple moving average is $120.01 and its 200-day simple moving average is $105.35. Ryman Hospitality Properties, Inc. has a twelve month low of $83.82 and a twelve month high of $132.41.
Ryman Hospitality Properties Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th were paid a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a yield of 3.8%. The ex-dividend date of this dividend was Tuesday, June 30th. Ryman Hospitality Properties’s dividend payout ratio is currently 126.65%.
Analyst Upgrades and Downgrades A number of research analysts have commented on RHP shares. Morgan Stanley raised their price target on shares of Ryman Hospitality Properties from $105.00 to $112.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. BMO Capital Markets reiterated an “outperform” rating and issued a $137.00 price objective on shares of Ryman Hospitality Properties in a research note on Friday, June 12th. Barclays upped their price objective on Ryman Hospitality Properties from $110.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. JPMorgan Chase & Co. increased their target price on Ryman Hospitality Properties from $111.00 to $113.00 and gave the stock an “overweight” rating in a report on Tuesday, May 5th. Finally, Truist Financial raised their target price on Ryman Hospitality Properties from $129.00 to $132.00 and gave the stock a “buy” rating in a research report on Tuesday, May 26th. Eleven research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Ryman Hospitality Properties currently has an average rating of “Moderate Buy” and an average price target of $122.27.
Ryman Hospitality Properties, Inc is a publicly traded real estate investment trust (REIT) specializing in the ownership and operation of group‐oriented, large convention center hotel resorts. The company’s portfolio is anchored by its Gaylord Hotels brand, offering integrated resort, convention, entertainment and dining experiences under long‐term management agreements with Marriott International.
Ryman’s flagship properties include Gaylord Opryland Resort & Convention Center in Nashville, Gaylord Texan Resort & Convention Center near Dallas/Fort Worth and Gaylord Palms Resort & Convention Center in Orlando, Florida.
See Also Five stocks we like better than Ryman Hospitality Properties Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding RHP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryman Hospitality Properties, Inc. (NYSE:RHP – Free Report).
Receive News & Ratings for Ryman Hospitality Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryman Hospitality Properties and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEShort Interest in Rocket One Inc. Common Stock (NASDAQ:RKTO) Decreases By 36.3%
NEXT HEADLINE »Relmada Therapeutics, Inc. (NASDAQ:RLMD) Sees Significant Growth in Short Interest
Financiere des Professionnels Fonds d investissement inc. cut its position in PPG Industries, Inc. (NYSE:PPG – Free Report) by 96.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,700 shares of the specialty chemicals company’s stock after selling 42,486 shares during the quarter. Financiere des Professionnels Fonds d investissement inc.’s holdings in PPG Industries were worth $182,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. CNB Bank boosted its position in shares of PPG Industries by 1.8% during the fourth quarter. CNB Bank now owns 4,514 shares of the specialty chemicals company’s stock worth $463,000 after buying an additional 80 shares during the period. IFP Advisors Inc increased its position in PPG Industries by 2.7% in the 4th quarter. IFP Advisors Inc now owns 3,302 shares of the specialty chemicals company’s stock valued at $338,000 after acquiring an additional 87 shares during the period. Whittier Trust Co. increased its position in PPG Industries by 1.4% in the 4th quarter. Whittier Trust Co. now owns 6,658 shares of the specialty chemicals company’s stock valued at $703,000 after acquiring an additional 89 shares during the period. Evolve Private Wealth LLC raised its stake in PPG Industries by 3.2% during the 1st quarter. Evolve Private Wealth LLC now owns 2,929 shares of the specialty chemicals company’s stock valued at $313,000 after acquiring an additional 92 shares in the last quarter. Finally, Insigneo Advisory Services LLC raised its stake in PPG Industries by 4.3% during the 4th quarter. Insigneo Advisory Services LLC now owns 2,234 shares of the specialty chemicals company’s stock valued at $229,000 after acquiring an additional 92 shares in the last quarter. 81.86% of the stock is owned by institutional investors and hedge funds.
PPG Industries Trading Down 1.1% Shares of PPG stock opened at $117.39 on Friday. The stock has a 50-day simple moving average of $114.79 and a 200 day simple moving average of $112.87. PPG Industries, Inc. has a fifty-two week low of $93.39 and a fifty-two week high of $133.43. The stock has a market capitalization of $26.17 billion, a P/E ratio of 16.75, a P/E/G ratio of 1.72 and a beta of 1.05. The company has a quick ratio of 1.17, a current ratio of 1.61 and a debt-to-equity ratio of 0.78.
PPG Industries (NYSE:PPG – Get Free Report) last issued its quarterly earnings results on Tuesday, April 28th. The specialty chemicals company reported $1.83 EPS for the quarter, topping the consensus estimate of $1.78 by $0.05. PPG Industries had a net margin of 9.83% and a return on equity of 21.68%. The firm had revenue of $3.93 billion for the quarter, compared to analysts’ expectations of $3.85 billion. During the same period in the previous year, the business earned $1.72 earnings per share. PPG Industries’s revenue for the quarter was up 6.7% compared to the same quarter last year. PPG Industries has set its FY 2026 guidance at 7.700-8.100 EPS. On average, sell-side analysts expect that PPG Industries, Inc. will post 7.94 earnings per share for the current fiscal year.
PPG Industries Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Monday, August 10th will be issued a $0.74 dividend. This represents a $2.96 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Monday, August 10th. This is an increase from PPG Industries’s previous quarterly dividend of $0.71. PPG Industries’s payout ratio is presently 42.23%.
Analysts Set New Price Targets A number of brokerages have recently commented on PPG. Wells Fargo & Company lowered their price target on PPG Industries from $135.00 to $130.00 and set an “overweight” rating on the stock in a report on Friday, April 10th. Deutsche Bank Aktiengesellschaft increased their target price on shares of PPG Industries from $120.00 to $130.00 in a research report on Friday, March 27th. BMO Capital Markets dropped their price target on shares of PPG Industries from $140.00 to $138.00 and set an “outperform” rating on the stock in a research report on Monday, July 6th. Mizuho increased their price objective on shares of PPG Industries from $125.00 to $135.00 and gave the company an “outperform” rating in a report on Wednesday, July 1st. Finally, BNP Paribas Exane increased their price objective on shares of PPG Industries from $115.00 to $116.00 in a report on Thursday, April 30th. Seven equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $126.13.
Get Our Latest Analysis on PPG Industries
About PPG Industries (Free Report)
PPG Industries is a global supplier of paints, coatings and specialty materials that serves industrial, transportation, consumer and construction markets. Founded in 1883 as the Pittsburgh Plate Glass Company, PPG has evolved from its origins in glass manufacturing into a diversified coatings and materials company headquartered in Pittsburgh, Pennsylvania. The company develops and manufactures a broad array of products used to protect and enhance surfaces, from consumer paints to highly engineered coatings for demanding industrial applications.
PPG’s product portfolio includes architectural and decorative paints, automotive original equipment and refinish coatings, industrial coatings for machinery and equipment, protective and marine coatings, aerospace and defense coatings, and packaging coatings and materials.
Further Reading Five stocks we like better than PPG Industries Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding PPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PPG Industries, Inc. (NYSE:PPG – Free Report).
Receive News & Ratings for PPG Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PPG Industries and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINESonos (NASDAQ:SONO) Trading Up 5.2% – Should You Buy?
NEXT HEADLINE »Simmons First National (NASDAQ:SFNC) Sees Large Volume Increase – Here’s Why
Copeland Capital Management LLC cut its holdings in shares of Automatic Data Processing, Inc. (NASDAQ:ADP – Free Report) by 90.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,178 shares of the business services provider’s stock after selling 38,477 shares during the quarter. Copeland Capital Management LLC’s holdings in Automatic Data Processing were worth $849,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of ADP. Assetmark Inc. grew its holdings in shares of Automatic Data Processing by 25.3% in the 1st quarter. Assetmark Inc. now owns 25,074 shares of the business services provider’s stock valued at $5,095,000 after acquiring an additional 5,057 shares in the last quarter. Angeles Wealth Management LLC increased its position in shares of Automatic Data Processing by 14.7% in the first quarter. Angeles Wealth Management LLC now owns 2,197 shares of the business services provider’s stock valued at $450,000 after acquiring an additional 281 shares during the last quarter. Financiere des Professionnels Fonds d investissement inc. bought a new stake in Automatic Data Processing during the first quarter worth about $163,000. Allspring Global Investments Holdings LLC boosted its position in Automatic Data Processing by 12.0% during the first quarter. Allspring Global Investments Holdings LLC now owns 53,157 shares of the business services provider’s stock valued at $10,699,000 after purchasing an additional 5,714 shares during the last quarter. Finally, Independent Financial Group LLC acquired a new position in Automatic Data Processing during the first quarter valued at approximately $421,000. 80.03% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth ADP has been the topic of several recent analyst reports. UBS Group boosted their price target on Automatic Data Processing from $210.00 to $218.00 and gave the stock a “neutral” rating in a research report on Thursday, April 30th. BMO Capital Markets dropped their price objective on Automatic Data Processing from $281.00 to $234.00 and set a “market perform” rating on the stock in a research note on Tuesday, April 7th. Jefferies Financial Group cut their price objective on Automatic Data Processing from $230.00 to $190.00 in a report on Thursday, April 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of Automatic Data Processing in a research note on Tuesday, July 7th. Finally, Morgan Stanley lowered their target price on shares of Automatic Data Processing from $311.00 to $274.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 28th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $248.64.
Read Our Latest Research Report on ADP
Automatic Data Processing Stock Performance Shares of ADP stock opened at $255.26 on Friday. The company has a market capitalization of $102.04 billion, a price-to-earnings ratio of 23.81 and a beta of 0.83. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.04 and a current ratio of 1.04. The company has a 50-day simple moving average of $228.00 and a 200 day simple moving average of $224.86. Automatic Data Processing, Inc. has a 52 week low of $188.16 and a 52 week high of $315.98.
Automatic Data Processing (NASDAQ:ADP – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The business services provider reported $3.37 EPS for the quarter, beating analysts’ consensus estimates of $3.30 by $0.07. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.85 billion. Automatic Data Processing had a net margin of 20.12% and a return on equity of 68.82%. Automatic Data Processing’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.06 EPS. Automatic Data Processing has set its FY 2026 guidance at 11.010-11.110 EPS. On average, sell-side analysts predict that Automatic Data Processing, Inc. will post 11.08 earnings per share for the current year.
Automatic Data Processing Company Profile (Free Report)
Automatic Data Processing, Inc (ADP) is a global provider of cloud-based human capital management (HCM) and payroll solutions. Founded in 1949 and headquartered in Roseland, New Jersey, ADP began as a payroll processing company and has evolved into a diversified provider of workforce management, HR, benefits administration, tax and compliance services, and analytics for employers of all sizes.
ADP’s product portfolio includes payroll processing and tax filing, time and attendance systems, benefits administration, talent management, and HR outsourcing.
Recommended Stories Five stocks we like better than Automatic Data Processing Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding ADP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Automatic Data Processing, Inc. (NASDAQ:ADP – Free Report).
Receive News & Ratings for Automatic Data Processing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Automatic Data Processing and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECorvus Pharmaceuticals (NASDAQ:CRVS) Trading Up 5.1% – Should You Buy?
NEXT HEADLINE »Copeland Capital Management LLC Boosts Stock Holdings in Wabtec $WAB
Copeland Capital Management LLC trimmed its position in The Sherwin-Williams Company (NYSE:SHW – Free Report) by 97.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,027 shares of the specialty chemicals company’s stock after selling 36,415 shares during the quarter. Copeland Capital Management LLC’s holdings in Sherwin-Williams were worth $329,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in SHW. Assetmark Inc. grew its position in Sherwin-Williams by 0.7% in the first quarter. Assetmark Inc. now owns 33,178 shares of the specialty chemicals company’s stock worth $10,635,000 after acquiring an additional 232 shares during the period. Angeles Wealth Management LLC increased its stake in Sherwin-Williams by 0.4% during the first quarter. Angeles Wealth Management LLC now owns 12,152 shares of the specialty chemicals company’s stock worth $3,895,000 after acquiring an additional 46 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in Sherwin-Williams by 22.6% in the first quarter. Allspring Global Investments Holdings LLC now owns 263,709 shares of the specialty chemicals company’s stock valued at $85,890,000 after purchasing an additional 48,540 shares during the period. Independent Financial Group LLC purchased a new stake in Sherwin-Williams in the first quarter valued at $1,535,000. Finally, Aware Super Pty Ltd as trustee of Aware Super acquired a new position in shares of Sherwin-Williams in the 1st quarter valued at $20,087,000. Hedge funds and other institutional investors own 77.67% of the company’s stock.
Sherwin-Williams Trading Down 1.9% Shares of NYSE SHW opened at $331.57 on Friday. The Sherwin-Williams Company has a twelve month low of $289.86 and a twelve month high of $379.65. The company has a current ratio of 0.86, a quick ratio of 0.53 and a debt-to-equity ratio of 2.10. The stock has a fifty day simple moving average of $319.72 and a 200-day simple moving average of $332.48. The stock has a market capitalization of $81.78 billion, a PE ratio of 31.82, a PEG ratio of 2.86 and a beta of 1.10.
Sherwin-Williams (NYSE:SHW – Get Free Report) last posted its quarterly earnings data on Tuesday, April 28th. The specialty chemicals company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.08. Sherwin-Williams had a return on equity of 64.55% and a net margin of 10.86%.The firm had revenue of $5.67 billion for the quarter, compared to the consensus estimate of $5.56 billion. During the same quarter in the previous year, the business earned $2.25 EPS. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. Sherwin-Williams has set its FY 2026 guidance at 11.500-11.900 EPS. On average, equities analysts forecast that The Sherwin-Williams Company will post 11.78 earnings per share for the current year.
Sherwin-Williams Announces Dividend The firm also recently declared a quarterly dividend, which was paid on Friday, June 5th. Stockholders of record on Friday, May 22nd were given a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, May 22nd. Sherwin-Williams’s dividend payout ratio is currently 30.71%.
Wall Street Analyst Weigh In A number of equities analysts have recently weighed in on SHW shares. Weiss Ratings cut Sherwin-Williams from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday. Citigroup initiated coverage on shares of Sherwin-Williams in a research report on Wednesday, June 24th. They issued an “overweight” rating on the stock. BMO Capital Markets increased their target price on shares of Sherwin-Williams from $355.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, July 6th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $405.00 target price (up from $391.00) on shares of Sherwin-Williams in a research note on Wednesday, July 8th. Finally, UBS Group cut shares of Sherwin-Williams from a “buy” rating to a “neutral” rating and dropped their price target for the company from $385.00 to $330.00 in a research report on Tuesday, June 2nd. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Sherwin-Williams presently has a consensus rating of “Moderate Buy” and an average target price of $374.38.
View Our Latest Stock Report on SHW
Sherwin-Williams Company Profile (Free Report)
Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.
The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.
Featured Articles Five stocks we like better than Sherwin-Williams Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHW – Free Report).
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.
Current Setup and Live Chart USD/NOK is currently trading within the context of two dominant macro themes: rising global energy prices and US dollar resilience. The Norwegian crude is gaining support due to Norway’s positioning as one of Europe’s largest oil and gas producers. At the same time, the US dollar retains support from safe-haven demand driven by a renewal of the U.S.-Iran conflict and the closure of the Strait of Hormuz, which poses the risk of a return of the oil shock risk premium that hit financial markets in March.
Higher oil prices support Norway’s export outlook and increase the country’s revenues, leading to a strengthening of the Krone. This factor offsets US dollar strength. This week’s price action in USD/NOK will depend on which currency gains the most from the current geopolitical risk premium, since it creates demand for both currencies.
USD/NOK Macro Drivers 1) Higher Oil Prices
Norway’s status as one of the world’s largest crude and natural gas exporters puts it in a position to benefit from higher oil prices. Most of this oil wealth goes into the sovereign wealth fund, and higher oil prices increase the fund’s contributions. Furthermore, higher oil prices increase the country’s export revenues, fiscal balances, and trade surplus, all of which serve as a direct tailwind for the Krone. But we must also recognize that where geopolitical risk premium has driven up oil prices, there will be safe-haven demand for the U.S. dollar, which helps offset the strength of the Norwegian Krone.
2) Fed Policy
Despite the Federal Reserve no longer providing forward guidance and making policy decisions based on macroeconomic data, markets continue to price in the bank’s projected hawkish trajectory. This is resulting in higher U.S. Treasury yields. The reduction of U.S. Treasury yields provides global demand for U.S. generative assets. It attracts institutional capital and maintains U.S. dollar strength. This has been the factor that has kept the USD/NOK supported despite the strengthening impact of higher oil prices on the Krone.
3) Hawkish Norges Bank
Despite a cooling in consumer inflation, Norway’s central bank remains cautious about policy easing. This is despite the cooling of consumer inflation. Still, not to the levels where the Norges Bank would consider a dovish change in its policy tone. Norway’s core consumer price index report for June, as released by Statistisk Sentralbyra (Statistics Norway), showed an easing of local inflation by more than anticipated (2.7% actual vs 3.1% prior). Overall, the CPI showed a 0.2% month-on-month reduction. The Norges Bank’s cautious policy stands in contrast to the easing path many developed-market central banks have already adopted.
Price Catalysts for the Week 1) Brent crude prices: Oil prices remain the primary price catalyst for the USD/NOK. Any further gains in Brent crude would likely strengthen the Norwegian krone, but not by much, as the safe-haven demand for the greenback remains intact.
2) US Treasury yields: Despite a cooling of the June Consumer Price Index and Producer Price Index prints, US bond yields remain high. This is because the CPI and PPI data captured activity in June, when the ceasefire was holding. It does not reflect the return of the geopolitical risk premium in July (the current month), which is why traders are still pricing inflationary trends into the US 10-year bond yield. However, a decline in yields could allow the krone to outperform the greenback.
3) Norges Bank communication: Markets will monitor commentary from the Norges Bank regarding local inflation and future interest-rate policy. For a bank that is notoriously slow in adopting any changes in monetary policy pathway, any commentary that points to interest rate changes can produce a move on the NOK.
USD/NOK Forecast Scenarios Base case: Mild bearishness is expected due to the support that higher oil prices will grant to the Norwegian Krone. However, safe-haven dollar demand will provide an offsetting contrast that will limit the USD/NOK’s downside push.
Bull case: The US Dollar gains from rising US bond yields and stronger US economic data. The overriding impact of these drivers will only allow the USD to flourish at the expense of the Krone as oil prices decline and commodity support for the NOK weakens.
Bear case: a further rise in Brent crude (>$100 per barrel), alongside softer US inflation and falling bond yields, allows the commodity strength of the Krone to shine through. In this circumstance, whatever safe-haven demand for the USD that is available will be too weak to override the weakening macro fundamentals mentioned above.
USD/NOK Technical Outlook The decline in the USD/NOK looks set to test the 9.6207 support level. If this level fails to hold firm, the resulting downside move will reclaim the 9.4682 support level, which houses the former lows of 12 February and 23 March 2026. A further breakdown of this support lines up a move to test the 9.3606 support, which forms the neckline of the previous rounded bottom pattern.
Fig 1: USD/NOK daily chart showing key price levels (snapshot taken on 19 July 2026) However, a bounce on the 9.6207 support will have to uncap the prior highs of late March/early April at 9.7956, exposing the 30 June high at 9.9302. If this resistance is broken, the recovery trend continues, with 10.1179 (16 January high) lining up as the next upside target.
Chicago Partners Investment Group LLC purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 10,756 shares of the biopharmaceutical company’s stock, valued at approximately $535,000.
Other institutional investors have also added to or reduced their stakes in the company. Morgan Stanley grew its position in shares of Royalty Pharma by 25.2% during the 4th quarter. Morgan Stanley now owns 55,274,069 shares of the biopharmaceutical company’s stock valued at $2,135,790,000 after purchasing an additional 11,110,115 shares in the last quarter. Capital International Investors raised its holdings in Royalty Pharma by 14.3% during the 4th quarter. Capital International Investors now owns 31,104,309 shares of the biopharmaceutical company’s stock valued at $1,201,870,000 after buying an additional 3,891,615 shares during the last quarter. Norges Bank purchased a new position in shares of Royalty Pharma in the fourth quarter valued at about $131,923,000. Qube Research & Technologies Ltd raised its stake in shares of Royalty Pharma by 737.3% during the third quarter. Qube Research & Technologies Ltd now owns 2,481,771 shares of the biopharmaceutical company’s stock valued at $87,557,000 after acquiring an additional 2,185,366 shares during the last quarter. Finally, Millennium Management LLC raised its stake in shares of Royalty Pharma by 379.2% during the third quarter. Millennium Management LLC now owns 2,235,133 shares of the biopharmaceutical company’s stock valued at $78,855,000 after acquiring an additional 1,768,702 shares during the last quarter. Hedge funds and other institutional investors own 54.35% of the company’s stock.
Insiders Place Their Bets In other Royalty Pharma news, Director Gregory Norden sold 3,045 shares of the company’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $53.00, for a total transaction of $161,385.00. Following the transaction, the director owned 191,803 shares in the company, valued at approximately $10,165,559. This represents a 1.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Christopher Hite sold 100,000 shares of the firm’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $56.52, for a total transaction of $5,652,000.00. Following the sale, the executive vice president directly owned 459,399 shares in the company, valued at approximately $25,965,231.48. The trade was a 17.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 427,800 shares of company stock valued at $23,333,723. 18.84% of the stock is currently owned by corporate insiders.
Royalty Pharma Trading Down 0.6% NASDAQ RPRX opened at $58.18 on Friday. The stock has a market cap of $33.50 billion, a P/E ratio of 39.58, a P/E/G ratio of 10.30 and a beta of 0.43. The stock’s fifty day moving average price is $55.01 and its 200-day moving average price is $48.52. Royalty Pharma PLC has a 12 month low of $34.08 and a 12 month high of $59.44. The company has a current ratio of 2.66, a quick ratio of 2.66 and a debt-to-equity ratio of 0.86.
Royalty Pharma (NASDAQ:RPRX – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The biopharmaceutical company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.08. Royalty Pharma had a net margin of 33.88% and a return on equity of 29.25%. The business had revenue of $630.58 million during the quarter, compared to analyst estimates of $881.69 million. As a group, equities analysts forecast that Royalty Pharma PLC will post 5.18 EPS for the current fiscal year.
Analyst Ratings Changes Several analysts recently issued reports on RPRX shares. Weiss Ratings cut Royalty Pharma from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 15th. Morgan Stanley lifted their price target on shares of Royalty Pharma from $61.00 to $63.00 and gave the company an “overweight” rating in a report on Friday, April 10th. UBS Group lifted their target price on shares of Royalty Pharma from $51.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, April 21st. JPMorgan Chase & Co. boosted their price target on shares of Royalty Pharma from $50.00 to $58.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Finally, Citigroup increased their price target on shares of Royalty Pharma from $50.00 to $66.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Seven investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $56.57.
View Our Latest Stock Report on RPRX
About Royalty Pharma (Free Report)
Royalty Pharma plc is a specialty finance company that acquires biopharmaceutical royalty interests and provides non-dilutive financing to drug developers and rights holders. The firm purchases future royalty streams, milestone-contingent payments and other revenue rights linked to approved and late-stage pharmaceutical and biotechnology products. By paying upfront consideration for these rights, Royalty Pharma seeks to generate long-term cash flows tied to the commercial performance of a diversified portfolio of medicines.
The company’s transaction structures include outright royalty purchases, structured financings and milestone arrangements tailored to the needs of innovator companies, academic institutions and investors.
Featured Articles Five stocks we like better than Royalty Pharma Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Royalty Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Royalty Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEFifth Third Bancorp Grows Stake in Alcoa $AA
NEXT HEADLINE »Chicago Partners Investment Group LLC Invests $505,000 in AptarGroup, Inc. $ATR
More than a year after the federal government renewed a push toward nuclear energy, the industry is building momentum thanks to a streamlined process for reactor authorization, an ambitious goal of 300 additional gigawatts of capacity by 2050, and more. The timing is crucial, as AI electricity demand continues to grow and low-carbon energy generation via nuclear facilities is particularly appealing in these contexts.
To be sure, challenges remain: sourcing the high-assay low-enriched uranium (HALEU) necessary for some next-gen reactors is difficult, and supply chain and manufacturing capacity limitations, workforce shortages, and the licensing process can all hold up the industry's capabilities to deliver nuclear energy quickly. Still, as the industry continues to evolve and grow, a number of exchange-traded funds (ETFs) can expose investors to the many potential growth opportunities in the nuclear industry. Now may be a good time to explore these options, as a sell-off in the industry in 2026 after a previous successful run can present buy-in opportunities.
Get NLR alerts:
A Selective Basket of Global Nuclear StocksVanEck Uranium and Nuclear ETF Today
NLR
VanEck Uranium and Nuclear ETF
$104.20 -0.47 (-0.45%)
As of 07/17/2026 04:10 PM Eastern
52-Week Range$101.92▼
$168.12Dividend Yield3.03%
Assets Under Management$3.73 billion
The VanEck Uranium and Nuclear ETF NYSEARCA: NLR is one of the oldest nuclear industry ETFs on the market, having launched in the summer of 2007. The fund's staying power may be due to its broad strategy within the industry, allowing access to the full nuclear power generation process from the sourcing and production of input materials to companies operating power plants and more.
NLR achieves this mix despite its fairly small basket of 32 stocks. With a targeted portfolio like this, investors should expect that some names will receive sizable allocations, and indeed, the largest positions here do range up to 8% or more. Still, given its global focus, NLR is able to funnel its assets into the most stable, highest-performance nuclear stocks available worldwide, aiming for both breadth and quality.
Like many nuclear funds, NLR's year-to-date (YTD) performance is in the red: the ETF has declined by almost 12% in 2026. This valuation reset across the industry could provide an opportunity, although investors must be willing to accept NLR's 0.56% expense ratio while they wait for the momentum to build again.
A Unique Play on Uranium Miners With a Commodities TwistSprott Uranium Miners ETF Today
URNM
Sprott Uranium Miners ETF
$48.22 -0.55 (-1.13%)
As of 07/17/2026 04:10 PM Eastern
52-Week Range$43.10▼
$84.95Assets Under Management$1.73 billion
For a more targeted play on uranium itself, investors might consider the Sprott Uranium Miners ETF NYSEARCA: URNM. This fund invests primarily in companies involved in the uranium mining industry, including those that explore, develop, produce, or hold physical uranium. This industry is a niche one, and URNM has only 31 holdings based on a global screen. Given the significant overlap between URNM's portfolio and NRL's holdings, it's unlikely that investors would want to hold both funds at the same time.
Three positions in URNM's basket make up nearly half of the fund's total assets, collectively. These include uranium providers Cameco Corp. NYSE: CCJ and NexGen Energy NYSE: NXE, but the third stands out: it is a position in the Sprott Physical Uranium Trust, which holds physical uranium. Thus, URNM is in part a commodities play on uranium itself. This may help to explain why the fund is somewhat more expensive than several of its nuclear peers, with an expense ratio of 0.75%.
Despite its YTD decline, URNM offers a dividend yield of 2.59%, a passive income perk even as the nuclear industry is in the midst of a reset.
An Alternative Approach to Uranium With a Standout Dividend YieldGlobal X Uranium ETF Today
URA
Global X Uranium ETF
$38.73 -0.38 (-0.97%)
As of 07/17/2026 04:10 PM Eastern
52-Week Range$35.64▼
$62.28Dividend Yield5.37%
Assets Under Management$5.38 billion
A competitor of URNM, the Global X Uranium ETF NYSEARCA: URA also focuses on the material essential for nuclear power. However, URA accesses uranium via shares of companies involved in mining and production, rather than through any type of direct investment in the commodity itself. URA has the broadest portfolio of these three ETFs, with about 56 holdings from developed markets around the world. Still, it is, in some ways, also the most concentrated: Cameco shares make up nearly a quarter of the fund.
URA's expense ratio of 0.69% lies between the two funds' fees above, and it has a solid asset base of $5.7 billion and a hearty trading volume to match. This makes the fund appealing to investors seeking the flexibility to make frequent trades without worrying about liquidity. It may also reflect the ETF's strong dividend yield of 5.26%. While UFA has also slipped so far this year, it has held up better than the other uranium-focused funds on this list.
Should You Invest $1,000 in VanEck Uranium and Nuclear ETF Right Now?Before you consider VanEck Uranium and Nuclear ETF, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VanEck Uranium and Nuclear ETF wasn't on the list.
While VanEck Uranium and Nuclear ETF currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
D.A. Davidson & CO. boosted its holdings in shares of Carrier Global Corporation (NYSE:CARR – Free Report) by 8.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 105,123 shares of the company’s stock after acquiring an additional 8,097 shares during the period. D.A. Davidson & CO.’s holdings in Carrier Global were worth $5,919,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. YANKCOM Partnership increased its stake in shares of Carrier Global by 78.5% during the fourth quarter. YANKCOM Partnership now owns 473 shares of the company’s stock valued at $25,000 after purchasing an additional 208 shares in the last quarter. Torren Management LLC bought a new stake in shares of Carrier Global in the 4th quarter worth approximately $25,000. True Wealth Design LLC boosted its position in shares of Carrier Global by 723.7% in the 4th quarter. True Wealth Design LLC now owns 486 shares of the company’s stock worth $26,000 after purchasing an additional 427 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new stake in shares of Carrier Global in the 4th quarter worth approximately $27,000. Finally, Board of the Pension Protection Fund bought a new position in Carrier Global during the 4th quarter valued at approximately $32,000. Institutional investors own 91.00% of the company’s stock.
Carrier Global Price Performance Shares of CARR opened at $68.71 on Friday. Carrier Global Corporation has a twelve month low of $50.24 and a twelve month high of $81.09. The company has a market capitalization of $57.07 billion, a P/E ratio of 45.20, a price-to-earnings-growth ratio of 2.75 and a beta of 1.31. The firm has a 50 day moving average of $68.27 and a 200 day moving average of $62.64. The company has a quick ratio of 0.75, a current ratio of 1.05 and a debt-to-equity ratio of 0.76.
Carrier Global (NYSE:CARR – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.06. The business had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.01 billion. Carrier Global had a return on equity of 14.81% and a net margin of 5.99%.The firm’s quarterly revenue was up 2.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.65 EPS. Carrier Global has set its FY 2026 guidance at 2.800-2.800 EPS. As a group, equities research analysts anticipate that Carrier Global Corporation will post 2.79 earnings per share for the current fiscal year.
Carrier Global Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 10th. Investors of record on Tuesday, July 21st will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 1.4%. The ex-dividend date is Tuesday, July 21st. Carrier Global’s dividend payout ratio (DPR) is presently 63.16%.
Analyst Ratings Changes CARR has been the subject of a number of recent research reports. Evercore lifted their price objective on Carrier Global from $75.00 to $85.00 in a research note on Friday, May 1st. BNP Paribas Exane began coverage on Carrier Global in a research note on Tuesday, April 14th. They issued a “neutral” rating and a $62.00 target price on the stock. Weiss Ratings upgraded Carrier Global from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, April 22nd. JPMorgan Chase & Co. raised their price target on Carrier Global from $63.00 to $67.00 and gave the company a “neutral” rating in a report on Thursday, May 14th. Finally, Sanford C. Bernstein assumed coverage on Carrier Global in a research report on Tuesday, June 9th. They issued a “market perform” rating and a $75.00 price target for the company. Twelve research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Carrier Global currently has an average rating of “Moderate Buy” and a consensus price target of $73.51.
View Our Latest Report on CARR
About Carrier Global (Free Report)
Carrier Global Corporation is a leading global provider of heating, ventilation and air conditioning (HVAC), refrigeration, fire and security, and building automation solutions. The company designs, manufactures and sells a broad portfolio of products that includes air conditioners, furnaces, heat pumps, chillers, rooftop units, commercial refrigeration systems, fire and smoke detection and suppression systems, security sensors and access controls, and a range of building controls and analytics software.
Recommended Stories Five stocks we like better than Carrier Global Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding CARR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Carrier Global Corporation (NYSE:CARR – Free Report).
Receive News & Ratings for Carrier Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carrier Global and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAIA Group Ltd Has $462.30 Million Holdings in iShares Russell 2000 ETF $IWM
NEXT HEADLINE »Bessemer Group Inc. Raises Stock Holdings in Advanced Energy Industries, Inc. $AEIS
FuelCell Energy, Inc. (NASDAQ:FCEL – Get Free Report)’s share price traded up 9.1% during trading on Friday . The company traded as high as $18.81 and last traded at $18.83. Approximately 3,834,039 shares changed hands during mid-day trading, a decline of 43% from the average daily volume of 6,723,344 shares. The stock had previously closed at $17.26.
Key Stories Impacting FuelCell Energy Here are the key news stories impacting FuelCell Energy this week:
Positive Sentiment: UBS raised its price target on FuelCell Energy to $27, saying recent deals with Fit Energy and Siemens could support about 45% upside and improve the company’s growth outlook. UBS Raises Its FuelCell Energy Stock Forecast With a $27 Stock Price Target Positive Sentiment: FuelCell Energy’s Siemens partnership is drawing attention because it targets commercial projects of 100 MW and above, which management has said is the scale needed to turn EBITDA positive. FuelCell Just Landed the Deal That Could Finally Turn It Profitable Neutral Sentiment: Recent market coverage comparing FCEL with other energy stocks has kept the company in the spotlight, but these articles are mainly commentary rather than new company-specific catalysts. Is FuelCell Energy (FCEL) Stock Outpacing Its Oils-Energy Peers This Year? Neutral Sentiment: Additional hydrogen-stock roundup pieces added sector attention, but they do not appear to contain a major new catalyst specific to FuelCell Energy. Hydrogen Stocks To Watch Today – July 15th Negative Sentiment: Some articles note that FCEL and peers had a sharp recent selloff, highlighting ongoing volatility and investor concern about execution and profitability. Bloom (BE) vs. FuelCell (FCEL): Which Energy Stock Is the Better Buy after This Week’s Selloff? Analysts Set New Price Targets A number of analysts have recently issued reports on FCEL shares. Jefferies Financial Group upgraded FuelCell Energy from a “hold” rating to a “buy” rating and increased their target price for the company from $16.00 to $24.00 in a report on Friday, June 26th. Wells Fargo & Company lifted their price target on FuelCell Energy from $6.00 to $8.00 and gave the company an “underweight” rating in a report on Tuesday, June 16th. Weiss Ratings raised FuelCell Energy from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 20th. Canaccord Genuity Group increased their price objective on FuelCell Energy from $12.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, June 9th. Finally, KeyCorp restated a “sector weight” rating on shares of FuelCell Energy in a research report on Tuesday, June 9th. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $22.83.
Get Our Latest Analysis on FuelCell Energy
FuelCell Energy Trading Up 7.2% The stock has a market cap of $1.25 billion, a price-to-earnings ratio of -2.82 and a beta of 2.31. The company has a debt-to-equity ratio of 0.18, a quick ratio of 7.20 and a current ratio of 8.59. The company’s 50 day simple moving average is $22.03 and its two-hundred day simple moving average is $13.00.
FuelCell Energy (NASDAQ:FCEL – Get Free Report) last released its earnings results on Monday, June 8th. The energy company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.52 by ($1.05). FuelCell Energy had a negative return on equity of 15.90% and a negative net margin of 132.41%.The company had revenue of $35.59 million during the quarter, compared to analysts’ expectations of $40.47 million. During the same quarter in the previous year, the company earned ($1.79) EPS. Research analysts expect that FuelCell Energy, Inc. will post -1.84 EPS for the current fiscal year.
Insider Activity In related news, EVP Shankar Achanta sold 2,500 shares of FuelCell Energy stock in a transaction on Monday, July 6th. The stock was sold at an average price of $28.71, for a total transaction of $71,775.00. Following the completion of the sale, the executive vice president owned 2,618 shares of the company’s stock, valued at approximately $75,162.78. This trade represents a 48.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 5.46% of the company’s stock.
Institutional Inflows and Outflows Several hedge funds have recently bought and sold shares of FCEL. Kestra Advisory Services LLC bought a new stake in shares of FuelCell Energy in the 4th quarter valued at approximately $29,000. Caitong International Asset Management Co. Ltd raised its position in FuelCell Energy by 1,316.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 7,618 shares of the energy company’s stock valued at $59,000 after acquiring an additional 7,080 shares in the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in FuelCell Energy during the fourth quarter valued at approximately $78,000. Franklin Resources Inc. acquired a new stake in FuelCell Energy in the fourth quarter valued at approximately $84,000. Finally, Optiver Holding B.V. acquired a new stake in FuelCell Energy in the first quarter valued at approximately $88,000. 42.78% of the stock is owned by institutional investors and hedge funds.
About FuelCell Energy (Get Free Report)
FuelCell Energy, Inc (NASDAQ: FCEL) is a publicly traded company that designs, manufactures and operates turnkey molten carbonate fuel cell power plants. These stationary, on-site energy solutions generate electricity and heat through an electrochemical process that combines natural gas or biogas with oxygen, producing power with lower greenhouse gas emissions than traditional fossil fuel-based generation. The company’s fuel cell technology is engineered for continuous, baseload operation and can be integrated into microgrid architectures and industrial power systems to provide reliable, around-the-clock energy.
The company’s core product suite, marketed under the SureSource brand, encompasses both power generation and integrated carbon capture or hydrogen production capabilities.
Further Reading Five stocks we like better than FuelCell Energy Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Receive News & Ratings for FuelCell Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FuelCell Energy and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINERohm (OTCMKTS:ROHCY) Shares Gap Down – What’s Next?
NEXT HEADLINE »Alpha Tau Medical (NASDAQ:DRTS) Trading 7.1% Higher – Here’s Why
Copeland Capital Management LLC boosted its stake in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 857.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 52,112 shares of the semiconductor company’s stock after acquiring an additional 46,671 shares during the quarter. Copeland Capital Management LLC’s holdings in Lam Research were worth $11,134,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. State Street Corp raised its position in shares of Lam Research by 0.4% during the 3rd quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company’s stock valued at $8,024,684,000 after acquiring an additional 265,805 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Lam Research by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 33,747,368 shares of the semiconductor company’s stock worth $5,764,117,000 after purchasing an additional 126,613 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Lam Research by 7.7% during the 4th quarter. Invesco Ltd. now owns 22,821,354 shares of the semiconductor company’s stock worth $3,906,559,000 after buying an additional 1,638,406 shares during the last quarter. Norges Bank bought a new stake in shares of Lam Research during the 4th quarter worth approximately $3,645,427,000. Finally, Price T Rowe Associates Inc. MD lifted its stake in Lam Research by 352.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after acquiring an additional 10,666,540 shares during the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.
Lam Research Stock Down 2.4% Shares of NASDAQ LRCX opened at $313.30 on Friday. The stock has a market capitalization of $391.80 billion, a P/E ratio of 59.11, a PEG ratio of 1.85 and a beta of 1.80. The stock’s fifty day moving average is $339.57 and its 200 day moving average is $268.94. Lam Research Corporation has a 52 week low of $90.93 and a 52 week high of $438.50. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.77 and a current ratio of 2.54.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.11. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The business had revenue of $5.84 billion during the quarter, compared to analysts’ expectations of $5.70 billion. During the same quarter in the prior year, the business posted $1.04 earnings per share. Lam Research’s revenue was up 23.8% compared to the same quarter last year. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Sell-side analysts forecast that Lam Research Corporation will post 5.68 earnings per share for the current fiscal year.
Lam Research Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Wednesday, July 8th. Investors of record on Wednesday, June 17th were given a dividend of $0.26 per share. The ex-dividend date was Wednesday, June 17th. This represents a $1.04 annualized dividend and a dividend yield of 0.3%. Lam Research’s dividend payout ratio (DPR) is currently 19.62%.
Analyst Upgrades and Downgrades LRCX has been the subject of a number of research analyst reports. Morgan Stanley lifted their price objective on shares of Lam Research from $331.00 to $404.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Deutsche Bank Aktiengesellschaft upped their target price on Lam Research from $300.00 to $325.00 and gave the company a “buy” rating in a research report on Thursday, April 23rd. Weiss Ratings lowered Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a report on Thursday, May 14th. Berenberg Bank lifted their target price on Lam Research from $265.00 to $335.00 and gave the stock a “buy” rating in a report on Thursday, April 23rd. Finally, Citigroup reissued a “buy” rating and issued a $450.00 target price (up from $315.00) on shares of Lam Research in a research report on Wednesday, June 17th. Twenty-eight investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $358.67.
Get Our Latest Stock Analysis on LRCX
Insider Activity In related news, Director Eric Brandt sold 54,500 shares of Lam Research stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This trade represents a 21.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 6,010 shares of the business’s stock in a transaction that occurred on Monday, April 27th. The shares were sold at an average price of $258.66, for a total transaction of $1,554,546.60. Following the transaction, the insider owned 53,205 shares of the company’s stock, valued at approximately $13,762,005.30. This represents a 10.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 104,621 shares of company stock worth $33,804,737. Insiders own 0.31% of the company’s stock.
About Lam Research (Free Report)
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
See Also Five stocks we like better than Lam Research Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp reduced its holdings in shares of Workday, Inc. (NASDAQ:WDAY – Free Report) by 7.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,256,446 shares of the software maker’s stock after selling 96,165 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.49% of Workday worth $163,238,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in the business. Brighton Jones LLC grew its position in shares of Workday by 230.2% in the fourth quarter. Brighton Jones LLC now owns 4,005 shares of the software maker’s stock valued at $1,033,000 after purchasing an additional 2,792 shares during the last quarter. Empowered Funds LLC raised its position in shares of Workday by 12.1% during the 1st quarter. Empowered Funds LLC now owns 11,142 shares of the software maker’s stock worth $2,602,000 after purchasing an additional 1,206 shares during the last quarter. Geneos Wealth Management Inc. raised its position in shares of Workday by 211.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 187 shares of the software maker’s stock worth $44,000 after purchasing an additional 127 shares during the last quarter. Sivia Capital Partners LLC purchased a new stake in Workday in the 2nd quarter valued at approximately $281,000. Finally, NewEdge Advisors LLC lifted its stake in Workday by 32.0% in the 2nd quarter. NewEdge Advisors LLC now owns 6,597 shares of the software maker’s stock valued at $1,583,000 after buying an additional 1,600 shares in the last quarter. 89.81% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity In other news, major shareholder David A. Duffield sold 107,500 shares of the stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $122.04, for a total transaction of $13,119,300.00. Following the transaction, the insider directly owned 105,049 shares in the company, valued at $12,820,179.96. This represents a 50.58% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Enslin sold 5,374 shares of the business’s stock in a transaction that occurred on Sunday, July 5th. The shares were sold at an average price of $134.90, for a total transaction of $724,952.60. Following the completion of the sale, the insider owned 239,469 shares of the company’s stock, valued at approximately $32,304,368.10. The trade was a 2.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 875,020 shares of company stock valued at $113,938,503 in the last 90 days. 18.64% of the stock is currently owned by insiders.
Workday Price Performance Shares of NASDAQ:WDAY opened at $144.78 on Friday. The company has a market cap of $35.76 billion, a P/E ratio of 45.24, a P/E/G ratio of 1.55 and a beta of 1.11. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.30. Workday, Inc. has a 52 week low of $110.36 and a 52 week high of $249.85. The business has a fifty day simple moving average of $131.46 and a 200-day simple moving average of $144.55.
Workday (NASDAQ:WDAY – Get Free Report) last released its earnings results on Thursday, May 21st. The software maker reported $2.66 EPS for the quarter, beating the consensus estimate of $2.51 by $0.15. Workday had a return on equity of 14.75% and a net margin of 8.60%.The firm had revenue of $2.54 billion during the quarter, compared to analyst estimates of $2.52 billion. During the same period in the prior year, the firm posted $2.23 earnings per share. The business’s quarterly revenue was up 13.5% compared to the same quarter last year. Equities research analysts forecast that Workday, Inc. will post 5.34 EPS for the current year.
Analysts Set New Price Targets Several research firms have weighed in on WDAY. Monness Crespi & Hardt raised Workday from a “neutral” rating to a “buy” rating and set a $150.00 price target for the company in a research report on Thursday, June 25th. HC Wainwright set a $140.00 price objective on Workday in a research report on Wednesday, May 27th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Workday in a research note on Wednesday, June 17th. Summit Redstone set a $275.00 price objective on Workday in a research report on Wednesday, May 27th. Finally, Piper Sandler boosted their target price on shares of Workday from $135.00 to $145.00 and gave the company a “neutral” rating in a research note on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Workday has a consensus rating of “Moderate Buy” and an average price target of $184.00.
View Our Latest Research Report on WDAY
Workday Profile (Free Report)
Workday, Inc (NASDAQ: WDAY) is a provider of cloud-based enterprise applications focused on human capital management (HCM) and financial management. Founded in 2005 by Dave Duffield and Aneel Bhusri following their tenure at PeopleSoft, the company develops software-as-a-service solutions that help organizations manage workforce and financial processes in a unified, cloud-native environment. Workday’s platform emphasizes continuous updates, data security, and a configurable architecture aimed at large and mid-sized enterprises.
The company’s product portfolio centers on Workday Human Capital Management and Workday Financial Management, with additional offerings for payroll, talent management, workforce planning and analytics.
Featured Stories Five stocks we like better than Workday Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding WDAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Workday, Inc. (NASDAQ:WDAY – Free Report).
Receive News & Ratings for Workday Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Workday and related companies with MarketBeat.com's FREE daily email newsletter.
Investors choosing between Salesforce (CRM 0.86%) and Dell Technologies (DELL +1.27%) are weighing the merits of software-as-a-service (SaaS) against physical infrastructure in an era increasingly defined by artificial intelligence integration and cloud computing.
Salesforce focuses on customer relationship management (CRM) through its digital platform, while Dell provides the hardware and servers necessary to power modern computing. Both companies are adapting their business models to capture a larger share of enterprise spending.
The case for SalesforceSalesforce is a major player among tech stocks because of its dominance in customer relationship management. The company provides cloud-based software and AI tools that help businesses manage sales, marketing, and customer service on a single platform. A recent strategic move includes the June 2026 acquisition of Fin for nearly $3.6 billion to enhance its autonomous agent capabilities.
In its 2026 fiscal year (FY), revenue reached $41.5 billion, representing a growth of nearly 10% over the previous year. This revenue expansion contributed to a net income of $7.5 billion for the period. These figures indicate a net margin of 18%, reflecting the company's ability to convert sales into profit.
As of its January 2026 balance sheet, the company reported a debt-to-equity ratio of 0.3x. This ratio compares total debt to shareholder equity, while the current ratio of 0.8x measures its ability to cover short-term liabilities with short-term assets. Free cash flow, which is the cash remaining after operating costs and capital expenditures, reached $14.4 billion. Note that stock-based compensation (SBC) represented 23.4% of operating cash flow, which inflates reported cash generation since SBC is a non-cash expense added back in the cash flow statement.
The case for Dell TechnologiesDell provides a wide range of technology solutions, including personal devices, storage, and AI-focused infrastructure. The company serves a diverse global audience across commercial and consumer segments. Recently, it refined its North American distribution strategy by terminating its enterprise computing partnership with Arrow Electronics-owned Arrow Enterprise Computing Solutions.
For FY 2026, the company reported revenue of $113.5 billion, which is growth of nearly 19% compared to the prior year. This led to net income of $5.9 billion. This performance resulted in a net margin of 5% for the fiscal year.
As of its January 2026 balance sheet, the current ratio was 0.9x. The debt-to-equity ratio was -12.8x, which indicates that total liabilities exceed shareholder equity. This negative value is primarily attributed to Dell’s aggressive stock repurchase initiative, which significantly reduced the outstanding share count. Free cash flow for the year reached $8.6 billion, representing the cash generated from operations minus money spent on capital assets.
Risk profile comparisonSalesforce faces significant competition from established enterprise vendors like Microsoft and various AI-native startups. The company is currently engaged in an antitrust lawsuit against Microsoft regarding the bundling of collaboration software. Additionally, it faces legal scrutiny through a class action investigation and must manage persistent cybersecurity threats to its cloud data.
Dell Technologies relies heavily on third-party vendors and contract manufacturers in Asia, creating potential supply chain vulnerabilities. It faces intense pressure in the hardware market. The company also faces litigation from XTX Markets, and must defend against ongoing cyber threats targeting its supply chain.
Valuation comparisonSalesforce currently trades at a significantly lower earnings multiple than Dell, although Dell offers a more attractive valuation when looking at total sales.
MetricSalesforceDell TechnologiesSector BenchmarkForward P/E12.1x21.7x33.8xP/S ratio3.4x2.3xn/aSector benchmark uses the SPDR XLK sector ETF. Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Artificial intelligence has impacted the share price performance for both Salesforce and Dell this year, but in exactly opposite ways. Wall Street’s fear that AI would eat into Salesforce’s CRM business caused a sell-off that drove shares to a 52-week low of $146.32 in June. Meanwhile, AI’s need for massive amounts of computing hardware resulted in a surge in sales that powered Dell’s stock to a 52-week high of $469.47 that same month.
It would seem Dell is obviously the better stock to buy. After all, the company reported record revenue of $43.8 billion for its fiscal first quarter, ended May 1, which represents an impressive 88% year-over-year increase. Dell’s soaring sales contributes to the stock’s low P/S ratio.
However, Salesforce’s business does not appear impacted by AI. In reality, revenue in its fiscal first quarter, ended April 30, rose 13% year over year to $11.1 billion. The company has responded to the AI threat by launching its own AI solutions tailored specifically to CRM, and that contributed to its decision to acquire Fin.
Because of Wall Street’s sell-off, Salesforce is the better stock to buy. Its low forward earnings multiple suggests it is at a compelling share price, and once investors begin to realize AI is not a danger to its business, Salesforce shares will be poised to rise.
AIA Group Ltd purchased a new position in Applied Materials, Inc. (NASDAQ:AMAT – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 36,720 shares of the manufacturing equipment provider’s stock, valued at approximately $12,551,000.
A number of other large investors have also modified their holdings of AMAT. Cornerstone Financial Management LLC purchased a new position in Applied Materials in the fourth quarter valued at $25,000. Wilkerson Advisory Group LLC purchased a new stake in Applied Materials during the 4th quarter worth about $26,000. Financial Freedom LLC acquired a new stake in Applied Materials in the 1st quarter valued at about $28,000. Highline Wealth Partners LLC raised its position in Applied Materials by 48.7% in the 4th quarter. Highline Wealth Partners LLC now owns 116 shares of the manufacturing equipment provider’s stock valued at $30,000 after purchasing an additional 38 shares in the last quarter. Finally, Joseph Group Capital Management purchased a new position in shares of Applied Materials in the 4th quarter valued at about $31,000. Hedge funds and other institutional investors own 80.56% of the company’s stock.
Applied Materials News Summary Here are the key news stories impacting Applied Materials this week:
Positive Sentiment: Erste Group Bank raised its FY2026 and FY2027 earnings estimates for Applied Materials and reiterated a Buy rating, signaling confidence in the company’s growth outlook and AI-driven demand. Article link Positive Sentiment: Applied Materials CEO comments reinforcing the AI investment thesis may help support longer-term sentiment around the stock. Article link Neutral Sentiment: Zacks noted that AMAT has been drawing increased attention from investors, but the piece was mainly a stock-screening update rather than a new fundamental catalyst. Article link Neutral Sentiment: Recent commentary suggested Applied Materials may be trading above fair value after a strong multi-year run, which could limit upside even if earnings remain solid. Article link Negative Sentiment: A broad semiconductor selloff is pressuring AMAT along with peers like AMD and Intel, as the market rotates out of chip stocks and into other areas. Article link Insider Activity In other Applied Materials news, Director Thomas J. Iannotti sold 9,250 shares of the firm’s stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $599.77, for a total transaction of $5,547,872.50. Following the transaction, the director directly owned 40,559 shares of the company’s stock, valued at approximately $24,326,071.43. This trade represents a 18.57% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Timothy M. Deane sold 8,621 shares of Applied Materials stock in a transaction on Monday, June 15th. The shares were sold at an average price of $590.76, for a total transaction of $5,092,941.96. Following the completion of the transaction, the senior vice president owned 134,631 shares in the company, valued at approximately $79,534,609.56. This represents a 6.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 278,088 shares of company stock worth $169,654,805 over the last 90 days. 0.30% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In A number of equities analysts have recently commented on the company. Weiss Ratings reissued a “buy (b-)” rating on shares of Applied Materials in a research report on Wednesday, June 24th. UBS Group raised their target price on shares of Applied Materials from $570.00 to $705.00 and gave the company a “buy” rating in a report on Wednesday. Wall Street Zen upgraded shares of Applied Materials from a “hold” rating to a “buy” rating in a report on Saturday, May 23rd. Jefferies Financial Group increased their price objective on shares of Applied Materials from $510.00 to $770.00 and gave the company a “buy” rating in a research report on Friday, June 26th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Applied Materials from $400.00 to $515.00 and gave the company an “overweight” rating in a research report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $593.84.
Get Our Latest Stock Analysis on Applied Materials
Applied Materials Trading Down 5.6% NASDAQ:AMAT opened at $529.66 on Friday. The company has a market capitalization of $420.53 billion, a PE ratio of 49.73, a P/E/G ratio of 1.35 and a beta of 1.57. Applied Materials, Inc. has a 52-week low of $154.46 and a 52-week high of $739.67. The stock’s 50 day moving average price is $533.12 and its 200 day moving average price is $413.05. The company has a quick ratio of 1.80, a current ratio of 2.51 and a debt-to-equity ratio of 0.22.
Applied Materials (NASDAQ:AMAT – Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The manufacturing equipment provider reported $2.86 earnings per share for the quarter, beating analysts’ consensus estimates of $2.68 by $0.18. The company had revenue of $7.91 billion during the quarter, compared to analysts’ expectations of $7.68 billion. Applied Materials had a return on equity of 36.97% and a net margin of 29.31%.The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.39 earnings per share. Applied Materials has set its Q3 2026 guidance at 3.160-3.560 EPS. On average, research analysts anticipate that Applied Materials, Inc. will post 12.14 EPS for the current year.
Applied Materials Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Thursday, August 20th will be given a $0.53 dividend. The ex-dividend date is Thursday, August 20th. This represents a $2.12 annualized dividend and a yield of 0.4%. Applied Materials’s dividend payout ratio is 19.91%.
Applied Materials Profile (Free Report)
Applied Materials, Inc is a U.S.-based supplier of equipment, services and software used to manufacture semiconductor chips, flat panel displays and other advanced materials. Headquartered in Santa Clara, California, the company designs and sells capital equipment and related technologies that enable production of integrated circuits, display panels and materials used across the electronics supply chain.
Applied Materials’ offerings include process equipment and factory software that support critical steps in device fabrication, such as deposition, etch, implantation, inspection and metrology, as well as systems for packaging and advanced heterogeneous integration.
Featured Stories Five stocks we like better than Applied Materials Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Want to see what other hedge funds are holding AMAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Applied Materials, Inc. (NASDAQ:AMAT – Free Report).
Receive News & Ratings for Applied Materials Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Materials and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBessemer Group Inc. Grows Stake in FirstService Corporation $FSV
NEXT HEADLINE »AIA Group Ltd Takes Position in Parker-Hannifin Corporation $PH
JasmyCoin (JASMY) trades at around $0.0045. Trading volume has skyrocketed by over 300%. JasmyCoin (JASMY) has rised 3.66% in value, currently trading at $0.004532, with its trading volume skyrocketing 367%, settling at $25.86 million. The asset’s chart is printing a Double Top, two rejections at the same resistance level with sellers stepping in hard both times.
Also, the buyers have tried and failed to push to new highs, and that pattern carries a clear bearish message until proven otherwise. The neckline is the level that matters most right now. A confirmed break below it opens the door to increased downside momentum and a more sustained selloff.
If bulls reclaim the recent highs and break the multi-resistance area cleanly, the Double Top gets invalidated, and a steady rally of over 10% becomes a target. Moreover, the market sentiment of JASMY sits at a bearish bias until buyers reclaim resistance.
Will JasmyCoin Extend Its Gains or Lose Momentum? The four-hour trading session of JASMY displayed a positive trend, and its immediate resistance range might be at around $0.004605. If the bulls gained more traction, the upside pressure continues, and initiates the formation of the golden cross. Gradually, it would target a crucial price level above $0.0047.
On the contrary, once the bears take control of the JasmyCoin market, the risk of loss can be expected, with the price might retrace back to the support zone of $0.0044. A sustained correction on the downside triggers the death cross to unfold, and the potential bears may send the asset’s price below $0.004321.
In addition, JASMY’s Moving Average Convergence Divergence (MACD) and signal lines are above the zero line. It confirms that the short-term moving average is trading higher than its long-term average. The buyers have control of the macro market direction.
Any minor price drops could be a healthy pullback within an ongoing uptrend rather than a structural reversal. The primary market forces are working to push the price higher, and the path of least resistance remains upward.
The daily Relative Strength Index (RSI) value staying at 57.34 hints at a solid, bullish condition. As it is above the 50 midline, the upward price momentum is dominant, and buyers are driving the market action.
The reading is way below the overbought threshold; JasmyCoin is under no immediate pressure to exhaust its momentum. Notably, the buying pressure is strong and steady, suggesting it has the fuel to climb higher.
Crypto Market Highlights
Cardano (ADA) Nears a Falling Wedge Breakout: Can Bulls Spark a Strong Upside Move?
Content Writer | Crypto Enthusiast | Bridging Literature and Blockchain
